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THE ENTERIC UELIVERY OF MACROMOLECULES AND 
SUBSEQUENT IMMUNE RESPONSE IN THE CICHLID 
Oreochromis mossambicus. 
BY 
PAUL GEORGE JENKINS BSc. (Hons). 
ABSTRACT. 
Enhanced enteric delivery systems were examined in the cichlid 
Oreochromis mossambicus to evaluate the requirements for potential oral 
vaccination strategies in teleost fish. Human gamma globulin (HGG) was 
delivered enterically (orally or anally) to the intestine of O.mossambicus as a 
standard test antigen. The co"administration of the saponin Quillaja saponaria 
(Quil"A) was evaluated as a novel oral adjuvant,delivered with the antigen in a 
soluble form and also as a delivery vehicle in the form of micelles and immune-
stimulatory complexes (ISCOMS). HGG absorption across the intestine was 
monitored utilising sensitive immunocytochemical techniques which showed that 
the enterically delivered antigen was transcytosed in a temporally complex 
manner,underwent extensive interaction with the enterocytes and gut-associated 
lymphoid tissue (GALT) cells and was eventually transported to the vicinity of 
the irltestinal circulatory system Co"administration of Quil-A resulted in an 
increase in the HGG absorbecl;increased antigen localisation in the lamina 
propria and substantial interaction of the adjuvant with the enterocyte lumenal 
membranes. 
The levels of HGG absorbed into the plasma were directly quantified by 
enzyme-linked immunosorbent assay (ELISA) and showed that administration 
of Quil•A concurrently with HGG greatly increased absorption above levels 
observed without adjuvant in the delivery system. Western blotting and laser 
densitometry demonstrated that HGG was absorbed as both an intact 
macromolecular antigen and as fragmented epitopes of distinct molecular 
weights. The fragmentation of the enterically delivered HGG was modified by 
the delivery of Quil-A suggesting that manipulation of conformational aspects 
of the delivered antigen may be possible. The systemic and mucosal immune 
responses to HGG administration were monitored and enteric immunisation of 
antigen with Quil~A was found to be effective in increasing specific antibody 
levels in the plasma,bile and cutaneous mucus of immunised fish. 
Preliminary studies on the use of cholera toxin B-subunit,aluminium 
hydroxide and ammonium chloride shOwed that cholera toxin B-subunit acted to 
increase both level of absorbed antigen,after enteric delivery· and the subsequent 
immune response to HGG whereas the other two adji.lvants were unable to 
mediate any such responses. 
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CHAPTER 1 
INTRODUCllON 
1 
The epithelium of the gastrointestinal tract in vertebrates has an 
extensive surface area for the absorption of the digested food components 
needed for the normal nutritional requirements of the organism. Simultaneously 
it presents a barrier to large numbers of non-dietary antigens that continually 
pass along the alimentary tract and can potentially induce pathology. Most 
dietary components are broken down by digestive processes prior to 
absorption,thus most potential antigens in the gut never come into contact with 
the epithelial lining,as the lumenal contents are physically directed along a 
central course away from the epithelium. However,it has been demonstrated 
that a small but immunologically relevant quantity of antigen does gain access 
to the body tissues,often in an antigenically intact form (Walker,1981). 
As a consequence the vertebrate gut has evolved a local immune system 
mediated by the cells of the gut-associated lymphoid tissue (GALT) which are 
distributed along its length. This system is diversified and extremely complex 
involving a wide range of cellular and soluble factors,coordinating to maintain 
a state that is able to sample some lumenal antigens,exclude potential 
pathogens,carry out normal digestive and absorptive functions and allow a 
normal,beneficial,luminal bacterial ecosystem to co-exist with it. 
GAL T is more complex in evolutionarily recent vertebrates such as 
mammals than in lower vertebrates such as fish,where one of the major 
differences is an apparent lack of highly structured,organised lymphocyte 
populations. The nature of the underlying GALT is directly influenced by the 
2 
other aspects of the physiology of the alimentary tract such as the mode of 
nutrition of the species,which will have a major influence on gut passage times 
and hence on the eventual levels and qualitative status of any antigens that may 
be absorbed and come into contact with the GAL T cells. Fish have widely 
divergent nutritional strategies and this is effected in species specific differences 
in gut structure and function. 
Vertebrate intestines,including those of fish,have the capability to absorb 
a wide variety of antigens in a multitude of forms. This lends itself to the 
possibility of stimulating GALT cells via the oral delivery of antigenic substances 
and the production of oral vaccines. 
Oral delivery of antigen remains potentially the most convenient route of 
vaccination against a wide variety of pathogenic organisms,particularly those 
which gain access to the host organisms body via the mucosal surfaces,whether 
in humans,other mammals or fish. Oral delivery maximises the speed of 
administration of vaccine and local action at the site of infection for many 
pathogens yet minimises the stress to the recipient organism,which may be an 
important contributing factor in disease eg in furunculosis in fish. In fish,oral 
vaccination regimes may also reduce labour costs,time of vaccination and reduce 
problems of accessibility of stock (Ellis,1988). 
Oral vaccination studies in fish to date have largely utilised standard 
protein molecules as test antigens or actual derivatives from enteric (often 
bacterial) pathogens. Recent increases in intensive aquaculture practices have 
resulted in a potential requirement for the delivery of a variety of biologically 
active macromolecules. Oral delivery systems in more sophisticated aquaculture 
3 
practices may also allow delivery of other macromolecules such as 
chemotherapeutics,hormones and colouring agents (McLean and 
Donaldson, 1990;McLean,Donaldson,Dye and Souza, 1990). Such systems largely 
rely on the ability of the gastrointestinal tract of vertebrates,especially the distal 
regions,to absorb macromolecules that are antigenically defined and possibly 
immunogenic or wholly intact. Such macromolecules are then thought to 
interact with the underlying GALT and also via mediators with other lymphoid 
tissue to provide a relevant and protective immune response (Mestecky, 1987). 
Intact protein absorption,once thought to occur only in neonates, has 
been shown in adults of most classes of vertebrates and it appears that the 
capacity of the intestine to absorb macromolecules declines in adults but does 
not completely cease ie gut "closure" is not necessarily complete. Intact protein 
macromolecules are also absorbed across the gut of embryonic,larval,juvenile 
and adult fish by a variety of mechanisms often analogous to those more 
thoroughly investigated in mammalian systems. 
Macromolecules can be absorbed across the intestine by both 
transcellular and paracellular (intercellular) pathways. The precise mode of 
transport of an antigen across the intestine depends on several extraneous 
factors including,the nature of the antigen delivered,its dose and the presence 
of any modifying agents such as adjuvants. 
Intact protein absorption may,under normal physiological conditions, have 
several roles including transfer of passive immunity in neonates,a nutritional 
role,provision of a selective barrier for dietary antigens and an enteropancreatic 
enzyme recirculation system. However "artificial" delivery of macromolecules 
4 
in a vaccination protocol requires the triggering of an immune response beyond 
all the roles outlined above. The fate of an orally delivered antigen is not as 
straight-forward as the direct,rapid,production of a suitable protective immune 
response,often generated by intraperitoneal administration of the same antigen. 
Oral delivery of antigen can lead to the induction of a mucosal immune 
response (mediated by secretory IgA,in mammals,and lgM in fish) at the site of 
administration. It may also allow systemic priming,resultant immunological 
memory and a secretory immune response at other mucosae. However,oral 
delivery of antigens can also result in low mucosal responses,no viable disease 
protection and it can also induce a state of systemic unresponsiveness to the 
antigen (oral tolerance). Oral tolerance does not totally preclude some cell-
mediated immune responses per se but it does minimise the effectiveness of oral 
vaccination for some antigens. As such, oral vaccination regimens have been 
largely concerned with overcoming the problems associated with gastric 
destruction of antigens and the poor immune response sometimes elicited 
(Warren,Vogel and Chedid,1986;Ellis,1988). 
Mammalian vaccine design techniques employ a variety of strategies 
such as genetically recombinant organisms as both antigen carriers or direct 
immunogens,live bacterial organisms (avirulent but immunogenic strains or 
aromatic-dependents),cloned epitopal vaccines,enhanced delivery systems 
(adjuvants,liposomes and microencapsulated antigens) and targeting agents for 
specific intestinal factors (Curtiss,1990). Little is known of the true ability of 
orally delivered antigens to cross the intestine,interact with the local and 
systemic lymphoid tissue and elicit an immune response in fish. Fish vaccine 
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technology is more basic,as yet, but all of these approaches are being considered 
as candidates for the production of useful vaccines against bacterial pathogens. 
Current fish bacterial vaccines are largely confined to the delivery of crude 
cellular products en masse. 
As part of a broad study on GAL T and the absorption of enterically 
delivered antigens,carried out in this laboratory (Hart,1987;Doggett,1989) a 
number of aspects of macromolecular administration were examined. The 
specific aim of this study was: 
1) To increase knowledge of the uptake of antigens in a species of 
teleost fish after oral delivery,in terms of their mode of absorption,temporal 
fluctuations,quantity of absorption and certain qualitative aspects of their uptake. 
2) To gain some data on aspects of the interactions of orally delivered 
antigen with intestinal tissues and GALT. 
3) To modify the delivery of the antigens by a variety of novel methods 
such as the use of adjuvants. 
4) To monitor any subsequent immune response elicited. 
5) To develop and use a wide variety of technologies for the study of 
oral antigen delivery In fish including classical 
microscopy,histochemistry,immunohisto- and cyto-chemistry,analytical protein 
techniques (electrophoresis and blotting) and serological immunoassays such as 
ELlS A. 
The species of teleost used in this study was the cichlid Oreochromis 
mossambicus,chosen for a variety of reasons,including the previous 
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CHAPTER 2. LITERATURE REVIEW. 
This review is intended to discuss the variety of factors that can influence both 
the absorption of macromolecules delivered to the intestine and any subsequent 
immune responses generated,and the strategies currently being investigated as 
delivery systems for oral vaccination in mammals and fish. Previous studies have 
recently comprehensively reviewed mammalian and fish GALT (Hart,1987; 
Kagnoff, 1987;Nicklin, 1987;Hart, Wrathmell,Harris and Grayson,1988; Doggett, 
1989} and this literature review is not intended as a comprehensive discussion 
of these areas. 
2.1. THE STRUCTURE OF GALT. 
The normal mammalian gastrointestinal tract encounters a massive 
antigenic load during the course of its normal function,including a wide variety 
and quantity of dietary antigens and microorganisms. The gut has evolved a 
complex immune system reflecting this : the associated lymphoid tissues,in 
mammals, are larger than all other lymphoid tissues combined (Nicklin,1987). 
For example the GALT in the human small intestine consists of 10 10 IgA-
producing cells per metre of its length as well as almost 70% of the body's 
antigen-presenting cells (Curtiss, 1990) and these account for only two aspects of 
GAL Tfunction (Brandtzaeg,Thrane and Sollid, 1988;Schreiber and Walker,1988). 
The components of GALT can be divided into two major parts : 
organised lymphoid tissues such as the Peyer's patches, isolated lymphoid follicles 
and mesenteric lymph nodes and diffuse lymphoid tissue which is found 
scattered throughout the epithelium and the lamina propna 
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(Kagnoff,1987;Mowat,1987). A third putative population of functional 
immunocytes has been suggested - a transient population of cells inhabiting the 
intestinal lumen itself,but having a positive protective role (Heatley and 
Bienenstock, 1982). 
Peyer's patches are macroscopic aggregations of lymphoid tissue situated 
beneath a specialised membrane (Carlson and Owen, 1987) consisting of normal 
enterocytes interspersed by modified domed absorptive cells with few microvilli 
(M cells or follicle-associated epithelium (FAE),which allow GALT leucocytes 
to approach within 0.3J,£m of the luminal source of antigen (Marsh and 
Swift,1969;0wen and Jones,1974;Kagnoff,1987). 
Large lymph nodes lie within the mesentery and are identical to 
peripheral lymph nodes with thymus-dependent areas,primary follicles and 
germinal centres. These develop in parallel with the Peyer's patches and the 
presence of intestinal antigen is required for their development. Mammalian 
mesenteric lymph nodes are probably a primary site of contact between the 
intestinal and systemic lymphoid compartments (Chanana,Schaedeli,Hess and 
Cottier,1973;Barg and Draper,1975). Isolated lymphoid follicles are similar to 
Peyer's patches in possessing an overlying cuboidal epithelium with M-cells 
(Owen and Nemancic,1978). 
The diffuse mucosal lymphoid tissue is composed of an enormous number 
of cells. The normal lamina propria is infiltrated by a wide variety of leucocytes 
including lymphocytes,plasma cells,macrophages,eosinophils,basophils and mast 
cells. Lymphocytes,in the lamina propria, consist of approximately equal 
numbers ofT and B cells. However the most predominant cell is of the helper-
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T phenotype (60-80% of laminal T-cells)(Selby,Janossy and 
Jewell,1981;Selby,Janossy,Bofill and Jewell,1983) whereas 80-90% of the B 
lymphocytes are terminally differentiated and committed to IgA synthesis 
(Tseng,1984). 
The epithelium is the layer in closest contact with luminal antigen. In 
mammals 60% of the intraepithelialleucocytes (IEL's) are granulated and 15% 
have a "locomotor" aspect and are situated at the basement membrane or 
visualised passing across it (Toner,Carr and Wyburn,1971). The majority of 
epithelial leucocytes are T-cells the majority of which have the T 
cytotoxic/suppressor phenotype (Cerf-Bensussan,Scheenburger and Bhan,1984). 
Mammalian GAL T therefore consists of specialised absorptive structures 
(FAE and M-cells),normal absorptive enterocytes and both highly organised 
lymphoid structures and large numbers of diffuse lymphoid cells consisting of a 
wide variety of leucocyte-types often in unique numerical combinations 
(Bjerke,Brandtzaeg and Fausa,l988). 
Fish are the earliest vertebrates which have a well developed immune 
system characterised by both cellular and humoral branches,endowed with 
specificity (McCumber,Sigel,Trauger and Cuchens,1982) and,in some cases 
memory (Cooper,1976;McCumber et al.,1982;Rijkers,l982). GALT is found in 
a number of evolutionarily diverse species of fish (Hart et al.,1988). Primitive 
fish,such as the cyclostomes have intraepithelialleucocytes with a few lymphoid 
accumulations (Tomonaga,Hirokane and Awaya,1973) while the anterior gut of 
the sea lamprey has an invagination which is a primitive analogue of the spleen 
and similarly hagfish have haematopoietic foci in their lamina propria. 
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Elasmobranch intestines have lymphoid accumulations in the spiral valve 
as weU as large numbers of diffuse leucocytes in the lamina propria. A few 
species of elasmobranchs also have encapsulated lymphoid accumulations 
underlying an epithelial layer that has some morphological similarities to the 
domed FAE in mammals (Tomonaga,Kobayashi,Hagiwara,Yamaguchi and 
Awaya,l986;Hart et a/.,1988). 
In teleosts GALT consists mainly of diffuse leucocytes in the epithelium 
and lamina propria (Weinberg,1975;Temkin and McMillan,1986;Doggett, 
1989),with some aggregations of small numbers of cells (Pontius and 
Ambrosius,1972;Davina,Rijkers,Rombout,Timmermans and Van Muiswinkel, 
1980). There are no direct analogues of M-cells reported in fish and the 
overlying epithelium in teleosts is not as specialised mammalian F AE. The only 
organised GAL T in fish, exists as the elasmobranch spiral valve and a few small 
accumulations in the lower intestines of certain species. The percentages of 
leucocytes in the epithelium and lamina propria of teleosts and mammals appear 
similar. 
There is less known about the phenotypic composition of the leucocytes 
in fish GALT. There is a predominance of surface-immunoglobulin negative 
(slg-) lymphocytes in the epithelium of teleost species (Davina et 
a/.,1980;Miller,Bly,van Ginkei,Eilsaesser and Clem,1987;Rombout,Bot and 
Taverne-Thiele,1989) and as in mammals a greater number in the lamina 
propria. About 10% of the lymphocytes in the lamina are positive for surface 
Ig in carp (Rombout et a/.,1989a),a smaller percentage than in other organs in 
the body eg kidney. Lymphocytes positive for cytoplasmic Ig were rare. It 
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appears that the lamina propria is conserved as a site of terminal differentiation 
of lymphocytes. Phenotypic analyses of the GALT lymphocytes using T-cell 
markers,anti-thymocyte antisera and conserved Thyi+ cell markers derived from 
species specific brain tissue,have shown that positive cells are present in both the 
epithelium and the lamina propria (Davina et al., 1980;Ellsaesser,Bly and 
Clem,1988). T-cell functions have also been indicated by rainbow 
trout,Oncorhynchus mykiss,cell mediated immune responses to Mycobacterium 
tuberculosis and M.salmoniphilum such as delayed type hypersensitivity (DTH) 
(Bartos and Somner,1981). In vitro studies also suggested the possibility of 
similar lymphocyte subsetting as well as the existence of a range of soluble 
mediating factors analogous to the cytokines and monokines found in mammals 
(Miller,Deuter and Cl em, 1986;Eisaesseret al., 1988;Graham and Secombes, 1990). 
Other leucocytes include a variable population of granulocytes of unclear 
lineage and function and macrophages that in some species appear to have 
morphological similarities with melanomacrophages and mammalian follicular 
dendritic cells (Doggett, 1989). 
Fish GALT is less structurally organised than that of mammals but may 
still operate as its direct functional analogue (Temkin and Mcmillan, 1986) with 
respect to the ability of the intestine to absorb functionally intact 
macromolecules and to have a direct immunological interaction with them. 
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2.2. THE MECHANISMS OF UPTAKE OF MACROMOLECULES 
ACROSS THE GASTROINTESTINAL TRACT. 
Before orally delivered antigens can have any interaction with the 
immune system the delivered macromolecules must cross the mucosal barrier 
from the lumen to the intestinal sites of the GALT,and also to the associated 
vascular supply for any systemic attention. The macromolecular absorptive 
processes are therefore important in determining the eventual fate of orally 
delivered antigens. 
Several cell types throughout the vertebrate gut are involved with the 
uptake and transport of macromolecules. These include ubiquitous cell types 
such as the intestinal absorptive enterocytes (Schreiber and Walker, 1988),Paneth 
cells (Erlandson and Chase 1972a,l972b),and the specialised mammalian M-cells 
(Owen and Jones,1974;Wolf and Bye,l984). Some of these cells are specific to 
mammals or to specific regions of the gut. However,there are some basic 
similarities in the way in which delivered macromolecules are absorbed in both 
fish and mammalian gastrointestinal tracts. 
There are two principal modes of absorption,the first involving passage 
of macromolecules through the absorptive cell (transcellular pathway) and the 
second involving passage of material between the cells (paracellular pathway) 
and there are several controversial routes of absorption that are thought to be 
of less importance. 
2.2.1. TRANSCELLULAR ABSORPTION. 
Transcellular absorption involves endocytosis of macromolecules by one 
of three routes,depending on the nature and source of the macromolecules. 
13 
Fluid-phase macromolecular absorption,including soluble proteins is 
encompassed by the term "pinocytosis" and particulate macromolecules by the 
term "phagocytosis". Bacterial macromolecules (whole live or dead organisms) 
often pass across the intestinal mucosa,employing a transmural or resorptive 
process. Resorptive processes involve the passage across the intestine of 
immunologically or pathologically viable organisms which may have mechanisms 
influencing and\or increasing their own uptake (Nicklin,1987). 
Endocytosis has a defined sequence of events for the transport of 
material from the lumen. There are at least two endocytotic processes,one in 
which receptors specific for the delivered macromolecule are present on the 
luminal surface of the absorptive cell (receptor-mediated endocytosis) eg in the 
transfer of passive immunity via gamma globulins in neonatal mammals and in 
some larval fish. The second mechanism is termed fluid-phase endocytosis, 
where the lumenal macromolecules are internalised in proportion to their 
exogenous concentration. The rate of uptake of macromolecules in both 
processes is largely determined by endocytotic vesicle size and the rate of vesicle 
formation (McLean,1987). However receptor-mediated endocytosis may allow 
the cell to concentrate and select specific macromolecules and exclude most 
coincident lumenal material. 
Receptor-mediated endocytosis is initiated by the binding of specific 
ligands to specific receptors in inward foldings of the apical surface of the 
plasma membrane (Udall and Walker,1987). Binding of a ligand to a receptor 
(Goldstein,Anderson and Brown,1979) causes clustering of receptors in the 
coated-pit of the cell and the conformational allowance of increased binding. 
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There may be more than one form of receptor for a certain ligand : one which 
allows its binding and another that allows its internalization (McLean,1987). 
Fluid-phase endocytosis occurs by a generalised binding of macromolecules to 
the apical surface of the cell and although common to all cells may be of 
primary importance in M-cells (Nicklin, 1987;Udall and Walker, 1987). Bacteria 
may be endocytosed via either of these methods or in certain cases by highly 
specialised mechanisms. Many enterotoxigenic E. coli species (and others) have 
bacterial adhesins which allow specific binding to and translocation by 
enterocytes eg E.coli K88 (Udall and Walker,1987), E.coli RDEC 101 which is 
specifically absorbed by rabbit M-cells (Mowat,1987) and Vibrio cholerae which 
specifically adheres to the GM1 ganglioside,a glycoprotein receptor on 
enterocytes (Boedeker and McQueen,1988;Holmgren,Ciemens,Sack and 
Svennerholm,1989). 
In teleosts and mammals it appears that adhesion of a macromolecule to 
the intestinal absorptive cell,by either method, is directly followed by 
internalisation. Fluidity of the cells plasma membrane changes and it becomes 
invaginated. This invagination has been described in many studies on the 
absorption of soluble protein antigens in teleosts (Georgopoulou,Sire and 
Vernier,1985 ;Georgopoulou,SireandVernier,1986;McLean,1987;Georgopoulou, 
Dabrowski,Sire and Vernier,1988;Doggett,1989,Le Baii,Sire and Vernier,1989). 
Invagination of material (receptor bound or otherwise) is followed by the 
formation of vesicles enclosing the absorbed material (Silverstein,Steinman and 
Cohn,1977;Goldstein et a/.,1979). 
Vesicular morphology is variable (Georgopoulou et a/.,1986,1988) and the 
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time taken for these vesicles to migrate from the plasma membrane to the apical 
cytoplasm of the cell is also variable. Differential uptake dynamics occur for 
various delivered macromolecules (Fujino,Ono and Nagai,1987;Georgopoulou 
et a/.,1988;Rombout and van den Berg,1989) though a defined sequence of 
events is maintained. The time course, however variable, results in vesicle 
fragmentation or multi-vesicular coalescence (Iida and 
Yamamoto,1985;Georgopoulou et al.,1988) both in vitro and in vivo. Coalescing 
vesicles eventually form characteristic supranuclear vacuoles in teleosts within 
5 hours for horseradish peroxidase (HRP) (Watanabe, 1982) and up to 10 hours 
for human gamma globulin (HGG,Georgopoulou et a/.,1986) in rainbow trout. 
The rate of this phase of vesicular migration may also be dependent on the 
initial mode of absorption,mammalian studies indicating variability for receptor-
mediated absorption of colostral IgG (Rodewald and Abrahamson,1982). 
The majority of supranuclear vacuoles coalesce with cellular 
lysosomes,effecting the formation of secondary lysosomes (Watanabe, 1981,1982). 
It is at this juncture that the first level of post-lumenal processing of antigens 
occurs,with intracellular epithelial transcytosis exerting a major influence on the 
ultimate structure (and immunological fate) of a delivered macromolecule 
(Bland and Warren,1986a,1986b;Bland,1989). Lysosomal degradation may move 
to completion,often in macrophages, for some delivered antigen. Receptor 
mediated endocytosis may provide some protection from this whereby 
"receptorsomes" may have a different fate from other lysosomes in their ultimate 
direction to the basal and lateral enterocyte membranes for exocytosis. Orally 
delivered macromolecules in fish may be biochemically deactivated by 
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fragmentation in lysosomes and still retain nascent immunologically recognisable 
epitopes (Rombout and van den Berg,1989). 
Two forms of transport systems have therefore been outlined 
(Abrahamson and Rodewald,l981),one resulting in lysosomal merger and the 
other in intercellular exocytosis. Selective degradation or escape of proteins 
from such lysosomal activity may be due to distinct populations of vesicles 
(McLean,1987). Vesicular transport of antigen across the cell may be 
augmented by and/or augment,transport of macromolecules by cytoplasmic 
tubules ; a system often noted in teleost absorption studies (Iida and 
Yamamoto,l985) where cytoplasmic tubules can form complex,often fenestrated 
extensions linking pinocytotic vesicles with the basolateral membranes where 
deposited antigen can be detected. 
Receptor delivered antigen requires a specific acidic intracellular 
compartment during its uncoupling and it is at this point that primary 
immunological interactions with orally delivered antigen can occur. Intestinal 
enterocytes in mammals,and possibly in fish,are known to have distinct major 
histocompatibility-complex antigens (MHC 11) associated with their basolateral 
membranes and as an acidic environment is a prerequisite for antigen processing 
and presentation (Chain,Kaye and Shaw,1988,Vallejo,Miller,Jorgensen and 
Cl em, 1990) it can therefore be considered that under certain circumstances 
enterocytes may have an antigen presentation function (Bland and Warren 
1986a,1986b,Chain et a/.,1988;Mayer,1991). Enterocyte transcytosis may be the 
first stage in the immunological scrutiny of an antigen. Transcytotic-exocytotic 
mechanisms can therefore result in the degradation or the relatively intact 
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passage of macromolecular antigen together with the possibility of antigen 
presentation of certain epitopes. 
2.2.2. THE PARACELLULAR PATHWAY AND OTHER MODES OF 
UPTAKE. 
Classical transcellular absorption is not the only method of passage of 
macromolecules across the intestine. The other major route of uptake of 
macromolecules is via the paracellular pathway often termed persorption 
(Volkheimer,1975,1977;Nicklin, 1987). Persorption occurs when particulate 
antigens of varying sizes and forms (including starch,latex,Sephadex,pYC, 
solutions of colloidal metals,asbestos fibres and resin) are absorbed between the 
intestinal cells with the motive force being supplied by peristalsis. Persorption 
is restricted to single-cell layers of the intestine. The intestines of many species 
undergo a cycle of contraction and relaxation where old enterocytes on the villus 
tips are extruded and replaced by maturing cells. The integrity of the villus is 
partially compromised at such a stage and antigen can be directly absorbed into 
the lamina propria via this route. The membrane composition and architecture 
of the enterocytes is also intimately involved with absorption of macromolecules 
(Udaii,Bloch,Vachine,Feldman and Walker,1984) and may determine whether 
macromolecules or bacteria bind to the cell surface. Maturation of 
cells,paradoxically,may reduce transcellular absorption,as cellular protein content 
increases. Newborn vertebrates have enterocyte plasma membranes with 
reduced protein : phospholipid ratios. Such modifications can also be induced 
in adults eg homeoviscous adaptation of teleost cells to temperature 
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(Bly,Cuchens and Clem,1988) and in each case it results in the increased surface 
binding and internalisation of certain substances eg cholera toxin (Udall and 
Walker, 1987). Increased amounts of cholesterol (Egberts,Brinkhoff, Mouwen, van 
Dijk and Koninkx,1985) are correlated with the ability of certain cells (M-cells) 
to absorb proteins such as HRP (Owen,1977) and viral particles (Owen and 
Ermak,1990). Orally intubated HRP has been detected in the goblet cells of 
mammals (Hugon and Borgers,l968;McLean, 1987) though whether this mode 
of uptake is significant remains uncertain. Other controversial non-specific 
forms of uptake have also been postulated. These involve the potential uptake 
of antigen between the tight-junctions of enterocytes which can become 
"loosened" by the action of substances such as bacterial lipopolysaccharide 
(endotoxin),which in turn may be released by the gut bacterial populations and 
certain pathogens (Nicklin, 1987). 
2.3. FACTORS INFLUENCING THE ORAL DELIVERY OF 
ANTIGENS. 
Despite the variety of factors modulating the uptake of 
macromolecules,numerous studies have shown that intestinill absorption still 
occurs,in significant amounts,in mammals and teleosts (see McLean,1987; 
Georgopolou et a/.,1986,1988;Doggett,1989;Rombout and van den Berg,1989). 
Oral delivery of antigen can result in uptake of macromolecules that have 
been modified to a varying degree. Physiological functioning of the intestine 
while effecting qualitative aspects of delivered antigen also has a considerable 
influence on the overall efficacy of any vaccine by directly controlling the 
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amount of macromolecules transported (McLean and Donaldson,1990) 
A variety of more or less non-specific factors (Rijkers,1982) influence the 
uptake of oral antigens. The overriding factor regulating oral delivery of 
antigen as vaccine in mammals and teleosts is presumed to be gastric 
degradation,which differs between species but is considerable in every case 
(Kraft,Rothberg and Kramer,1967;McLean,1987;EIIis,1988). The importance of 
gastric secretions in limiting the amount of antigen in contact with the 
intestine,often beneficially,is exemplified by human patients with the hereditary 
syndrome,achlorohydria. This results in gastric HCI levels being reduced or 
even absent,hence causing substandard gastric secretions and as a consequence 
the formation of allergenic responses to dietary antigens (Kraft et a/.,1967). 
Gastric secretions can also be influenced by a range of factors such as the 
nutritional status of the organism. During the acquisition of neonatal passive 
immunity,colostral inhibitors of enterokinase (the enzymatic convertor of 
trypsinogen to trypsin) mediate an increased lumenal content of intact 
immunoglobulins. Reduction of intestinal proteolysis by pancreatic enzymes also 
leads to an increased uptake of macromolecules,viruses,toxins and bacteria 
(Walker,1981). Similarly in teleosts gastric and intestinal secretions have been 
found to greatly influence the level of uptake of bacterial antigens (Johnson and 
Amend, 1983a, 1983b ). 
Secretion of mucus provides an important physical barrier against 
macromolecular uptake,especially against bacterial attachment and the chemical 
action of toxins (Schreiber and Walker, 1988). An increase in mucus layer 
thickness slows down antigen absorption and increases the interaction time 
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between a delivered antigen load and any lumenal digestive processes. Mucus 
is chemically complex and contains several substances that can influence 
absorption. Lysozyme (muramidase) is a bactereolytic enzyme,an obvious factor 
that will modulate the delivery of live or dead bacteria in a possible oral 
vaccine. Similarly Iactoferrin (an iron sequestering agent) produces a 
bacteriostatic effect as a consequence of its competition for free iron. Iron is 
often required by surface receptors (siderophores) which are associated with 
virulence in some bacterial species eg Aeromonas spp (Dooley and 
Trust,1988;Bayer,1990,pers.comm.). Other less well characterised 
glycoproteins,such as transferrin,are produced which also specifically bind to 
bacterial toxins (Udall and Walker, 1987). 
The indigenous intestinal flora deters overpopulation by pathogens. Both 
the quality and quantity of the flora is important for the competition of 
substrates with pathogens and the alteration of the microenvironment to sustain 
their own survival. 
2.4. IMMUNOLOGICAL INTERACTIONS OF ABSORBED 
ANTIGEN WITH GALT. 
Antigen delivered to the intestine can be seen to be absorbed and acted 
on,possibly in an immunologically relevant manner,by enterocytes. Antigen 
processing and presentation are among the central events involved in the 
induction of an immune response to certain {thymus-dependent) antigens. 
(Vallejo et al.,1990). Absorbed orally delivered antigens interact with GALT 
tissue macrophages in teleosts in a manner analogous to classical antigen-
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processing cells (APC) in mammals (Rombout and van den Berg,1989). Antigen 
processing can be defined as the conversion of a molecule from a non-MHC 
binding to a MHC-binding form. The degree of processing required by an 
antigen is related to its structure (Chain et a/.,1988). Antigen processing and 
presentation can occur prior to antigen interaction with GALT (see above). 
GAL T cells capable of antigen presentation,characterised by MHC li expression 
,include dendritic cells, veiled cells (Mayer,l991 ),macrophages and B-cells 
(Chesnut and Grey,1981;Vallejo et a/.,1990). Teleost cells,such as activated B-
cells, are found to be efficient presenters of antigen in vitro. The initial 
interaction between antigen and APC is at the cell surface membrane although 
most antigens require passage through acidified endosomes intracellularly. 
Endosomes containing antigen rapidly interact with other compartments 
including the Golgi apparatus and plasma membranes (positive antigen 
processing at a neutral pH) or lysosomes (degradative processing). The final 
interaction of antigen with MHC complexes occurs in a trans-Golgi compartment 
and the complex is expressed at the cell surface. MHC complex expression has 
been defined in fish (Kaastrup,Stet,Tigchelgaar,Egberts and Van 
Muiswinkel,1989) and it appears from such studies that MHC-restricted antigen 
processing may be necessary for some antigens delivered to GAL T cells. 
2.5. THE IMMUNE RESPONSE TO ORALLY DELIVERED 
ANTIGENS. 
Immunological factors also have a selective role on the uptake of 
macromolecules and the potential for the induction of a local immune response 
is the primary reason for oral vaccination in both mammals and teleosts. 
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The existence of a protective local immune system functioning 
independently of systemic immunity was first proposed by Besredka in 1919. In 
this study it was shown that oral immunisation of rabbits with killed Shigella 
flexneri bacteria (Shiga bacilli) was protective against bacillic dysentery 
(Besredka,1927). Similarly Davies (1919) successfully immunised soldiers against 
Shigella spp. and showed serum antibody responses against the bacteria. The 
local secretory immune system is largely mediated by a distinct subclass of 
immunoglobulins,in mammals - dimeric IgA (Tomasi,Tan,Solomon and 
Prenderport,1965). IgA is also present in the serum but its structure differs as 
it is monomeric. Other immunoglobulin classes (primarily IgG and IgM) are 
also present in secretory immune responses but in much lower concentrations, 
than in the serum. Secretory lgA is heterogenous and usually occurs as a dimer 
of approximately 380 kDa molecular weight (consisting of a protective secretory 
component (SC) of 80 kDa and a joining (J) chain of approximately 15 kDa 
(Brandtzaeg,Baklien,Bjerke,Rognum,Scott and Valnes, 1987,Brandtzaeg et 
al., 1988,Brandtzaeg, 1990). Secretory lgA is locally-derived with only 2% of 
intestinal and 50% of biliary IgA being derived,in humans,from the serum 
(Delaocroix,Dive,Rambaud and Vaerman,1982;Delacroix,Hodgson,McPherson, 
Dive and Vaerman,1982). Other mammals may derive more IgA from the 
serum than humans (Orlans,Peppard,Payne,Fitzharris,Mullock,Hinton and 
Hall,1984;Vaerman and Delacroix,1984;Ahnen,Brown and Kloppel,1985; 
Mestecky and McGhee,1987). In these species secretory immunoglobulin is 
produced by plasma cells of the GALT,transported through the enterocytes and 
secreted into the mucus where it has the potential to cross-link 
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antigen,agglutinate bacteria,render bacteria mucophilic and neutralize viruses. 
The modus operandi of GAL T is much more complex than just secretion of lgA 
into the mucus lining and lumen (Marsh, 1987). Lamina! cells from guinea 
pigs,for example,orally immunised with a killed preparation of Salmonella 
typhimurum could passively transfer antigen specificity and sensitivity to naive 
guinea pigs (Owen and Ermak,1990). Similar results were found with the oral 
delivery of other antigens such as bovine serum albumin (BSA) in rabbits and 
hamsters and also sheep red blood cells (SRBC) in mice (Brandtzaeg et 
a/.,1988). Such cells were characterised as antigen specific T-cells of the T-
helper /inducer phenotype, which could have been capable of inducing an 
immunoglobulin or a cellular (cytotoxic Tor macrophage )response. Interactions 
between T-cells and antigen presenting cells (macrophages,dendritic cells and 
veiled cells) and the secretory epithelium regulate the secretory-component 
dependent polymeric lgA (plgA) response to oral antigens (Russel and 
Mestecky, 1989). 
Oral immunisation routes lead to the induction of local and generalised 
immune responses manifested by the parallel appearance of slgA to antigen in 
secretions of glands distant from the site of immunisation (Mestecky, 1987). This 
is the basis of the proposed common mucosal system,largely recognised in 
mammals. Table 2.1 shows some examples of specific antibodies secreted at 
mucosal sites after oral immunisation. 
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TABLE 2.1. EXAMPLES OF SECRETORY ANTIBODY 
PRODUCTION IN ANATOMICALLY REMOTE SECRETIONS 
AFTER ORAL IMMUNISATION. 
ANTIGEN DELIVERY SECRETION COMMENT REF 
FORM 
E. coli Live Bacteria Milk No serum Mestecky 
response (1987) 
Hinjluenzae Killed bacteria Saliva Increase in Mestecky 
plus enteric slgA (1987) 
coat 
S.mutans Formalin Saliva and Specific Curtiss,Goldsch 
killed bacteria tears antibodies in mitt,Pastian, 
in capsules blood. 
Lyons,Michaelek 
and Mestecky, 
(1986) 
S.mutans Glucosyl Parotid saliva Increase in Curtiss et 
transferase sigA a/.,(1986) 
plus 
aluminium 
phosphate 
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Montgomery,Colin and Lally (1974) found antigen specific antibodies to 
orally administered dinitrophenol-Pneumococcus spp. conjugates in the milk of 
lactating mammals and through elegant ligation studies demonstrated that the 
antigen was not transported via the lymph or bloodstream 
(Montgomery,Lemaitre-Coehlo and Lally,1976). Similar results were obtained 
with certain microbial and dietary antigens (Mestecky,McGhee,Russell, 
Michaelek,Kutteh,Gregory,Scholler-Guinad,Brown and Crago,1985). The 
presence of slgA in milk was found to be due to an active transport system 
(Sheldrake,Husband, Watson and Cripps, 1984) where immunocompetent cells 
seed the mucosal secretory site from the (distant) site of antigen contact. 
Peroral immunisation with Salmonella typhi led to the presence of predominantly 
IgA cells in the peripheral blood (Kantele,Avrilommi and Jokinen,1986). 
Locally antigen-sensitized cells (plasma cells or T-cells) may migrate from one 
mucosal site eg the intestine after oral delivery of antigen to many others 
urogenital,respiratory mammary and salivary mucosae and may appear in any of 
the secretions. 
Teleosts appear not to have multiple serum isotypes of immunoglobulin 
(Lobb and Clem,1981a) and rely on a (usually) tetrameric IgM-Iike molecule 
(Hart et al., 1988) which has a species variable molecular weight (Lobb and 
Clem,l981d;McCumber et a/.,1982;Philips and Ourth, 1986;Hart,1987;Giynn and 
Pulsford,1990). Secretory IgM has been found in gut mucus (Diconza and 
Halliday, 1971 ;Doggett, 1989) cutaneous mucus (Lobb and 
Cl em, 1981 b;Rombout,Blok,Lamers and Egberts, 1986;Lobb, 1987;Peleteiro and 
Richards,1988;Doggett,1989;Rombout and van den Berg,1989) and bile (Lobb 
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and Clem,198lc;Lamers, 1985;Rombout et al., 1986;Hart,Wrathmeii,Harris and 
Doggett,l987;Doggett,1989). It seems that teleosts,like humans and some other 
mammals,have immunoglobulins that are not derived from the serum (Lobb and 
Clem,1981a-d) and that mucosa specific plasma cells are responsible for local 
lgM production with putative differences in the immunoglobulin heavy and light 
chains between those immunoglobulins and those in serum. A notoriously poor 
transport mechanism exists between teleost skin and the bloodstream 
(Harreii,Etlinger and Hodgins,1976;Lobb and Clem,1981b). Secretory 
component has not been recognised in fish (Hart et al., 1987, 1988) although the 
concentration of biliary Ig paralleled that of serum raising the possibility of 
active secretion,and fish lg has been reported to be able to bind human se 
(Underdown and Socken,l978). 
Particulate antigens can induce an immune response at teleost mucosal 
surfaces (Rombout et al., 1986). Peroral administration of antigen elicited 
antibody titres at distant mucosal surfaces that while low (Doggett,1989) may be 
protective (Rombout and van den Berg,1989) and indicate the possibility of a 
functional common mucosal system. Soluble protein antigens had less 
immunogenic effect in teleosts (see below) though the antigenic nature of the 
macromolecule may be the decisive factor. Oral delivery of antigen also caused 
direct cellular migration of granulocytes (Davina et al.,1980),and small 
macrophages (Rombout and van den Berg, 1989),into the intestine. It was 
postulated that such highly mobile populations of small macrophages and 
granulocytes could be a primary factor in the induction of systemic immunity. 
The efficay of oral delivery of antigens to fish is also influenced by the state of 
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ontogenic development ,especially in relation to the gut,as although antigen can 
be absorbed across the intestine of adults the level of absorption may be greater 
in larval and juvenile fish. 
Initial delivery of a bacterial,viral,dietary protein,chemical or cellular 
antigen to the intestine by the oral route can lead to a marked decrease in the 
subsequent ability to initiate a systemic immune response to the same antigen 
even if it is delivered by another route (anally,parenterally,intravenously, 
intradermally or intramuscularly;MacDonald, 1982;Kagnoff, 1987). Table 2.2 
shows some of the possible consequences of oral immunisation. 
TABLE 2.2. POTENTIAL IMMUNE RESPONSES TO ORAL 
IMMUNISATION. 
INDUCTION. INITIAL RESPONSE. LEADS TO: 
Local injection or Local. Systemic and 
penetration of antigen. inflammatory. 
Ingestion or inhalation. General mucosal and/or Systemic unreactivity. 
secretory. 
Parenteral. Rapid systemic. Mucosal unreactivity. 
This induction of systemic hyporesponsivness to an intestinally delivered 
antigen is termed "oral tolerance" and is well documented in mammals 
(MacDonald, 1982;Strobel ,Mowat,Drummond,Pickering and Ferguson, 1983). 
Immune tolerance to orally administered protein was first reported by Wells 
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(191l,cited by Michael,1989). The complete mechanism of oral tolerance 
induction has not yet been evaluated,however the presence of immune 
complexes has been linked to its induction (Kagnoff, 1987) but it is more likely 
that an antigen specific population of T-cells of the cytotoxic/suppressor 
phenotype from the intestinal epithelium (see above) are the mediating factors. 
This population would then migrate systemically lessening any antigen specific 
response (Bergmann and Waldman,1988). Induction of oral tolerance in 
mammals depends on the nature of the antigen,its dose,the frequency and 
temporal kinetics of its administration and the recipient organisms current 
immune status (Peng,Turner and Strobe!, 1990). 
Orally delivered antigens were rendered tolerogenic by the normal 
physiological action of gastric enzymes (Michael,1989). Untreated BSA was 
tolerogenic if orally but not illeally administered. Subsequent in vitro studies 
indicated that proteolysis degraded the BSA molecules,revealing molecular 
conformations suited for tolerance induction (Michael,l989). 
Teleost unresponsivness has been directly linked to the form (particulate 
vs soluble) and nature (T-dependent vs T-independent) of the antigen. 
Particulate,T-independent antigens,such as some bacterial antigens (eg from 
Aeromonas salmonicida and Vibrio anguillamm ) appear not to be tolerogenic. 
Route dependent immunosuppression was found with BSA (Serero and 
Avtalion,1978) and HGG (Mughal,Farley-Ewens and Manning,1986) but not 
with ferritin (Rombout and van den Berg,1989). High doses of antigen at short 
intervals were found to be more efficient at tolerance induction but evidence 
suggests dose-dependent tolerance is not universal in teleosts (Whiskovsky and 
29 
Avtalion, 1982). 
Orally delivered antigen has several consequences as described above and 
a potential vaccine administered via this route must be designed in such a way 
as to maximise antigen delivery to effector GALT cells,induce a protective 
secretory immune response (possibly at mucosal sites divorced from that of 
immunisation) and to minimise systemic hyporesponsivness which often appears 
to be a consequence of intestinal antigen administration. 
2.6. ORAL ANTIGEN DELIVERY SYSTEMS (V ACCINES) 
POTENTIALLY USEFUL FOR THE INDUCTION OF A 
PROTECTIVE IMMUNE RESPONSE. 
An efficient and long lasting topicaiJy induced secretory immune response 
generally requires repeated doses of antigen that may be several orders of 
magnitude greater than that administered parenterally (Mowat,1987;Mestecky, 
1987). As a consequence a variety of novel delivery systems are being 
investigated. 
2.6.1. LIVE VACCINES. 
Live microorganisms that are naturally or artificially non-pathogenic but 
are immunogenic and can multiply within the intestinallumen,on enterocytes or 
within the GALT may provide a more effective stimulus for a secretory immune 
response than killed formulations (Waldman and Ganguly 1974;Mestecky 
1987;Pierce,Kaper,Mekalanos,Cray and Richardson, 1987;Curtiss, 1990). 
Inactivated whole cell vaccines of Salmonella spp orally administered are 
well tolerated but their efficacy could not be demonstrated (Germanier and 
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Cryz, 1989). Salmonella spp are organisms that preferentially colonise the Peyers 
patches. From this it was found that optimal protection was achieved by 
vaccination with live bacteria attenuated by general chemical mutagenesis or 
site-directed genetic lesions eg S.typhi strain Ty21a which lacks the enzyme 
UDP-4-galactose epimerase causing the lipopolysaccharide (LPS) virulence 
factor to be expressed only under conditions that cause autolysis of the bacteria 
(Levine,DuPont and Hornick,1976;Germanier 1984;0'Callaghan,Maskell 
,Liew,Easmon and Dougan,1988;Germanier and Cryz,1989). Such live vaccines 
have been extremely protective - up to 96% protection in large scale field trials 
in humans (Wahdan,Serie,Cerisier,Sallam and Germanier,1982). There remains 
sufficient scope for study of other genetic modifications as there are 
approximately 200-500 gene products involved in oral infection with S.typhi 
(Curtiss,1990). Other attenuated S.typhi strains were derived via a series of 
genetic mutations : cotE mutants (requiring exogenous galactose),purA gene 
mutants (effecting the synthesis of purines) and aroA gene mutants (effecting the 
synthesis of the shikimate pathway enzyme 5-enolpyruvylshikimate 3-phosphate 
synthase (EPSP) which is required to synthesise aromatic amino acids 
(tyrosine,phenylalanine and tryptophan) and eventually folic acid and vitamin K. 
However derivatives of aroA and purA mutant strains failed to produce 
significant antibody titres though positive cell-mediated responses were elicited 
(Hackett,l990). Similarly modifications in S.typhimurum have produced 
immunogenic mutants designated delta-crp (lacking the cAMP receptor protein) 
and delta-cya (lacking adenylate cyclase),respectively (Curtiss,1990). 
Temperature-sensitive S.typhi mutants,with some of the above genetic 
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lesions,have been found to be especially useful in the induction of secretory 
immunity,especially for antigens that are only expressed in vivo 
(Hooke,Wang,Cerquetti and Bellanti,1991). 
Other bacteria have been studied for the production of live vaccines that 
are non-pathogenic and self-limiting via genetic (or chemical lesions). These 
include Vibrio clzolerae where the production of a live vaccine could imitate a 
natural infection (which confers a high degree of protection against subsequent 
reinfection) and through a single dose protect susceptible age classes. Many 
pathogens such as V.cholerae are capable of (plasmid borne) genetic exchange,so 
putative vaccine strains must be rendered combination deficient so that 
reversions to wild-type through conjugation or transduction is less likely eg 
through lesions in toxin structural genes (cM or ctxB),Zot-gene the products of 
which alter the integrity of the enterocyte tight-junctions and regulatory genes 
(Kaper,Lockman,Baldini and Levine,l984) including tox R,tox S and tox T genes 
(Curtiss,1990). Similar strategies have been employed in other mammalian 
bacterial pathogens eg Shigella spp using non-invasive strains (Formal,Hale and 
Kaper, 1989;Linde,Dentchev,Bondarenko,Marinova,Randhagen and 
Bratoyeva, 1990) and E. coli strains that cause enterotoxigenic and enteroinvasive 
disease (ETEC and EIEC) where oral immunisation is found to be highly 
protective against intraintestinal challenge (Sack,Kline and Spira,1988). 
Studies on teleost pathogens have included the production of attenuated 
strains of Vibrio anguillarum made avirulent by transposon mutagenesis 
(Norquist,Hagstrom and Wolf-Watz,1989). Such vaccines caused a 10 to 30 fold 
increase in the LDSO values in pathogenic challenge regimes. Protection was 
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elicited one week after immunisation and lasted up to 12 weeks with a limited 
associated antibody response (Norquist et a/.,1989). AroA mutants ofAeromonas 
salmonicida have been constructed (Vaughan,Smith and Foster,1990) and these 
appear to provide protection combined with avirulence when administered via 
the peritoneal route but have not been orally evaluated. Other live vaccines of 
Vibrio anguillamm,Aeromonas hydrophila,Cytophaga spp and Pseudomonas spp 
have also been recently patented but their efficacy remains unknown (Symbicom 
Corporation, 1989). 
2.6.2. BACfERIA AS LIVE DELIVERY VEHICLES. 
Organisms that colonise the intestinal tract or GAL T such as Salmonella 
spp or Shigella spp make good candidates for genetic manipulation so that they 
can act as vehicles to deliver other antigens (Curtiss,1990) from less-tractable 
bacteria,that are required for protective immunity. 
Salmonella spp is often the chosen delivery organism and antigens can be 
introduced into it by cloning techniques (Hosieth and Stocker,1981). The 
success of the hybrid ie containing cloned,heterologous,DNA depends on the 
stability of the introduced DNA,the level of expression of the product and its 
location in the carrier organism,the selection of the carrier strain eliciting the 
immune response (eg Ty21a has problems associated with its overattenuation so 
that it may only be moderately immunogenic in some instances) and the choice 
and inherent immunogenicity of the introduced antigen (Hackett,1990). 
Foreign antigenic sequences can often be inserted into a region that 
expresses a surface determinant eg into the lamB region in E.coli 
(Leclerc,Charbit,Molla,Cholla and Hofnung, 1989). Protein antigens from 
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Streptococcus mutans (glucosyl transferase and surface A protein) have been 
introduced into Sa/momella typhimurum as recombinant plasmids 
(Katz,Michaelek,Curtiss,Harmon,Richardson and Mestecky,1988). Orally 
delivered it induced a secretory IgA response in saliva (Mestecky, 1987). 
Rationally attenuated live vaccines can also be used to deliver recombinant 
bacterial toxins eg V.cho/erae B-subunit or ETEC heat-labile toxin (LT). Triple 
hybrid (recombinant) vaccines have been proposed for Salmonella typhi,cholera 
and ETEC,using Ty21a as the carrier (Chatfield,Strugnell and Dougan,1989; 
Clemens,Harris,Kay,Chakraborty,Sack,Ansaruzzaman,Rahman,Stanton,Khan, 
Khan,Yunus,Rao,Ciznar,Svennerholm and Holmgren,1989). The choice of 
carrier organism throughout such studies is vital,to maximise immunogenicity 
and decrease the dose of vaccine eg the potential use of E.coli K12,Shigella 
flexneri,Listeria monocytogenes or Vaccinia virus (Linde,Abraham and Beer,1991 ). 
An important adjunct to the use of live expression vectors for the delivery of 
foreign antigens is the potential development of a foreign antigen secretion 
system in Mycobacterium kansasii (with a view to similar development in 
Mycobacterium bovis). Such a system would allow the delivery of antigen(s) in 
a vehicle that naturally resides intracellularly in macrophages and hence the 
possibility that the antigens could be processed and presented on the cell surface 
and continously stimulate a relevant immune response (Matsuo,Yamaguchi, 
Yamazaki,Tasaka,Terasaka,Totsuka,Kobayashi,Yukitake and Yamada,1990). 
A novel antigen delivery method involves the use of "bacterial ghosts" 
which are produced by the genetically controlled release of the internal contents 
of a bacterium without the destruction of the bacterial sacculus. This system 
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allows delivery of intrinsic or cloned colonisation or virulence antigens that are 
present in the outer membrane (Curtiss,1990). 
Protective antigens,outside novel live regimes,are obvious candidates for 
oral vaccines and may be derived by traditional or cloning methods. 
An oral vaccine to cholera is possible as its pathogenesis is more readily 
understood than any other organism (Holmgren et a/.,1989). Cholera toxin 
consists of a binding region of five B-subunits into which is inserted the toxic 
active component, the a-subunit. The toxin binds to the GM1 ganglioside on the 
brush borders of enterocytes. Pathogenesis occurs when the a-toxin subunit 
activates adenylate cyclase and intracellular cAMP levels rise. 
B-subunit is widely used as a targeting agent for conjugated antigen and 
as a protective immunogen. The most advanced oral vaccine for cholera consists 
of whole formalin and heat-killed cells (Inaba,Ogawa and El Tor biovars) plus 
B-subunit. These antigens act synergistically to give a protective antibody 
response to toxin and structural protective antigens such as LPS,fimbrial 
adhesins and colonization factors (Holmgren et al.,1989;Ghose and 
Dasgupta,1989;Srivastava,Srivastava and Jacob,1989). Cholera B-subunit is also 
protective against organisms that have similar toxins and invasive strategies such 
as ETEC (Svennerholm,Holmgren and Sack, 1989;Svennerholm,Holmgren,Lopez-
Vidal,Sanchez and Ahren,1989) and Aeromonas spp (Ciznar,Hussain,Ahsan, 
Kay,Clemens and Sack,1989). Vaccines using cholera B-subunit as an 
immunogen or a targeting agent have not,until now,been employed in teleosts 
but are likely to provide an efficient mechanism of antigen introduction and also 
possibly a protective immunogen against teleost Aeromonads. 
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The identification of the protective antigens for a teleost bacterial vaccine 
ts a prerequisite. For Aeromonas salmonicida,the aetological agent of 
furunculosis,a wide variety of antigens have been outlined as possibly protective 
and/or as being virulence factors. Such as A layer,LPS,crude extracellular 
products (ECP),toxoids,cell extracts,proteases and glycerophospholipid 
cholesterol acyl transferase ((GCAT);Ellis,1988;Ellis,1990) and salmolysin 
(Kawahara,Ueda and Nomura,1991). Other bacterial species have their distinct 
antigens such as the aerolysin (siderophore) and ECP ofAeromonas hydrophila 
(Rodriguez,Fernandez and Nieto,1990;Karunasagor,Rosalind and 
Karunasagor,1990),0-antigen,LPS and heat-sensitive factor (HSF) of Yersinia 
ruckeri (Furones-Nozal,1990). Fish bacterial vaccines are mostly restricted to 
heat or formalin killed products administered by routes other than perorally 
(Klontz and Anderson,1970;Eilis,1988) as no commercially successful oral 
administration regimes are used as yet (Campbell,Tatner and Adams,l990). 
Such procedures are often unprotective for more intractable diseases such as 
Renibacteriumsalmoninarum (Sakai,Atsu taand Kobayashi,1989a;Ellis, 1981, 1988) 
and a-haemolytic disease from Streptococcus iniae (Sakai,Atsuta and 
Kobayashi,l989b ). However,delivery of certain antigens orally to teleosts can 
elicit protection (Duf£,1942). Formalin killed Vibrio anguillarum ,orally given in 
experimental field trials,was found to significantly reduce the mortality of ayu 
Plecoglossus altevelis with a 32% mortality in vaccinated groups as opposed to 
52-61% in control groups (Kusuda,Kawai,Jo,Akizuki,Fukunaga and 
Kotake,1978;Kawai and Kasuda,1985). Oral delivery required a greater dose of 
bacterin but,unlike immersion methods with the same antigen 
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(Kitao, 1990),elicited a protective,bacteriostatic, mucosal immune response. A 
similar result was found in carp,Carassius auratus with V.anguillarum 
(Rombout,van den Berg,van den Berg,Witte and Egberts,1989). Similarly orally 
and anally administered Yersinia ruckeri elicited protection under challenge 
stimulus in rainbow trout Oncorhynclzus mykiss (Johnson and 
Amend,1983a;1983b). Protection after orally delivered A.salmonicida ECP or 
ECP-toxoid has been reported (Rodgers and Austin,1985). Chinook salmon 
Oncorhynclzus kisutch can be orally immunised against Vibrio but have little 
specific serum antibody (Fryer,Rohovec,Tebbit,McMichael and 
Pilcher,1976;Fryer,Amend,Harreii,Novotony,Plumb,Rohovec and Tebbit, 1977). 
Protection can be elicited by direct oral vaccination with derived bacterial 
products in teleosts and can be both rapid and long lasting (Kawai and 
Kasuda, 1985). 
2.6.3. SYNTHETIC PEPTIDES. 
The synthesis of peptides,corresponding in sequence to the primary 
structure of certain antigenic regions of a pathogen represents another way of 
constructing non-infectious surrogate vaccines (Lerner,1982;Salk and 
Zanetti, 1989). Synthetic peptides can be constructed from primary amino acid 
sequences derived from nucleotide sequences. Synthetic peptides can be made 
that address different subpopulations of leucocytes via unique topographical 
conformations (Sercarz, 1989). There are usually minimal requirements for 
peptide antigens to elicit an immune response (Goodman-
Smitkoff,Eisele,Heimer,Felix,Andersen,Fuerst and Mannino, 1990). Peptides can 
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be synthesized that are recognized by T-cells (Th epitopes) orB-cells and trigger 
both protective immunity and immunological memory and also minimise 
conformations that are likely to induce T-suppressor cell activity ie factors that 
minimise oral tolerance. Synthetic peptide efficacy as an oral vaccine is 
especially dependent on the form of the presented antigen. 
The immunomodulatory synthetic peptide 1<565 (Mine, Watanabe,Tawara, 
Yokata,Nishida and Goto,1983;Kitao,Yoshida,Anderson,Dixon and Blanch, 1987) 
can specifically boost both B-cell responses (to antigen) and activate 
macrophages in mammals and fish. Levels of serum antibody and numbers of 
splenic antibody-forming cells were elevated against 0-antigen preparations of 
A.salmonicida and Y.ruckeri,by increasing antigen processing and B-cell 
expression (Kitao et a/.,1987). 
Antigenic determinants of immunoglobulins can substitute for protein or 
carbohydrate antigens and elicit an immune response against these antigens 
(Lindeman 1973;Jerne,1974,1984;Salk and Zanetti,1989). Such anti-idiotypic 
vaccines rely on the fact that antibody specificity is such that an immunoglobulin 
binding domain can act as a partial template for an antigen,as its mirror-image. 
A few potential vaccine studies using anti-idiotypes have been carried out in 
mammals but none in fish. 
2.7. NOVEL DELIVERY SYSTEMS. 
One method of increasing the amount of orally delivered antigen that 
reaches the mucosal lymphoid tissue is to provide it with direct physical 
protection from gastric degradation in a specialised capsule or coating. 
Such a strategy involves the use of Liposomes (Gregoriadis, 1990). 
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Liposomes are fluid-filled spheres formed spontaneously by !the ;presence of 
amphipathic ,phospholipids,such as lecithin; in water (Bangham and 
Home, 1962;0stro,l988). Liposomes represent ~n unbrok~n bimolecular sheet 
of lipids. Any antigens added to the formation solution will be :enclosed in the 
aqueous spaces ~if soluble~ or in ,the phospholipid matrix; Liposomes range 
from 25nm to 101-'in in diameter :a:nd may be multilayered ~mi.Jltilamellar 
vesicles;MLV's),single-Iayered (small or large unilamelhu vesicles;SUV's or 
LUV's),dehydration-rehydration vesicles ~DRY's) or reverse phase evaporation 
vesicles ~REV's) (New,1990). Uptake of !)iposomes is affected, by their 
charge,size and degree of lipid unsaturation. '0psonization with ;IgG or ·lgM 
(Senlor,1987),greater negative charge and the presence.ofsterols can all increase 
liposorile stability to gastr:ic enzymes and' uptake ·~Hsu and. Juliano,19.82). 
Liposomes can :adsorb to almos~ all cell types (Ostro,l988) and the 
phospholipid matrix may exchange lipid components with cell membranes 
and/or fuse with them (Gregoriadis,1990). Delivered liposomes lhave a 
propensity for irtgesticm by hiacrophages (,Mvlng,·1989} and :from this an a:Imost 
direct immunological intera~tion' can be ~nvisaged. Endocytosis can ca11se .the 
direct delivery of antigen and 'lysosomal catabolism of liposomes can be 
.circumvented by pH-sensitive vesicles that degrade in the .endosomal acidic 
milieu and are released to the cytoplasm prior to lysosomal fusion 
(Gregoriadis,J990). Liposomes have ·also been found to provide T•dependent 
help •to weak antigens (such as some synthetic peptides) when rationally 
constructed complementary to the intrinsic nature of the .delivered protein 
.(Garcon and Six, 1991). 
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In mammals a wide variety of antigens have been included in liposomes 
for immunisation regimes (Alving,1991) although there have been few studies 
in fish. Intraperitoneal and immersion delivery of antigens in liposomes in fish 
have largely concentrated on isolating the tissues involved in their sequestration 
(Rodgers and Austin, 1985;Rodgers, 1990). Table 2.3 shows some of the antigens 
studied in immunisation protocols using liposomes 
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TABLE 2.3. ANTIGENS DELIVERED IN LIPOSOMES TO INDUCE 
IMMUNITY. 
ANTIGEN SOURCE SPECIFIC ANTIGEN REFERENCE 
BACTERIA Streptococcal cell wall Wachsmann,Kiein,Scholler and 
antigen. Frank,1989. 
Streptococcus pneumoniae Wachsmann et a/.,1989. 
type3 
Streptococcus sobrinus Wachsmann et a/.,1989. 
ribosomal protein 
Brucella abortus antigen Kersten,Teerlink,Derks, Verklei 
j,van Wezel,Crommelin and 
Beuvery,1988. 
Kersten,van de 
Put,Teerlink,Beuvery and 
Crommelin,1988. 
Gonococcal protein Kersten et a/.,1988a,1988b. 
Salmonella typhimurum Mestecky,1987. 
LPS 
BACTERIAL TOXIN Cholera toxin Pierce,Sacci,Alving and 
Richardson,1984. 
Chiacumpo and Pareiro,1988. 
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ANTIGEN SOURCE SPECIFIC ANTIGEN REFERENCE 
BACfERIAL TOXIN Tetanus toxin Alving,1989. 
PROTEIN ANTIGENS Horseradish peroxidase Therian and Shahum,1989. 
Lysozyme Gregoriadis,l990. 
PROTEIN ANTIGENS 
Bovine serum albumin Therian and Shahum,1989. 
Gamma globulins Senior,1987. 
Orally delivered liposomal antigens retain their biological activity eg both 
delivered glucose oxidase and insulin reduced blood sugar levels 
(Gregoriadis,1976). Liposomes reduce the number and size of oral doses to 
elicit an immune response and direct interaction with enterocytes has been 
evaluated in vitro. Certain virulence factors introduced into liposomes,such as 
V.cholerae toxin, could both enhance the intestinal targeting of the vaccine and 
act as adjuvants (Pierce et al., 1984;Alving,Richards and Moss, 1986;Chiacumpo 
and Pareiro,l988). 
The immune response to liposomal delivered antigen is increased with 
respect to free antigen and the physical association between the antigen and the 
phospholipid matrix is an integral cause of this (Therian and 
Shahum,1988;Gregoriadis,1990). The provision of a critical epitope density on 
the hydrophobic surface of the liposome is thought to be an important factor 
(Genco,Linzer and Evans, 1983). Drugs can be targeted to infected tissue and 
the release of vaccine antigen can be "pulsed" allowing a strong immune 
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response. Antibody levels can be increased up to 1000-fold (Ostro,1988) 
because of the ability of liposomes to function as an antigen-depot for 
gradual,"pulsed",release of antigen to recipient lymphoid tissue. Liposomal 
ability to elicit a cell-mediated response lies in the degree of hydrophobicity of 
the matrix which influences antigen presentation to T-cells 
(Senior,1987;New, 1990). 
Liposomes,as yet,remain unused as oral delivery systems in fish. 
Parenteral administration of liposomes in rainbow trout showed that they 
targeted for similar cells and in a similar manner to mammals,with the 
spleen,anterior and posterior kidney being the primary sites of localisation 
(Power,Markham and Donald,1990). A Iiposomal preparation ofA.salmonicida 
antigen has also been studied by immersion (Rodgers,1990) where a liposomally-
encapsulated trivalent vaccine preparation of Aeromonas salmonicida was found 
to induce a greater degree of protective immunity (as evidenced by subsequent 
challenge) than the same,unencapsulated,preparation. 
Other methods of protection against digestive degradation have been 
utilised. One is enteric coating which in its most common form involves the 
encapsulation of an antigen in a gelatin capsule and the subsequent spray-
coating of the capsule with a substance such as hydroxyprophy-methyl-cellulose-
phthalate or methyacrylic acid plus acrylic acid ethyl ester both of which are 
resistant to pH 1.5 for up to 2 hours but degrade at pH > 6 in 10 minutes 
(Lehman and Dreher, 1981; Black,Levine,Ferreccio,Ciements,Lanata,Rooney and 
Germanier,1990;Lillehaug, 1989, 1990). This results in protection of antigen until 
its release in the intestine. This approach has been utilised in the oral delivery 
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of Salmonella typhi Ty21A in mammals where enteric coating of the live vaccine 
was found to increase protection to challenge with virulent strains 
(Levine,Ferrecio and Black,1987;Black et a/.,1990;Forrest,Sheannan and 
LaBrooy,1990). Other biodegradable microparticles have been investigated as 
controlled-release antigen delivery systems (O'Hagan,1989;0'Hagan,Palin and 
Davis, 1989;0'Hagan,Rahman,McGee,Jeffery,Davies, Williams,Davis and 
Challacombe,1991). These include the use of 6-7J.Lm PLGA (D,L,-lactide-co-
glycolide) microparticles which can,reputedly,induce a humoral immune response 
of a similar magnitude to that obtained with the administration of antigen in 
Freunds adjuvant (O'Hagan et a/.,1991) and the eventual production of non-
toxic breakdown products (lactic and glycolic acids). 
In fish,enteric coating has been used to test the oral administration of 
V.anguillarum bacterin to rainbow trout. Challenge regimes however resulted 
m less protection usmg this method than unprotected antigen 
(Lillehaug,1989,1990). The lack of effect of enteric coating may be due to the 
possible damage of protective antigens during encapsulation, the coating causing 
blockage of LPS-associated antigen or the requirement for gastric action on the 
antigen to reveal epitopes that are immunogenic (Lillehaug, 1989, 1990). In the 
same study another,related,protective delivery system was used. This was the 
incorporation of the same antigen preparation of V.anguillarum into a matrix of 
heavily degraded fatty acids- a "prill" (Baalsrud and Velle,l974). "Prills" act by 
encompassing the delivered antigen in a matrix that is slowly broken down in the 
alimentary tract and appeared to allow greater uptake of antigen,as measured 
by greater protection,although were less protective than unprotected antigen. 
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Direct physical protection of vaccine can be seen to increase antigen 
uptake and immune response in some cases. Oral vaccine delivery,of all forms -
live,dead,toxin,subunit and protected- is usually carried out in the presence of 
an immunomodulatory compound or adjuvant. 
One method of antigen delivery,exclusively attempted in fish, is the use 
of bacterial antigens incorporated into a live zooplankton feed. Zooplankton 
Branchionus plicatilis were used to incorporate antigens from heat and formalin 
killed V.anguillarum and subsequently fed to ayu (Kawai,Yamamoto and 
Kusuda, 1989). These zooplankton would only incorporate certain antigens such 
as LPS but were found to elicit protection. On challenge,92.4% and 64.2% of 
the vaccinated and unvaccinated ayu were protected,respectively. Such a 
method of vaccination may prove useful for certain antigens in certain fish. 
2.8. THE USE OF ADJUVANTS IN VACCINATION. 
The term adjuvant is used almost exclusively in current texts and its use 
is often ambiguous as it usually encompasses substances that can modify the 
immune response to an antigen when given with that antigen (the classical 
definition of an adjuvant) but can also apply to those substances that can modify 
the immune response independently of its action on the antigen (previously 
termed immunostimulators). The term immunostimulator or immunopotentiator 
is still applied to some substances that can increase non-specific defence 
mechanisms (Ell is, 1988). However due to the multiplicity of action of adjuvants 
(see below) "immunostimulator" is less fashionable,as most 
adjuvants,indirectly,act in this manner. 
Adjuvants were first used in 1925 by Raman who showed it was possible 
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to specifically increase the serum antibody response to diphtheria and tetanus 
toxins by the addition of unrelated substances,such as bread 
crumbs,tapioca,starch ,lecithin and saponins,to the vaccine. Since then adjuvant 
development has largely been empirical (Warren et a/.,1986) and an enormous 
number of very diverse compounds have been found to modulate the immune 
response in a wide range of species. 
Adjuvants may be classified by a variety of means such as their mode of 
action on the delivered antigen (acting as an antigen repository,directly on 
antigen delivery or on recipient organism cells such as lymphocytes and 
macrophages) or their source (eg mineral,bacterial,plant,synthetic or host). The 
latter method of classification is useful as most antigens act by more than one 
mechanism but can usually be assigned by their origins (Warren et a/.,1986). 
Table 2.4 shows one classification of the major adjuvants (Jolivet,1989). 
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TABLE 2.4. CLASSIFICATION OF THE PRINCIPAL ADJUV ANTS. 
CLASSIFICATION OF PRINCIPAL ADJUV ANTS. 
MINERALS Aluminium hydroxide. 
Aluminum phosphate. 
Calcium phosphate. 
Fluoride. 
SURFACTANTS AND Emulsions of oil in water. 
HYDROPHOBIC SUBSTANCES 
Emulsions of oil in water. 
RIBI formulation (monophosphoryl 
lipid A + trehalose dimycolate). 
Adjuvant 65 (a mixture of Arlacel,oleic-
mannide and aluminium monoesterate). 
Squalene. 
Liposomes. 
Block polymers. 
Saponins. 
ISCOMS 
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CLASSIFICATION OF PRINCIPAL ADJUVANTS. 
CLASSIFICATION OF PRINCIPAL ADJUVANTS. 
SYNTHETIC POL YNUCLEOTIDES. Oligodeoxyribonucleotides. 
Polyribonucleotides. 
BACTERIA. Mycobacteria (Mycobacterium 
tuberculosis and M.bovis). 
Propionibacteriaceae. 
Parvo and Enterobacteriaceae. 
BACTERIAL DERIVATIVES. Wax D. 
WSA (soluble). 
Cord factor (a mixture of trehalose and 
mycolin). 
MDP and derivatives. 
LPS. 
Outer membrane proteins (such as 
TraT and Omp). 
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ClASSIFICATION. OF PRINCIPAL. ADJ.l:JV:ANTS: 
·-
ICI!ASSIFICA tiON 'OF 'FRINCIPAL A'OJUVA'NTS . 
. 
SYN!fHE'11IC MOI!JECULES~ Imuthiol. 
I '0xamisole. 
'I 
I Jsoprinosine, 
I 
-
'Levamisole. 
- .. --- -- -
:li 
1ihiazalobenzin1idazo(e. 
,1, 
Avfidihe., 
I JDIDA. 
'I 
VITAMINS 
'---- -- - ,_ . Vitamin.A.. 
Retinol palmitate. 
Retinoic acid. 
CYTOKINES~ lnterferons. 
Interleukins. 
2.8;•1'. NON-BACifER.Iit\L .JMi.>JUV·ANifSl 
li'he most widely ·usedi and ,the only .currently commer~ially available 
;under ilcensing restrictions;adjuvant .in• ·humans is .aluminium 'hydrQxid~ 
(AIOH3;Kiausner,.19S8)l li'he. first reported use of ·ahmiinium compounds as 
adJuvants, was in 1'926. (Oienny;Pope;Waddihgtbri arid Wallace):. ;In this study 
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administration of AlOH3 plus diphtheria toxoid elicited significantly higher 
antibody titres than diphtheria toxoid on its own. Other substances used were 
cerium nitrate,colloidal iron hydroxide,zinc sulphate and calcium chloride. The 
main action of AlOH3 is to act as an antigen repository ("depot") allowing a slow 
release of antigen which behaves as a secondary stimulus to previously released 
antigen (Warren and Chedid,l988). AlOH3 prolongs lymphocyte circulation in 
lymph nodes thus increasing the amount of contact between the antigen and 
lymphocytes (Edelman,1980). These classes of compounds are relatively weak 
adjuvants,increasing the humoral immune response slightly and directly 
activating the complement pathway but having little effect on the cellular 
immune responses. Even these may be associated with local granuloma in tissues 
if injected or if sufficient lamina! localisation occurs after oral delivery. Most 
of the above data is derived from mammalian studies (Warren and 
Chedid,1988). In fish Al0H3 has no adjuvant effect on injection in salmonids 
with keyhole-limpet haemocyanin-dinitrophenol (KLH-DNP) as an antigen, with 
the inducible serum antibody titres being decreased in some instances 
(Cossarini-Dunier,1985). Similar compounds such as alum (potassium 
aluminium hydroxide) also offer no adjuvant effect in salmonid immunisation to 
Vibrio vaccine (Horne,Roberts,Tatner and Ward,1984). Oral administration of 
Vibrio vaccine with alum caused increased protection to subsequent challenge 
but took longer to develop and was less effective than injected vaccine without 
adjuvant (Agius,Horne and Ward,1983). 
Administration of sodium fluoride (widely present in drinking water 
sources) is also reported to have a considerable immunopotentiating effect in 
50 
mammals,when delivered intragastrically (Butler,Satam and Ekstrand,1990). 
Synthetic chemical polymers have been produced in order to attempt to 
improve the immune response to antigens. Non-ionic polymers act as 
surfactants (surface-acting agents with or without an antigen repository function) 
and host responses to such compounds were dependent on both the local 
presentation of the antigen and its concentration. Oral administration of BSA 
was enhanced most efficiently by polyol compounds with a hydrophobic central 
region flanked by two hydrophilic regions (Warren et al., 1986). Copolymers of 
hydrophilic polyoxyethylene and hydrophobic polyoxy propylene in different 
proportions promoted an antibody response to BSA (Hunter,Strickland and 
Kedzy,1981;Hunter and Bennett,1984) possibly mimicking the effect of oil 
droplets (see below). Other synthetic substances such as aliphatic amines can 
be utilised as adjuvants (Dalsgaard, 1987) with C16 hydrocarbons such as 
dimethyldioadecylamine (DDA) and N,N-dioctadecyi-N,N-bis (2-hydroxyethyl) 
pronaediamine (Avridine) being the least toxic and most effective. Such 
compounds have only been tested in mammals and have been found to activate 
macrophages and cause interleukin-1 release,stimulating the cell-mediated and 
humoral immune mechanisms (Klausner,l988). Similar substances are present 
in fish and therefore aliphatic amines may eventually be considered as practical 
adjuvants. Synthetic substances under consideration (in mammalian systems) 
include the polyanionic synthetic double-stranded polyribonucleotide complexes 
along with polyacrylic acid,dextran,bentonite and naturally occuring double-
stranded RNA (Warren and Chedid 1988;Klausner,1988) all of which act on 
receptor systems by antigen presentation and\or release mechanisms and act as 
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specific B-cell mitogens (Genco et a/.,1983). 
Liposomes have been examined as delivery systems in their own right,but 
it should be mentioned that part of their phospholipid structure,if absorbed 
intact can act as an adjuvant and can decrease the thymic dependency of an 
antigen where applicable (Yasuda,Dancey and Kinsky,1977;Yasuda,Kanegasaki, 
Tsumita,Tadakuma,Homrna,Inage,Kusumoto and Shiba ,1982;Taubman,Ebersole, 
Smith and Stack,1984). Liposomes can act as efficient adjuvants for 
carbohydrate antigens and therefore may be useful in vaccines utilising bacterial 
capsules such as Meningococcal vaccine. The essential hydrophobicity of the 
liposome phospholipid may be a controlling influence on its adjuvanticity to a 
particular antigen. Liposomes have adjuvant action by either direct action on 
the immune system or by presenting the relevant epitopes more efficiently to the 
immunocompetent cells (Garcon and Six,l991). 
One obvious method of potentially increasing immunological responses 
to orally delivered antigen is by the use of substances that neutralize gastric 
acidity or peptic activity such as sodium bicarbonate,pepstatin or carbonic 
anhydrase (McLean,1987). Sodium bicarbonate is used as both a solution and 
tablet prior to,or concurrently with,oral cholera vaccination in large scale field 
trials as cholera toxin is known to be strictly pH sensitive 
(Clemens,Jetborn,Sack,Stanton,Holmgren,Khan and Huda,1986). Similarly,the 
addition of proteolytic inhibitors such as aprotinin (affects chymotrypsin) and 
soy-bean trypsin inhibitor (SBTI;affecting trypsin) can increase uptake of BSA 
in new-born rabbits (Udall et al.,1984) and other mammals. Administration of 
SBTI to rainbow trout was found to enhance the mean tissue accumulation of 
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HRP by 55-220% in the liver and kidney but did not influence its plasma levels 
(McLean,1987) in contrast to mammals where aprotinin caused a 60% increase 
in plasma-borne antigen (Seifert,Sass and Dreyer,1984). Such adjuvants seen to 
be effective solely due to their power to reduce the gastric degradation of 
antigen and some studies have suggested that increased protection to bacterial 
challenge after anal administration of antigen (thus bypassing the major 
degradative routes) is a direct result of greater antigen dose across the intestine 
(Johnson and Amend, 1983a;1983b) rather than any modifications on the antigen 
or recipient tissue. 
Adjuvants that affect the pinocytotic,endocytotic or lysosomal-degradative 
processes are also theoretically capable of acting as adjuvants to certain 
antigens. However the antibiotic monensin was found to be ineffective as an 
adjuvantfor the increase of HRP in rainbow trout after oral or anal delivery 
(McLean, 1987). Chloroquine and ammonium chloride are also both 
lysomotrophic agents and deserve further study as adjuvants (Bland and 
Whiting,1990). 
One of the most studied classes of adjuvants are the detergents 
(Edelmann,1980;Dalsgaard,1987). There are an enormous variety that have 
been tested eg the polyoxyethylene sorbitan monolaurate (Tween) class of 
substances (Warren and Chedid, 1988). One of the major groups recognised as 
potentially powerful adjuvants are the saponins and they are already in use as 
adjuvants for veterinary vaccines against equine influenza and feline leukaemia 
virus. Saponins are a naturally occuring and widespread group and,though not 
fully defined chemically,consist of glycosides mainly a triterpenoid aglycan in 
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glycosidic linkage with several naturally occunng steroids 
(Dalsgaard,l978,1987;Campbell and Bede,l989). The most studied of these is 
a purified saponin extract of Quillaja saponaria [Molina] or Quil-A the 
separation and characterization of the active components of which is 
complex,resulting in the delineation of several immunologically active 
components (Kensil,Patel,Lennick and Marciani,1991). Quil-A acts as a 
surfactant,directly binding to surface cholesterol and causing several membrane 
effects including pore formation (Dalsgaard,1987;Bomford, 1980,1982,1988). It 
also has several other effects,acting as an antigen repository,a B-cell mitogen 
and a non-specific stimulator of macrophage activity and interleukin release 
(Campbell and Bede,1989). In mammals Quii-A increased the cell-mediated 
and plaque-forming cell (PFC) responses to T-dependent and T-independent 
antigens (Bomford,1980;Flebbe and Braley-Mullen,1986). Quii-A,whilst being 
a B-cell mitogen,cannot induce an antibody response in conditions where one 
would not already occur and as such differs in its mode of action from bacterial 
LPS. Potentiation of a mammalian oral vaccine to rabies virus,by Quil-A, 
resulted in strong antibody response and protection from intercerebral challenge 
from live virus (Maharaj,Froh and Camp bell, 1986). Injection studies with 
saponins in fish showed no adjuvanticity (Home et al., 1984;Cossarini-
Dunier, 1985) and immersion studies in rainbow trout also showed no increase 
in protection but an increase in the non-specific mechanisms involved in the 
bacterial clearance of Yersinia ruckeri (Grayson,Williams,Wrathmeli,Munn and 
Harris,1987). Saponins can also be induced to form three-dimensional structures 
due to their physical nature (micelles and immune-stimulatory 
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complexes,ISCOMS) that may give a novel aspect to their adjuvanticity 
(Morein,Sundquist,Hoglund,Dalsgaard and Osterhaus,1984;Morein and 
Simon,1985;Morein,Lovgren,Hoglund and Sundquist, 1987) and act to induce an 
immune response that would otherwise be unobtainable often by overcoming 
specific antigen tolerance (Mowat,Donachie,Reid and Jarrett,1991). ISCOMS 
have been used in several studies in mammals for the delivery of viral proteins 
but can also be produced with the incorporation of standard proteins (Mowat 
et al., 1991) and proteins derived from bacterial pathogens (Kersten et 
al.,1988a,1988b). Other detergents have been used as adjuvants for orally 
delivered antigens in fish such as Mega 9 (McLean,1987). This detergent 
enhanced the uptake of orally and anally administered antigen,but had a 2-4 
times greater effect anally. Mega 9 had its effect by gelatinising the mucus layer 
of the intestine,thinning or removing it altogether, and allowing a 
greater,direct,interaction of the antigen with the enterocytes surface as well as 
possibly other surfactant attributes. 
Recent attention has been focused on the use of vitamins as potential 
adjuvants (Friedman,1991). Water-miscible vitamin A,and several of its 
bioactive components,were found to act as extrinsic adjuvants ie. they induced 
an immune response to ovalbumin without being immunogenic itself,of a similar 
level to that obtained with the delivery of ovalbumin with MOP 
(Friedman, 1991 ). 
These adjuvants are derived from many different sources and many are 
in current use as experimental vaccine adjuvants. 
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2.8.2. BACTERIAL ADJUV ANTS. 
The most widely used adjuvants in test systems are bacterial in nature -
Freunds Complete Adjuvant (FCA). This adjuvant is largely restricted to use 
with injected antigens but is mentioned due to its importance and because its 
use has motivated research into the active components which can be used orally 
and oil-droplet based adjuvants which still remains the most potent method of 
enhancing administration (Freund,l956;Taubman et a/.,1984). The active 
components of FCA are a mineral oil and a Mycobacterium tuberculum strain 
which in combination are very potent stimulating both the cellular and humoral 
immune systems but are,however,very toxic (Freunds Incomplete Adjuvant,FIA 
lacks the bacterium and is often used as a booster adjuvant but remains 
potent;Warren et a/.,1986;Warren and Chedid,1988). It acts on antigen by its 
presentation in an organised manner,exposed on the surface of microdroplets of 
the mineral oil thus facilitating its interaction with,already 
stimulated,immunocompetent cells (Dalsgaard,1987),but has also been reported 
to confer protection against subsequent challenge non-specifically,in fish 
(Olivier,Evelyn and Lallier, 1985). The active component of such mixtures is one 
of the smallest bioactive peptides known ; consisting of two peptides flanked by 
one sugar residue, -N-acetylmuramyl-L-alanyl-D-isoglutamine (muramyl 
dipeptide,MDP;Ellouz,Adam,Ciorbaru and Lederer,1974). MOP retains its 
adjuvanticity when delivered by the oral route,especially with T-dependent 
antigens ( Mes tecky, McG hee,Arnold, M ichaele k, Pri nee and 
Babb, 1978;Smith,Taubman and Ebersole, 1979). Oral delivery of MDP with 
antigens enhanced the secretory immune responses from increased antibody 
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titres to the induction of isotype specific T-suppressor cells (Langbeheim,Arnon 
and Sela,1978) and can elicit an antibody response when given orally even if the 
antigen is given by another route (Warren et a/.,1986). MDP can stimulate 
macrophages to produce interleukin 1,decrease their migration,increase their 
adherence and spreading and cause them to release prostaglandins or act as T-
cell replacing factors for B-cells (Watson and Whitlock,1978;Byers, 1982; 
Taubman et a/.,1984). MDP has been used in numerous studies on oral delivery 
of antigens in mammals (Warren and Chedid,1988). In fish MDP had no effect 
on the immune response of rainbow trout when injected peritoneally (Cossarini-
Dunier,1985) on its own,in terms of elevated serum antibody titres. It has not 
been used in the oral delivery of antigens in fish. Natural water in oil emulsions 
have been produced to mimic the effect of this form of adjuvant with a mixture 
of lecithin+ glycerin+ peanut oil (LIPOV ANT) being used as an effective 
adjuvant in equine encephalitis vaccine (Dalsgaard,1987). In fish Bacille 
Calmette-Guerin (BCG) mycobacterial preparation was found not to act as an 
effective adjuvant for Y.ruckeri in immersion vaccines (Grayson et a/.,1987). 
The other main bacterial adjuvants are LPS,Bordetella pertussis and a 
variety of detoxified bacterial products (Klausner, 1988). 
The use of LPS as an adjuvant was first described in 1956 
(Johnson,Gaines and Landy). LPS (endotoxin) can affect the tight junctions of 
enterocytes,facilitating greater levels of uptake of orally delivered antigen across 
the intestine. The classical effect of LPS,however,is its T-cell independent 
mitogenic effect on B-cells where it can stimulate production of non-specific 
antibody (-antigen) and specific antigen in the presence of antigen (Warren et 
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al.,1986). LPS can also directly affect macrophages by stimulating monokine 
production and by altering their level of la antigens thereby influencing antigen 
presentation. As an adjuvant LPS is very toxic due to the Lipid-A portion of the 
molecule. Most studies in fish (EIIis,1988) have utilised LPS as a candidate 
antigen for vaccines rather than an adjuvant although it has been shown in 
mammals that non-specific LPS (eg from Kleibsella spp) can afford protection to 
mice against pathogens such as Listeria monocytogenes (Fujiki,Kutsukake,Imai 
and Tanaka,1988). 
Bordetella pertussis LPS and pertussis toxin are also used as adjuvants in 
mammalian test systems (Waksman,1979). Pertussis-based adjuvants enhances 
cell-mediated immunity by its modulation of the recirculation of lymphocytes 
and the subsequent alteration of the balance of T-cells in the secondary 
lymphoid tissue (Tamura,Tanaka,Takayama,Sato and Uchida,1985). Such 
adjuvants can cause an elevated immune response (antibody titre) against SRBC. 
Other microbial products being commercially evaluated as potential 
adjuvants are monophosphoryl Lipid A,Propionibacterium aranes-pyridine 
extract,trehalose dimycolate,mycobacterial cell wall skeleton and 
Corynebacterium parvum/rubrum DNA (Kiausner,1988). The eo-administration 
of antigen with non-pyrogenic integral membrane proteins (Imps) derived from 
E.coli has also been evaluated recently (Croft,Walsh,Lioyd and Russell-
Jones,1991). The extraction and use of the TraT outer membrane protein and 
its conjugation to standard antigens (its use as a carrier-molecule adjuvant) was 
found to elicit a significantly increased antibody titre to a protein derived from 
Plasmodium falcipwum (Croft et a/.,1991). 
'-
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The nmge of (ldjuvants available for use with:.oral vaccines is immense 
and it :is almost certain ~that optimisation: of vacdtiatiori regimes' to: produce an. 
effiCient and protectiveiirrunune r~sponse in fish and mammals, will ~require the if 
:use; 
Oral vaccination: ·to achieve a' viable,long~lasting andl commercially 
feasible J)rote·ctive :response' is !likely to require a11 enhanced fmm of 
:specific;purifiec:t: 11.ntigen (or antigens in multivalent vaccines) in a ,precise• 
deliver)' system,~ith: the :presence of an !adjuvant. 
CHAPTER3. 
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CHAPTER 3. IMMUNOCYTOCHEMISTRY OF THE UPTAKE OF 
PROTEIN ANTIGENS AND THE USE OF ENHANCED DELIVERY 
SYSTEMS. 
3.1 INTRODUCTION. 
The ability to absorb intact protein macromolecules has been 
demonstrated in several studies on mammals (Walker,Isselbacher and 
Bloch,1972;Walker and Bloch,1983a,1983b) and in larval and adult fish including 
elasmobranchs (Hart,1987),rainbow trout Oncorhynchus mykiss (McLean and 
Ash,1987),goldfish Carassius auratus (lwai,l969;Watanabe,1982),carp, Cyprinus 
carpw (Iwai,1969;Rombout,Lamers,Helfrich,Dekker and Taverne-
Thiele, 1985;McLean and Ash, 1987) and others (Watanabe,1984) including tilapia 
Oreochromis mossambicus (Doggett,1989). Some studies have dealt with the 
accumulation of antigen in the bloodstream and other organs of the body 
(McLean,1987;McLean and Ash,1987,1990;McLean and Donaldson,1990) while 
others have addressed the mechanisms of the temporal passage of antigens 
across the intestine and its associated cellular interactions in vivo including 
those with cells of the gut-associated lymphoid tissue (GALT) (Georgopoulou 
et a/.,1986;Georgopoulou et a/.,1988;Rombout and Van Den Berg,1989). 
Most of the studies on intestinal absorption of protein antigens in teleosts 
have relied on the direct physical visualisation of the antigen (under light or 
electron microscopy) by the immediate colorimetric development of a delivered 
enzymatic antigen eg the direct physical development of horseradish peroxidase 
((HRP);Graham and Karnovsky, 1966);or by a radioimmunoassay detection 
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system. 
Both of the above techniques have shortcomings with radioimmunoassays 
being less effective for monitoring protein antigen uptake for a variety of 
reasons including the effect of the isotope on the detecting antibody and the 
possible splitting of the isotope from its associated antibody and its subsequent 
spurious detection (Larssen,1988). Direct visualisation of antigens that can be 
degraded after delivery is problematic,especially for the cytochemical detection 
of macromolecules such as HRP and ferritin,as the signal-generating reaction is 
largely dependent on the presence of relatively intact macromolecules 
(Larssen, 1988;Rombout and van den Berg, 1989). Immunocytochemical detection 
has several distinct advantages over these more conventional methods,for 
analysis of absorption of delivered protein antigens (Bullock and 
Petrusz,1982;Polak and Van Noorden,1986;Beesley,1988;Larssen,1988) as they 
can potentially visualise both intact macromolecules and derived antigenic 
fragments that may be important as nascent immunogens (Rombout and van den 
Berg,1989). 
Immunocytochemical detection systems appear to allow greater sensitivity 
of antigen detection along with a less artifactual visualisation of antigen 
distribution. To date,the technique has been used to monitor macromolecular 
absorption after oral delivery m relatively few studies m fish 
(Hart,l987;Georgopoulou et al., 1986;Rombout and van den Berg, 1989). Proteins 
have been shown being absorbed across the intestinal enterocytes of various 
species of gastric (Georgopoulou et al., 1985, 1986,1988) and agastric fish (Davina, 
et al.,1980,Rombout, et a/.,1985;Rombout, et a/.,1986). Proteins,once thought to 
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be ::tbsorbed l?redominantly across the enterocytes of the posterior intestines ·of 
fish (NoaillaccDepeyre:and:Gas, 1973;Watanabe, 1984)ihave .been· reported.b_eing 
·absorbe.d across the anterior ·regions·of the intestine (Lamers, 1985) as· is the case 
for HR:P .and ferritin in •til'apia· ~Doggett,1989). 
Onilly dellvered· protein macromolecules have been reported being 
absorbed very >rapidly in anjntact form across ,the posterior and.anterior regions 
of.the intestine of tilapia (Doggett,1989). However,protein antigens deiivered 
to O.mossambicus are also .recognised as being heavily degraded by a variety of 
digestive processes;which c()uld l~ad to the production of definable .and 
potentially immunogenic fragments which could have value in the oral induction 
of a relevant immune response, 
Orally delivered protein macromolecules have been obser.Ved in 
association With the various· cells of .the GALT .underlying the intestinal· 
enterocytes of fish ~Davina et a/.,1980;Georgopoulou et al.,l986;Rombout and 
van den Berg,1989). The 1leveis of antibodies generated by oral delivery of 
proteiris;such as.fetritih;are relatively'low but may ~e substantially proteciive.for 
certain ·!Jacterial aQtigens (Rombout .et ql., 1989b} One method of increasing 
both tbe levels .of absorbed protein macromolecules after oral' delivery and: the 
resuJtant immune •responses io these proteins 'is by· the ·use of adjuvants 
(Ellis;l988). T:he saponin adjuvant,Quil-A,has been shown to enhance. the 
uptake and immune respons·e to orally .delivered aQtigeQs in m~mmals for 
antigens from .a wide yariety of sources (Dalsgaard,l9i78;1987;Maharaj et 
a/.,1986;Campbelli and Bede,1989) and: by a variety of mechanisms. Quil~A,and 
saponin adjuvants in .general;have been largely neglected for oral delivery 
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systems m teleost fish and only rarely used via the intraperitoneal and 
immersion routes (Cossarini-Dunier,1985;Tatner and Horne,1985;Grayson et 
a/.,1987). 
The current study attempts to analyse the tissue localisation and 
mechanics of absorption of orally and anally delivered protein macromolecules 
utilising a variety of sensitive immunocytochemical techniques and the effects on 
absorption of the saponin adjuvant Quii-A. 
3.2 MATERIALS AND METHODS. 
3.2.1. ANIMALS. 
Adult tilapia,Oreochromis mossambicus, of both sexes weighing between 
30-50g were retained in a recirculating freshwater system at 24-26 ·C. 
3.2.2. INTUBATION PROCEDURES. 
Groups of tilapia (n = 3) were intubated with test antigen,human gamma 
globulin (HGG,molecular weight 150kDa,Cohn fraction II,Sigma,Poole Dorset). 
Each fish received 0.2ml of a lOmg/ml HGG solution using phosphate buffered 
saline as diluent (PBS,pH 7.2;Appendix I). Peroral and peranal intubation was 
carried out using thin bore pVC tubing (l.OOmm and 0.75mm external diameter 
for oral and anal administration,respectively) attached to a lml syringe via a 23g 
needle. Control groups of tilapia (n =3) were intubated with PBS pH 7.2. Oral 
and anal administration of HGG was carried out over a structured time course 
and tissue sampled as follows: after 5,15,30,60 minutes and 2,6,12,24 and 48 
hours. 
HGG was administered orally and anally with the purified saponin 
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adjuvant Quii-A,derived from Qui/laja saponaria [Molina] (Superfos,Denmark). 
Quii-A was administered with antigen in several forms: 
1) At various concentrations (100J.Lg/ml;10J..Lg/ml and lJ..Lg/ml),l hour 
prior to the intubation of HGG,by a complementary route (ie orally or anally). 
2) Concurrently with the antigen,at various concentrations (as above),by 
a complementary route. 
3) As a micellar package (see 3.2.3.). 
4) As an immune stimulatory complex (ISCOM)(see 3.2.4.). 
5) At 100J..Lg/ml (in PBS pH 7.6;0.2ml dose) on its own for the 
determination of any direct effects on the intestine. 
3.2.3. THE FORMATION OF MICELLES WITH OUIL-A. 
All saponins,including Quil-A, have the ability to spontaneously form 
micelles when in an aqueous solution above a defined critical concentration. 
For this purified preparation of Quil-A this critical micellar concentration 
(CMC) was approximately 0.03% (Dalsgaard,1978). 
Micelle formation is characterised by a drop in the overall conductivity 
of the solution as levels of free ions lessen,with the hydrophilic regions of the 
saponin molecules being bound up in the micelle structure (Dalsgaard,1978). 
The formation of Quii-A micelles with HOG was monitored by detection of 
conductivity of the solution with a Electrical Instruments conductivity meter 
(Kent Meters,LtD,Luton,U.K.). Micelles were prepared by prolonged vortexing 
of lOmg/ml HGG with Quil-A above the CMC and 0.2ml of this solution was 
subsequently administered to groups of fish (n = 3). 
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3.2.4. THE PREPARATION OF IMMUNE STIMULATORY 
COMPLEXES (ISCOMS) 
ISCOMS were produced utilising concentrations of Quit-A above the 
CMC but were structurally distinct from micelles. ISCOMS were prepared 
according to the method of Morein et a/.,(1984). Brietly,6ml of HGG 
(10mg/ml) in O.OSM Tris-HCI- 0.1ml NaCI (Tris-saline,pH 7.4) buffer plus 60~1 
(1 %) E. coli strain L:026:B6 lipopolysaccharide (LPS;Sigma) and 0.03% Quii-A 
was layered over approximately 30ml of a 10-40% sucrose density gradient also 
containing 0.03% Quil-A,and was ultracentrifuged at 44000rpm (150 OOOg) for 
4 hours at 20 • C using a 70 T.I rotor head in a Beckman L7 ultracentrifuge 
(Beckman,High Wycombe). 
A tight white band of ISCOMS were formed and fractions of 
approximately 1ml were eluted and dialysed against O.OSM ammonium acetate 
for 48 hours at 4 ·C. All fractions were tested for protein content using a 
commerciai,Bradford (Bradford, 1976),total protein assay system 
(Biorad,Watford) and also for antigen content using a HGG specific enzyme-
linked immunosorbent assay (ELISA) as described in Chapter 4. The 
concentration of ISCOMS was subsequently adjusted in Tris-saline to 
approximately lOmg/ml HGG and 0.2ml administered to fish. 
Control groups of tilapia (n =3) were immunised with an uncentrifuged 
HGG/Quii-A/E.co/i LPS mixture,a HGG/LPS mixture or HGG alone by a 
complementary route. 
3.2.5. TISSUE COLLECTION. 
Fish were sacrificed by a sharp blow to the head,and the intestine,from 
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the pyloric sphincter to the anus,immediately excised. The intestine was divided 
into the anterior,mid and posterior regions of approximately equal length 
(Doggett,1989). 
3.2.6. IMMUNOHISTOCHEMJSTR Y. 
Tissue was fixed for immunohistochemistry m 2% 
paraformaldehyde,buffered in PBS pH 7.6,for 2 hours at 4 • C and subsequently 
washed for 2x10 minutes in PBS. Tissue was prepared for paraffin wax 
immunohistochemistry by automatic dehydration through graded alcohols,cleared 
in xylene and was embedded in molten Fibrowax (BDH,Bristol) at 56-58· C. 
Sections were cut at 5-6~-tm on a Reichert-Jung rotary microtome (Reichert-
Jung,London). 
3.2.6.1. IMMUNOPEROXIDASE STAINING. 
An antigen-specific streptavidin-biotin-HRP complex staining procedure 
was used to localise antigen in tissue sections as described by Hsu,Reine and 
Farger (1981). All reagents are as outlined in Appendix I. The antibody 
concentrations were optimised,on section,using a checkerboard titration method 
of primary antisera from 1/100 to 1/1000 and secondary antisera from 1/300 to 
1/1000. 
Sections were deparaffinised and rehydrated,equilibrated in Tris-saline 
(TBS) pH 7.5 for 10 minutes and endogenous chemical activity suppressed using 
3% v /v H20 2 for 5 minutes (for endogenous peroxidase activity) and 0.01% v /v 
streptavidin followed by 0.001% v /v biotin (for endogenous avidin activity). 
Sections were washed for 10 minutes in Tris-saline and incubated in normal goat 
serum (1/5 in TBS) for 20 minutes to eliminate cross-reactivity with the 
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secondary antiserum (Bourne,1983). 
All antisera (Dako Ltd,High Wycombe,Bucks) were diluted in TBS plus 
0.1% bovine serum albumin (BSA) as a blocking agent and the sections were 
washed for 3x 5 minutes in TBS after each incubation. Sections were incubated 
with rabbit anti-HGG (Sigma) antiserum optimised at 1/500 for 1 hour at 
ambient temperature (primary antiserum) followed by incubation in biotinylated 
goat anti-rabbit IgG antiserum (Dako,Ltd) optirnised at 1/1000 (secondary 
antibody) for 1 hour at ambient temperature. After washing as previously, the 
sections were incubated in streptavidin-biotin-HRP (sABC-HRP) complex for 
30 minutes at ambient temperature and subsequently developed in peroxidase 
substrate solution consisting of 6mg of 3'3' diaminobenzidine tetrahydrochloride 
(DAB) in lOml TBS plus lOOJ.Ll of 3% vfv HP2 as the reaction initiator,for 3-5 
minutes. Positive,specific,peroxidase activity is defined by a deep-brown colour 
reaction product that is insoluble in alcohol. The reaction was stopped by 
extensive washing in distilled water and the sections counterstained,dehydrated 
and mounted in DPX. 
3.2.6.2. TWO-STAGE IMMUNOPEROXIDASE STAINING. 
Two-stage immunoperoxidase staining was carried out by sequential 
antisera incubations and washings as previously,using TBS as the washing 
medium and TBS-BSA as the incubation solution. Primary antisera incubation 
was as in 3.2.6.1. and secondary antisera incubation was with goat anti-rabbit 
peroxidase conjugate (Sigma) at 1/1000 for 1 hour at ambient temperature. The 
development of the peroxidase-labelled conjugate was carried out using the 
DAB substrate as previously described. 
67 
3.2.6.3. IMMUNOGOLD-SILVER STAINING. 
A silver-enhanced immunogold staining method was also used to detect 
absorbed HGG based on the method of Hacker,Springall, Van 
Noorden,Bishop,Grimelius and Polak (1985). Some sections were pre-treated in 
Lugol's iodine (a 1% wfv iodine in 2% v/v aqueous potassium iodide solution) 
for 5 minutes followed by bleaching in sodium thiosulphate until colourless,in 
an attempt to accentuate staining. 
Sections were rehydrated and rinsed in 10mM PBS pH 7.2 and incubated 
in 5% heat-inactivated (52· C for 20 minutes) normal goat serum diluted in PBS 
for 20 minutes. All incubations were carried out in antisera diluted in PBS plus 
0.1% BSA and were followed by sequential washing in PBS for 3x 5 minutes. 
Sections were incubated in rabbit anti-HGG (primary antibody) at 1/500 for 2 
hours at ambient temperature followed by goat anti-rabbit IgG 5nm gold 
conjugate (1/100 for 1 hour) diluted in PBS-BSA plus 5% porcine gelatin. The 
sections were washed in PBS and distilled water (3x3 minutes) prior to silver 
enhancement. 
The sections were silver enhanced according to the manufacturers 
instructions (Amersham Ltd,Amersham,Herts.) for approximately 12 minutes 
and the reaction was stopped by rinsing in distilled water. 
A brief diagrammatical representation of the immunostaining methods 
used is shown in Figure 1. 
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FIGURE 3.1. METHODS OF IMMUNODETECTION OF HGG 
ANTIGENS. 
~ Sliver Precipitate 
J~•Ablg/~d 
Abi x 
3.2.7. COUNTERSTAINING AND CONTROLS. 
Comprehensive technical controls were carried out using blocking steps 
for endogenous peroxidase (Lewis,Johnson and Cruse, 1983) and avidin (Wood 
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and Warnke,1981),a serum blocking stage which reduces any potential cross-
reactions with the secondary antisera;control sections without primary or 
secondary antisera or ABC-HRP bridging-complex and pre-absorption of the 
antisera with appropriate antigen (HGG) and its subsequent use on sections. 
Counterstaining was carried out with Mayer's haematoxylin (Drury and 
Wallington, 1976), Wrights stain (Russell,pers.comm.),Giemsa's stain 
(McWann,pers.comm.) and haematoxylin and eosm (Drury and 
Wallington, 1976). 
3.2.8. IMMUNO-ELECTRONMlCROSCOPY. 
Intestinal tissue was fixed in a solution of 2% paraformaldehyde plus 
0.5% glutaraldehyde for 2 hours at 4 ° C. Tissue was then sequentially treated 
in 70% ,90% and 100% alcohol,equilibrated and embedded in LR White 
medium-grade hydrophilic resin at 48 ° C for 48 hours. Other tissue blocks were 
fixed,as previously,and prepared for embedding in Nanoplast FB101 water 
soluble melamine resin. For this, tissue was pre-stained in 1% v /v aqueous 
uranyl acetate for 4 hours in the dark,embedded in Nanoplast and dried in a 
desiccator for 48 hours at 40 ·C. Post-curing was carried out at 60 ° C for 48 
hours. 
Silver sections were cut at 500-800A on a Reichert-Jung Ultracut 
microtome and mounted on inert (gold or nickel) 200-400 mesh grids. 
The sections were stained using the two-stage immunoperoxidase and 
immunogold methods with the antisera being diluted as previously. All staining 
was carried out on droplets of the appropriate solutions at ambient temperature. 
The sections were washed by transferring the grids,step-wise,into droplets of 
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PBS buffer and blotting them carefully. The peroxidase-conjugated secondary 
antisera for the immunoperoxidase method was developed with a solution of 
DAB (as previously described) for 3-5 minutes. Immunogold stained grids were 
unenhanced. The sections were counterstained with lead citrate and examined 
under a Philips 300 transmission electron microscope. 
3.2.9. THE CYTOCHEMICAL DETECTION OF QUIL-A. 
Intestinal tissue blocks were fixed for cytochemistry in 2% glutaraldehyde 
for 2 hours and then post-fixed in 1% osmium tetroxide (Os04) for 60 minutes. 
Osmium tetroxide can act as a general stain for unsaturated lipids 
(Pearse,1968;Bayliss-High,1984) and was used to probe for Quil-A in this study. 
Tissue was dehydrated through a series of graded alcohols,embedded in Spurrs' 
resin (TAAB,Reading) and sectioned and examined as previously. Control 
tissue (without Quii-A) was processed and examined as above. 
J..J., RESULTS. 
3.3.1. THE ABSORPTION OF HGG. 
HGG was detected free in the gut lumen and associated with the mucus 
layer of the intestine 5 minutes after both oral and anal administration but was 
not observed in the intestinal epithelium itself (not shown). 
HGG was detected immunohistochemically in all regions of the intestine 
15 minutes after oral and anal intubation in the terminal webs of the enterocytes 
and,rarely,in the lamina propria (Figure 3.2e). Oral intubation generally 
resulted in less observable antigen throughout the intestine up to 1 hour and in 
less accumulated antigen (Figure 3.2a) although antigen was also observed in 
apparent contact with the intraepithelial leucocytes (IEL's) with this route of 
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delivery (Figures 3.2a and 3.2b). Maximum levels of HGG were detected in all 
regions of the intestine approximately 6 hour after oral delivery (Figures 3.3a 
and 3.3e) and antigen was observed in accumulations in the supra-nuclear 
cytoplasm of the enterocytes and throughout the lamina propria. Thirty minutes 
after anal intubation (Figure 3.2c) HGG was observed more often in the apical 
cytoplasm of the enterocytes and in the lamina propria free or apparently in 
contact with the IEL's situated near the basement membrane. Maximum levels 
of antigen were detectable in the posterior intestine 1 hour after anal intubation 
of antigen and was widely distributed after 2 (Figure 3.2d) to 6 hours (Figure 
3.3c). The amount of antigen after both oral and anal delivery decreased after 
6 hours. After 12 hours (Figures 3.3b and 3.3.d) there is less observable antigen 
in all the intestinal regions. Anally delivered antigen is still visualised in 
accumulations in the enterocytes but in reduced levels. Little trace of HGG 
could be detected 24 to 48 hours after administration. 
Experimental (PBS intubations) and technical controls were negative for 
endogenous,cross-reactive and specific staining (not shown). 
3.3.2. THE MECHANICS OF HGG ABSORPTION. 
Orally delivered antigen was visualised in contact with the enterocyte 
microvilli (Figure 3.4e) of the posterior intestine,with associated invaginations 
being formed in the lumenal plasma membranes of the cells (Figure 3.4a). 
HGG appeared to be absorbed by such invaginations being pinched off from the 
plasma membrane and compartmentalised in large spherical vesicles. HGG was 
also observed near cytoplasmic tubules (Figure 3.4a) that were associated with 
the plasma membrane. Vesicular formation appeared to be a composite of 
72 
antigen deposition from both pinocytotic invaginations of the enterocyte 
membrane and cytoplasmic tubule coalescence (Figure 3.4b) forming both 
amorphous (less-structured) deposits of antigen and structured pinocytotic 
vesicles. Anally delivered antigen was pinocytosed in a similar manner,with an 
apparent migration pattern towards the supranuclear cytoplasm (Figure 3.4c). 
Some anally delivered antigen appeared to be associated with phagolysosomes 
after approximately 1 hour. Small amounts of HGG were also observed in 
association with the goblet cells of the posterior intestine (Figure 3.4d). Antigen 
appeared to be situated in the basal regions of the mucus cell and in the 
phagolysosomes of the adjacent cellular cytoplasm. 
HGG was absorbed through the enterocytes by vesicular transport to the 
lateral intercellular regions of the cells (Figure 3.5e) or to the basal membrane 
and was then exocytosed from the enterocytes to the lamina propria and the 
underlying vasculature (Figure 3.5a). One hour after delivery,exocytosed antigen 
could be visualised in intimate contact with the capillaries of the intestine 
(Figure 3.5a;closed black triangle Figure 3.5b ). There was an observable 
morphological difference between antigen vesicles on the basis of their size and 
apparent lysosomal activity (Figures 3.5b and 3.5c). Some exocytosed vesicles 
had been broken down leaving amorphous,degraded,antigen (open black 
triangle,Figure 3.5c) in the lamina propria. 
After absorption, exocytosed antigen came into contact with a variety of 
GALT leucocytes. HGG was found being degraded in the phagolysosomes of 
macrophages in the lamina propria and epithelium after 2 hours and up to 12 
hours (not shown). Leucocytes with both macrophage and lymphocyte-like 
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morphologies were also found to bind HGG at their plasma membranes (Figure 
3.5d). Antigen could be observed being directed to the intercellular spaces 
between these leucocytes and the surrounding enterocytes or lamina! cells. 
hours. 
Antigen was largely absent after 12 hours and none was detected after 48 
3.3.3. THE EFFECf OF VARIOUS MODES OF DELIVERY OF 
OUIL-A ON THE ABSORPTION AND PROCESSING OF HGG. 
Orally administered Quil-A (100t.Lg/ml;0.2ml dose) on its own was 
cytochemically distinguished in various areas of the enterocytes of the intestine 
in large amounts 1 hour after delivery (Figures 3.6a and 3.6b ). 
Quil-A caused extensive pinocytosis of the lumenal contents (Figure 3.6c). 
Quil-A appeared to be absorbed directly across intercellular junctions and by a 
cytoplasmic tubule system. Conversely,micellar Quil-A could be observed 
coalescing with the enterocyte plasma membranes (Figure 3.6c). Quil-A also 
affected the cellular microvilli of the enterocytes causing them to become 
shortened and damaged (Figure 3.6d). 
Quil-A administration orally and anally conspicuously affected the extent 
of uptake of HGG when given prior to (Figure 3.7) and concurrently with the 
antigen (Figures 3.8 and 3.9). The concentrations of Quil-A administered 
appeared to have similar effects on the increase of observable HGG absorbed. 
The prior administration of Quil-A caused a more extensive uptake of 
orally delivered HGG throughout the intestine (Figures 3.7a and 3.7b) when 
compared with the delivery of the antigen on its own,with more being present 
74 
in the epithelium and lamina propria 1 hour after the administration of Quil-A. 
Transcellular protein uptake mechanisms appeared to be largely similar to that 
described earlier ie by pinocytotic vesicles and prior administration of Quil-A 
caused anally delivered HGG to be rapidly absorbed and increasingly associated 
with the capillaries (Figures 3.7c and 3.7d). 
Concurrent Qui l-A administration also caused increased uptake of HGG 
(Figure 3.8). Both oral (Figures 3.8a and 3.8b) and anal (Figures 3.8c,3.8d and 
3.8e) concurrent delivery of adjuvant caused extensive localisation and retention 
of antigen in the lamina propria. Large antigen-containing micelles could be 
observed coalescing with the intestinal epithelium after anal delivery (Figure 
3.8d). 
Delivery of ISCOMS and micelles had a similar effect on HGG 
absorption as the concurrent administration of Quil-A but with greater 
localisation in the lamina propria (Figure 3.9). Predominantly with micelles and 
ISCOMS,HGG was localised in large spherical vesicles in the lamina propria 
often near the vascular system. This was the major observable modification due 
to the delivery of ISCOMS and micelles. Some antigen was observed 
intracellularly (Figure 3.9a) and tubule-like connections were visualised 
projecting from the surrounding lamina] cells and contacting the intercellular 
antigen (Figure 3.9b ). 
Control administration of HGG largely gave results similar to those 
described above. 
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3.4. DISCUSSION. 
The present study indicates that orally and anally delivered proteins are 
rapidly absorbed by the intestinal enterocytes of Oreochromis mossambicus,by a 
complex mechanism of absorption,and that the administration of the saponin 
adjuvant Quil-A in several forms of delivery system has a significant effect on 
the absorption of protein. The study also shows that the intestine of 
O.mossambicus, can have complex interactions with intact,or epitopes of,orally 
and anally delivered protein throughout its length. This contrasts with the 
"classical" view of protein absorption which was thought to occur solely in the 
form of amino acids and small oligopeptides,which has also been challenged in 
mammals (Walker et a/.,1972;Walker 198l;Gardner,1983). Recent studies in 
other species of fish have also indicated that the intestines of teleosts have the 
potential to absorb intact proteins or potentially immunogenic fragments that 
can interact with GALT cells (Georgopoulou et a/.,1986;Rombout et a/.,1989). 
Protein absorption was also once thought to predominantly occur in the 
absorptive cells of the posterior intestine of fish (Noaillac-Depeyre and 
Gas,1973;Stroband and Kroon,1981;Stroband and van der Veen,1981; 
Georgopoulou et a/.,1985;Rombout et a/.,1986) but has recently been 
demonstrated in the anterior intestinal regions in gastric species such as 
O.mossambicus (Doggett, 1989) and agastric species such as carp,Cyprinus carpio 
(Rombout et al.,l985). 
HGG is absorbed across the intestinal enterocytes of O.mossambicus 15 
minutes after oral and anal delivery and localised accumulations of antigen are 
apparent in the apical cytoplasm and the supra-nuclear cytoplasm after 30-60 
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minutes and near the intestinal vasculature after an equivalent time. Levels of 
antigen increase intracellularly after delivery reaching a maximum after 6 hours 
and 1 hour for oral and anal administration,respectively. Gamma globulins have 
only been rarely investigated as candidate antigens for absorption across the 
intestine of fish (Georgopoulou et a/.,1986;Hart,1987;Fujino et al.,1987). In 
rainbow trout,Oncorhynchus mykiss,HGG absorbed after 60 minutes in vitro but 
specific intracellular localisation only occurred 5 hours after oral administration 
in vivo (Georgopoulou et a/.,1986),whereas direct administration of rabbit IgG 
perorally caused absorption after 3 hours (Fujino et a/.,1987). In O.mossambicus 
orally and anally HRP was absorbed after 5 minutes and was present throughout 
the enterocytes and in the phagolysosomes of macrophages 2 hours after oral 
delivery (Doggett, 1989). Ferritin uptake took longer in tilapia and was retained 
for longer in the enterocyte supranuclear vacuoles and GALT macrophages 
(Doggett, 1989). Ferritin is absorbed across the intestine in other species such as 
carp (Rombout and van den Berg, 1989) and it was observed that the distribution 
of biologically intact macromolecules and immunoreactive fragments is different 
(Rombout and van den Berg,1989). Proteins appear to be retained in the 
macrophages of several species from 24 hours to 4 days,such as ferritin in carp 
(Rombout and van den Berg,1989),rainbow trout (Georgopoulou et al., 1986) and 
perch,Percafluviatilis (Noaillac-Depeyre and Gas,1979). The observed temporal 
variability in the absorption of antigens across the gut in O.mossambicus may 
depend on the molecular weights of the antigens as has been suggested,for 
example, in rainbow trout (Georgopoulou et a/.,1986) and possibly carp 
(Rombout and van den Berg,1989). Macromolecules such as bovine growth 
I 
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hormone (molecular weight 22kD) are absorbed after 1 hour,HRP (molecular 
weight of 44kD) absorbed after 2 hours,ferritin (molecular weight of 460kD) 
after 18 hours and hepatitis B surface antigen (molecular weight of 2x106kD) 
taking some 20 hours (Georgopoulou et a/.,1985,1988;Le Bail et a/.,1989). 
However there is contradictory evidence which indicates that antigenically 
discernable protein fragments are detectable in the bloodstream 15 minutes after 
oral delivery (McLean and Ash,1987). There is also a wide discrepancy in the 
temporal kinetics of protein absorption across the intestines of teleosts,some of 
which may be due to the evolutionary divergence between the species 
studied,their (often widely) different modes of nutrition and the detection 
systems employed (McLean,1987;Georgopoulou et 
a/.,1988;Doggett,1989;Rombout and van den Berg,1989). Mammalian studies 
also demonstrate variability with both the species and antigen studied but most 
orally delivered proteins are detectable in the intestine after 1 hour and in the 
bloodstream (or lymphatic vessels) after 2 hours (Walker,1981;Walker and 
Bloch,1983a;1983b). 
HGG orally and anally delivered to O.mossambicus appears to be 
absorbed across the intestinal enterocytes by a pinocytotic mechanism similar to 
that described for HRP and ferritin in tilapia (Doggett,1989) and HRP in 
rainbow trout (Georgopoulou et a/.,1985,1988) and in vitro in isolated hindgut 
enterocytes from goldfish,C.auratus (lida and Yamamoto,1985). HGG 
absorption also seems to be mediated by a system of intracellular cytoplasmic 
tubules as well as pinocytotic vesicularisation. A similar system is implicated in 
the intracellular transcytosis of HRP in goldfish (Iida and Yamamoto,1985) and 
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in the active mechanisms of absorption and transport in other species (Noaillac-
Depeyre and Gas,1979;Ezeasor and Stokoe,1981). The status of such tubular 
systems is unclear,however,with their role alternately being implicated as sites 
of antigen deposit,after pinocytosis (Iida and Yamamoto,1985) and also as 
mechanisms of cellular access which ultimately form or combine with vacuoles 
and vesicles (Georgopoulou et a/.,1988). In this study it appears that the 
absorption of HGG in tilapia occurs by a dual mechanism of uptake implicating 
both tubules and pinosomes. 
A multiplicity of fates of HGG absorbed after oral and anal delivery were 
observed with exocytosis to the lamina propria;direct absorption into the 
vascular system;lysosomal degradation or contact with the GALT cells all being 
possible. Orally and anally delivered HGG was observed being degraded in 
phagolysosomes (as evidenced by the amorphous nature of some of the antigen) 
possibly in a similar manner to the degradation of orally delivered HGG in 
rainbow trout where degradation was initiated at the Fe portion of the molecule 
after 1 hour to 90 minutes (Georgopolou et a/.,1986). In carp,degraded (though 
antigenic) and intact ferritin follow different routes after absorption with 
degraded ferritin reaching the lamina propria and eventually the bloodstream 
whereas the intact protein remained in the enterocyte vacuoles (Rombout and 
van den Berg,1989). The degradation of absorbed proteins,after oral 
adrninistration,has been positively correlated with the activities of the enzymes 
acid phosphatase and cathepsin Band cathepsin D (Georgopoulou et a/.,1986). 
There was a greater level of visualisable antigen in the intestinal tissues 
of tilapia after the anal administration of HGG by comparison with oral 
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administration. A similar pattern was noted by Johnson and Amend 
(1983a,1983b) after the oral and anal delivery of bacterial antigens from Vibrio 
anguillarum and Yersinia ruckeri and in this study the circumvention of the gastric 
conditions in the stomach of rainbow trout was considered to be the major cause 
for the increased level of antigen absorbed and the increased antibody response 
achieved with anal delivery. Similarly,the amounts of antigen absorbed into the 
plasma and the resultant antibody responses of O.mossambicus altered with the 
various modes and routes of delivery of HGG (this study}. 
Absorbed HGG was also observed interacting with the plasma 
membranes of lymphocyte-Iike cells and macrophages in a manner similar to 
that described for ferritin and V.anguillarum antigens orally delivered to carp 
(Rombout and van den Berg,1989) and which was considered to be antigen 
presentation activity. It is well established that cells of the macrophage lineage 
and B-cells can effectively present antigen in lymphoid tissue in mammals 
(Chain et al., 1988;Pierce,Morris,Grusby,Kaumaya,van Buskirk,Srinvasan,Crump 
and Smolenski,1988) and a similar function is likely for comparable cells in fish 
(Vallejo et a/.,1990). Such activity,if truly indicative of antigen presentation,is 
thought to be one of the central events required for the generation of a local 
and/or systemic immune response and could indicate the potential of oral 
delivery for the establishment of an immune response. Oral and anal delivery 
of HGG can also result in the rapid transfer of antigen to the vicinity of 
capillaries and its subsequent passage to the systemic circulation and major 
body organs. 
Administration of the saponin adjuvant Quii-A caused an appreciable 
80 
increase in the uptake of orally and anally delivered HGG,which may result 
in,eventually,an enhanced specific immune response (Maharaj et a/.,1986). 
However,intraperitoneal injection and immersion administration (Cossarini-
Dunier,1985;Grayson et a/.,1987) of Quil-A failed to potentiate an immune 
response to antigens fromAeromonas salmonicida and Y.mckeri respectively,and 
indeed caused a decreased response in some instances. Saponins have not been 
previously used in oral or anal delivery systems in fish but in mammals the 
immune responses to orally delivered antigens such as rabies G antigen,can be 
increased by the prior or concurrent administration of Quii-A (Maharaj, et 
a/.,1986). Quii-A was observed having a number of physical effects on the 
intestinal enterocytes of tilapia such as "loosening" intercellular 
junctions,increasing the pinocytosis of coincident luminal contents, fusion with the 
plasma membrane and direct effects on the microvilli all of which probably serve 
to increase the permeability of the intestine to delivered HGG. These effects 
are similar to those reported for the oral delivery of saponins in mammalian 
intestines (Campbell,Maharaj and Roith, 1985;Campbell and Bede,1989). Quil-A 
binds to cholesterol in the plasma membranes of the enterocytes and causes the 
formation of "pores" (Bangham and Horne,1962),again increasing intestinal 
permeability. Such direct effects may explain the increase in observed antigen 
absorption in this study along with other possible modes of action such as the 
inhibition of the gastric and intestinal proteolytic enzymes such as 
trypsin,chymotrypsin and pepsin,observed for other saponins,which increase the 
levels of antigen reaching the intestine in mammals (Ishaaya and Birk,1965). 
Quii-A may also have a direct stimulatory effect on the macrophages of the 
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underlying GAL T in the intestine by causing them to produce interleukins and 
potentiate any resultant immune response. Quit-A has also been reported to 
have an adjuvant effect by acting as an antigen "depot" for the effective 
concentration and presentation of antigens, the structure of which it may or may 
not modify by its presence (Maharaj et a/.,1986). 
The administration of HGG in ISCOMS and micelles directly increased 
the amounts of antigen accumulated in the lamina propria along with its 
retention time. The interaction observed between the intercellular antigen after 
this mode of delivery and the surrounding lamina\ cells may be a result of the 
increased retention time. ISCOMS may give HGG an almost "particulate" 
nature,a factor which may induce different cellular processing. Micelles have a 
less well-defined tertiary structure but act,like ISCOMS,as both concentrating 
agents and delivery vehicles (Dalsgaard, 1987;Morein, 1987;Morein, et al., 1987). 
The current study indicates that the oral and anal delivery of protein 
macromolecules to the intestine of O.mossambicus results in complex patterns 
of absorption and cellular interactions (see Chapters 4 and 5). The levels of 
absorbed protein detected in the intestinal tissue are increased by several modes 
of delivery of Quil-A which has a direct effect on the enterocytes of the intestine 
and may contribute to an enhanced immune response (see Chapter 6). 
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FIGURE 3.2. THE ABSORPTION OF HGG 
The absorption of HGG in the intestine of Oreochromis mossambicus 
between 30 minutes and 6 hours after oral (3.2a,3.2b and 3.2e) and anal (3.2c 
and 3.2d) delivery. Posterior intestine. 
3.2a,HGG 1 hour after oral intubation in the epithelium (E,black arrows). 
The lamina propria (LP) and goblet cells (G) are not positive for HGG after 
this time. Intraepithelialleucocytes (IEL) are observed in intimate association 
with antigen (open black triangle). 
3.2b,HGG 2 hours after oral intubation. The gut lumen (GL) is largely 
free from staining for antigen which can now be detected (black arrows) 
throughout the epithelium (E) and lamina propria (LP). 
3.2c,anally intubated HGG after 30 minutes. The antigen is increasingly 
found in accumulations (AC) in the epithelium but also was detected penetrating 
the lamina (black arrow) and in contact with IEL's (open black triangle). 
3.2d,anally intubated HGG after 2 hours. Pink,unenhanced, colloidal 
gold can be seen (black arrows) in the epithelium and lamina propria. Antigen 
is widely distributed throughout the terminal webs of the enterocytes (t). 
Figure 3.2(a-d) is immunogold/silver stained with Wrights (3.2a,3.2c and 
3.2d) and Giemsa's (3.2b) counterstaining. 
3.2e,orally intubated antigen (insert) after 15 minutes showing staining of 
antigen largely confined to the epithelium (E) with a clear lamina propria (LP). 
i, 
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Figure 3;2e is twocsHige :immunoperoxidase stained! with. H&E 
cmfnterstaining, 
Figure 3.2 
H4 
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FIGURE 3.3. THE ABSORPTION OF HGG 
The absorption of HGG between 6 and 12 hours after oral (3.3a and 
3.3b) and anal (3.3c and 3.3d) delivery of antigen. Posterior intestine. 
3.3a,orally delivered HGG after 6 hours. HGG is beginning to be found 
in accumulations (white arrows) in the epithelium (E) while being cleared from 
the lamina propria (LP). 
3.3b,HGG 12 hours after oral intubation. There is less antigen (black 
arrows) present in both the epithelium (E) and lamina propria (LP). 
3.3c,6 hours after the anal intubation of HGG. Very similar to oral 
delivery at the same time,with accumulations (AC) in many parts of the 
epithelial (E) enterocytes,including the supranuclear regions. 
3.3d,anally intubated HGG after 12 hours. There appears to still be 
considerable staining in the terminal web region (T) and large conglomerates 
of antigen (C) in the epithelium (E) but little in the lamina propria (LP). 
3.3e,orally delivered HGG after 6 hours (insert) showing typical 
accumulations of antigen in supranuclear vacuoles (SNV) in the enterocytes. 
Figure 3.3 is immunogold/silver stained with Wrights counterstaining. 
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Figure 3.3 
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FIGURE 3.4. THE MECHANICS OF THE ABSORPTION OF HGG. 
Figure 3.4 (a-c) mid intestine,3.4d posterior intestine. 
3.4a,orally intubated HGG after 1 hour. Antigen is detected between the 
microvilli (MV) of the enterocytes,binding to the apical membrane often in 
intermicrovillous invaginations (small arrows). Antigen is also detected around 
the intercellular junctions (D,large arrows). Pinocytotic vesicles (PV) containing 
HGG are found in the apical cytoplasm (AC) in tubules (open triangles) that 
can be observed running from the enterocyte membrane into the apical 
cytoplasm. 
3.4b,similar to 3.4a,with amorphous antigen (large arrows) present along 
with pinocytosed antigen (PV). 
3.4c,anally intubated HGG m the apical cytoplasm (AC) of a mid 
intestinal enterocyte,after 2 hours. Pinocytosed antigen (PV) is directed towards 
the supranuclear cytoplasm (SNC). Antigen is also localised inside structures 
resembelling phagolysosomes (PL). 
3.4d,amorphous antigen (black arrow) 1 hour after the anal delivery of 
HGG inside a goblet cell (G). The cytoplasm surrounding the mucus body of 
the cell also contained phagolysosomes (PL). 
Figure 3.4 (a-d) is two-stage immunoperoxidase stained. 
3.4e (insert),antigen is intimately associated with the microvilli (MV) as 
well as the enterocyte lumenal membrane during uptake of orally delivered 
antigen. 
Figure 3.4e is immunogold stained (5nm particles). 
Figure 3.4 
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FIGURE 3.5. THE MECHANISM OF ABSORPTION OF HOG: 
CELLULAR INTERACfiONS. 
Figure 3.5 (a-c) mid intestine,3.5d posterior intestine. 
3.5a,absorption of orally intubated HGG after 2 hours. HOG was 
detectable in the lamina propria, near the capillaries (CP) containing 
erythrocytes (RBC) in several forms including intact vesicles (IV,Iarge solid 
arrow),active vesicles (AV),as amorphous antigen (open triangle) and as very 
small vesicles (small solid arrows). 
3.5b,similar to 3.5a showing the channelling of some HOG towards the 
capillary lumen (solid black triangle). 
3.5c,vesicles,with varying morphologies,containing HOG 2 hours after oral 
delivery. Legend as in 3.5b. 
3.5d,the interaction of orally delivered (12 hours) antigen (A) with an 
intralaminal leucocyte (N) with a lymphocyte-like morphology. The antigen is 
incorporated (solid black triangles) into the cells plasma membrane (PM). 
3.5e (insert),absorbed antigen is often associated with intercellular 
passage at the desmosomes (D). 
Figure 3.5 is two-stage immunoperoxidase stained. 
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FIGURE 3.6. THE CYTOCHEMICAL DETECTION OF OUIL-A IN 
THE INTESTINE. 
Figure 3.6,the tissue localisation of orally delivered Quil-A (1001-'g/ml) 
after 1 hour. Figure 3.6 is anterior intestine. 
3.6a,heavily stained Quil-A,spherically arranged ( arrows,QA) 
intracellularly,in the epithelium (E) of the posterior intestine. 
3.6b,accumulated Quil-A (arrows,QA) similar to 3.6a but deeper in the 
epithelium (E). 
3.6c,Quil-A from the gut lumen (GL),associated with the microvilli (MV) 
as small micelles (M). Quil-A causes copious cytoplasmic tubule formation (CT) 
and vesicularisation of both Quil-A (VAQ) and coincident lumenal material (P). 
3.6d,the direct physical effects of Quil-A on the epithelium (E) its 
damage to the microvilli (DMV) and effects at tight-junctions (TJ) and 
enhanced pinocytosis (P) as in 3.6c. 
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Figure 3.6 
FIGURE 3.7. THE UPTAKE OF HGG.WITH PRIOR 
ADMINISTRATION OF OUIL-A. 
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Figure 3.7,the distribution of HGG 1 hour after the oral delivery of 
100~-tg/ml Quil-A,after oral (3.7a and 3.7b) and anal (3.7c and 3.7d) antigen 
intubation. Figure 3.7 (a-c) mid intestine,3.7d posterior intestine. 
3.7a,the terminal web (T) of the epithelium (E) is heavily stained (dark 
arrows;ST) for HGG. The lamina propria (LP) shows some staining for antigen. 
There is some excess staining in the gut lumen (GL) that is likely to be due to 
antigen adhering to the lumenal mucus. 
3.7b,similar to 3.7a with the absorbed antigen in the terminal web (T) 
and positive inclusions (PI) of antigen extending into the apical cytoplasm. The 
goblet cells (G) are negative. 
3.7c,anally intubated HGG after 1 hour showing staining in the 
epithelium (E) and in the lamina propria (LP,white arrow) near the basement 
membrane (BM). Staining for antigen is also detectable near the capillaries 
(CP). 
3.7d,similar to 3.7c but from a region nearer the anus. There appears to 
be extensive staining of the epithelial membrane (E;black arrows) and in the 
lamina propria (LP;white arrows). There is also heavy staining in and around 
the underlying vascular supply (CP). 
Figure 3.7 is streptavidin-biotin-HRP (sABC-HRP) stained, 
with Mayer's haematoxylin counterstaining. 
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FIGURE 3.8. THE ABSORPTION OF HGG WITH CONCURRENT 
ADMINISTRATION OF OUIL-A IN VARIOUS FORMS. 
Figure 3.8,the distribution of HGG after oral (3.8a and 3.8b) and anal 
(3.8c,3.8d and 3.8e) intubation of antigen concurrently with lJJg/ml QuiJ-A). 
Posterior intestine. 
3.8a, 1 hour after oral intubation,antigen can be detected in the epithelium 
(Large arrow;E) and lamina propria (LP;small arrow;st). Antigen is 
accumulated in the lamina. 
3.8b,similar to 3.8a showing the strong association of some antigen with 
the intralaminal leucocytes (ILL's,white arrow) and the retention of Quii-A in 
the lamina rather than in the basal areas of the enterocytes. Legend as above. 
3.8c,anally intubated HGG 1 hour after concurrent administration of 
HGG similar to 3.8a. Staining is intensely associated around the small 
capillaries in the intestine (CP). 
3.8d (insert),Quii-A administered as a micelle (M-arrows) apparently in 
the process of fusing with the epithelium (E). 
3.8e,HGG 2 hours after anal intubation with antigen localised in the 
lamina propria (LP) and the epithelium (E) largely negative. 
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FIGURE 3.9. THE ACCUMULATION OF HGG AFTER DELIVERY 
OF OUIL-A. 
Figure 3.9 are mid and posterior intestine. 
3.9a,accumulated intercellular antigen (heavy black arrows,IAG) in the 
lamina propria (LP) 1 hour after the oral delivery of antigen as micelles or 
ISCOMS. In other areas of the lamina propria antigen is found within the cells 
(CAG;open black triangle) possibly being degraded. 
3.9b,similar to 3.9a,showing intercellular antigen (broad black 
arrows,IAG) in the lamina propria. Cytoplasmic tubules (CT;thinner black 
arrows) originating from the lamina! cells may be seen in contact with the HGG. 
Figure 3.9 is two-stage immunoperoxidase stained. 
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Figure 3.9 
CHAPTER 4. 
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CHAPTER 4 QUANTITATIVE SEROLOGICAL ASPECTS OF THE 
UPTAI<EOFPROTEINSWITHENHANCEDENTERICDELIVERY 
SYSTEMS. 
4.1 INTRODUCTION. 
The intestinal epithelium acts as a selective barrier between the intestinal 
lumen and the systemic circulation. In mammals it has been shown that antigen 
delivered to the intestinal lumen by the oral or anal route is,under normal 
circurnstances,transported across the enterocytes largely by a transcellular 
mechanism (Colony and Neutra,1985) and is capable of causing an immune 
response (Forrest et al., 1990) that can be substantially protective against 
pathogens such as Salmonella typhi. Adult mammals have specialised absorptive 
cells,M cells situated in the Peyer's patches,that allow the passage of intact 
proteins (Telemo, Westrom and Karlson, 1982),or antigenic fragments of proteins 
that arise from the processes of lumenal and intracellular degradation,to the 
blood circulation (Morris and Morris, 1978). Transport of antigens in mammals 
has been demonstrated for a wide variety of antigens,including standard proteins 
such as BSA (Rothberg,Kraft,Farr,Kriebel and Goldberg,1970),human serum 
albumin (HSA),HRP (Owen,1977),and a wide variety of bacterial and viral 
antigens (Mestecky 1987). Such transport occurs across the specialised M-cells 
when in low concentrations (Bye,Allan and Trier,1984) and through the 
absorptive enterocytes when present in higher concentrations (Owen and 
Ermak,1990). Antigens are therefore absorbed by mammalian intestines in 
levels which are considered to be capable of eliciting an immune response 
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(Walker,1981). Such antigens may interact with local,underlying,gut-associated 
lymphoid tissue (GALT) cells to give a mucosal lgA response or reach the blood 
and lymphatic circulation and eventually generate a systemic lgG and IgM 
response (Owen and Ermak,1990). Orally delivered proteins can also cause cells 
to respond antigen-specifically in tissues such as the spleen, indicating that a 
broad-range of immune responses can be induced by oral administration of 
antigen (Clarke,Wilson,Williams and Stokes,1991). 
Absorption of intact proteins and antigenic fragments occurs through the 
intestines of larval and adult teleosts,to varying degrees, in both gastric 
( Georgopoulou et al., 1986;McLean, 1987;Georgopoulou et al., 1988;Doggett, 1989) 
and agastric species (Davina et al.,1980,Rombout et al.,1986;Rombout and van 
den Berg, 1989). This absorption of protein antigens may be directly quantified 
on their reaching the systemic circulation (McLean,1987;Georgopoulou et 
al.,1988;Doggett, 1989;Doggett,Wrathmell and Harris, 1991). Despite the relative 
simplicity of teleost GALT (Hart et a/.,1988) and its general lack of 
(morphologically) specialised absorptive cells and organized lymphoid tissue,oral 
and anal delivery of antigen can result in intestinal accumulation (Davina et 
al., 1980;Watanabe,1982;Georgopoulou and Vernier, 1985),transport to plasma 
and secondarily to major organs such as liver,spleen and kidney (McLean,1987; 
Doggett,1989),observable interactions with lymphoid tissue (Davina et al.,1980; 
Rombout and van den Berg,1989) and eventually to relevant immune responses 
(Johnson and Amend,l983a,1983b) that can be protective (Rombout et al., 
1989b ). Gamma globulins are transcytosed across the intestine,after oral 
delivery,in large quantities in neonatal mammals (such as suckling rats),by a 
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receptor-mediated process that effectively confers protective immunity 
(Breuton, 1980). Absorption of gamma globulins across the intestine of fish 
appears to be less efficient and slower (Georgopoulou et a/.,1986) than in 
mammals and the relatively-lower immune responses to soluble antigens 
delivered orally (by comparison with injection) is thought to be due to decreased 
amounts of antigen being absorbed across the intestine (Johnson and 
Amend, 1983a, 1983b) or possibly the induction of a tolerogenic response. One 
strategy,to increase the levels of absorbed antigen after oral delivery is to 
employ the use of an adjuvant or immunopotentiating agent in the delivery 
system. The use of saponin adjuvants such as Quil-A has been shown to 
increase the levels of antigen absorbed in mammals after oral administration 
(Mahraj et a/.,1986;Campbell and Bede,1989) and potentiate the immune 
responses to these antigens (Campbell et a/.,1985;Crick,Brown,King,Williams, 
Thompson and Fearne,1985). This involves the use of a variety of preparations 
that can impart unique physical properties to an antigen (Morein et 
a/.,l984;Morein and Simon,1985;Morein,1987). Such delivery systems may allow 
the use of protein antigens,orally,that would otherwise be non-immunogenic or 
tolerogenic (Mowat et al., 1991 ). 
Saponins have been largely neglected in studies on the oral 
administration of antigens in fish and this study aimed to quantify the levels of 
HGG absorbed into the plasma of Oreochromis mossambicus,along with the 
temporal kinetics of absorption and any modifying effect that various modes of 
delivery of the saponin adjuvant Quil-A had on these systems. 
4.2. MATERIALS AND METHODS. 
4.2.1. ANIMALS. 
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Tilapia,Oreochromis mossambicus,of both sexes weighing 30-50g were 
maintained in a recirculating freshwater system at 24-26 o C until use. 
4.2.2. INTUBATION PROCEDURES. 
Tilapia were intubated perorally and peranally (as described in 3.2.2.) 
using human gamma globulin (HGG,Sigma) as test antigen. 
The effect of dose in groups of tilapia (n = 5) to orally and anally 
delivered HGG was investigated,at 1 hour, using a range of solutions from 
1mg/ml to 50mg/ml (intubated volumes of 0.2ml). Control groups (n =5) were 
sham intubated with 0.2ml PBS pH 7.2. 
0.2ml of an,optimised, lOmg/ml solution of HGG was administered orally 
or anally to groups of tilapia (n = 5) and the plasma tested over a structured time 
course viz: after 5,15,30 minutes and 1,2,6,12,24 and 48 hours. Control groups 
(n=5) were intubated with 0.2ml PBS pH 7.2. All intubations were carried out 
in fixed volumes (5L) of freshwater in individual,non-circulating,(12L) tank 
systems,kept at approximately 24 ° C. 
4.2.3. ADJUV ANT IMMUNISATION. 
Quil-A (Superfos,Denmark) was administered,orally and anally to groups 
of tilapia (n=5),prior to (1 hour before) and concurrently with HGG,at doses 
of0.2ml from 1mg/ml to 100pg/ml viz:1mg,100J.Lg,10J.Lg,1J.Lg,l00ng,10ng,1ng and 
lOOpg,by a complementary route,and also over the same time course as above. 
Quil-A plus HGG was administered as micelles (for preparation see 3.2.3.) and 
ISCOMS (for preparation see 3.2.4.). Controls were either PBS pH 7.2,HGG 
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(10mg/ml;0.2ml,anally) on its own or 10mg/ml HGG plus 10J.£g/ml E.coli 
lipopolysaccharide (Sigma;0.2ml intubated) for the ISCOM and micelle study,as 
described previously (3.2.4.). 
i.2A... SAMPLE COLLECTION. 
Fish were sacrificed by a sharp blow to the head and blood was collected 
in heparinised (10 units heparin (Sigma)/ml saline) capillary tubes (25J,£1 
volumes) and microhaematocrit tubes (100J,£1 volumes). Blood was pooled for 
each test group,centrifuged at 4000rpm for 4 minutes and the plasma removed 
and stored at -20 • C until required. 
Volumes of water (5ml) were randomly removed from different areas of 
each test group tank and retained for analysis of levels of voided HGG 
(regurgitated or excreted ) from the test system. Water samples were retained 
at -20•C until use. 
4.2.5. DETECTION OF ABSORBED HGG USING AN ENZYME-
LINKED IMMUNOSORBENT ASSAY (ELISA). 
The general procedure described by Voller,Bidewell and Bartlett (1979) 
and Ambler and Peters (1984) was employed as the basis for the optimisation 
of the assay. All ELISA buffers are listed in Appendix I. All samples and 
reagents were added at lOOJ.£1 per well to 96 well flat-bottomed polystyrene 
microtitre plates (Falcon,Ltd,Becton Dickinson,New Jersey,U.S.A.),unless stated 
(all immunoreagents were obtained from Sigma,unless stated). 
Extensive studies were undertaken to optimise the system for the 
detection of HGG in tilapia plasma. Two prospective ELISA systems were 
evaluated,each employing a sandwich antigen-capture technique,one utilising a 
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homologous antisera system and the other heterologous antisera (Figure 4.1). 
FIGURE 4.1. ELISA SYSTEMS EMPLOYED FOR THE 
DETECTION OF HGG. 
HETEROLOGOUS ANTISERA. 
!)Adsorption of goat anti-HGG 
to plate. 
2)Wash with PBST. 
3)Addition of HGG in plasma or 
as standards in PBST. 
4)Wash with PBST. 
S)Addition of rabbit anti-HGG 
in PBST (secondary antibody). 
6)Wash with PBST. 
?)Addition of swine anti-rabbit 
peroxidase conjugate (Dako,Ltd). 
8)Develop. 
9)Read at 492nm. 
HOMOLOGOUS ANTISERA. 
!)Adsorption of goat anti-HGG 
to plate (coating antisera). 
2)Wash with PBST. 
3)Addition of HGG in plasma 
or as standards in PBST. 
4)Wash with PBST. 
S)Addition of goat anti-HGG 
peroxidase conjugate. 
6)Wash with PBST. 
?)Develop. 
8)Read at 492nm. 
All antisera concentrations were optimised using a checkerboard titration 
method. Plates were coated with primary antiserum diluted in O.OSM 
carbonate/bicarbonate buffer at pH 9.6 (see Appendix I) overnight at 4 ·C. The 
plates were covered in aluminium foil and placed in a humid chamber to 
prevent evaporation. Plates were sequentially washed ( 4x3 minutes) after each 
incubation with approximately 150tLl PBST (PBS plus 0.5% Tween 
20,Polyoxyethylene sorbitan monolaurate ),by aspiration using a Titertek 
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Handiwash 110 washer (Labsystems,Basingstoke,U.K) and patted dry on paper 
towels. Antigen containing solution (test plasma,100% tank water,plasma + 
known concentrations of HOG or PBST + known concentrations of HOG) was 
incubated for 2 hours at ambient temperature. This was followed by the 
addition of either secondary antibody followed by antibody conjugate 
(heterologous system) or directly by peroxidase conjugate (homologous system) 
for 1 hour at ambient temperature. Standards of a known amount of HOG 
were analysed on each plate (from 40J.Lg/ml to 300pg/ml with sequential 1:5 
dilutions) to generate a standard curve. All reactions were developed using 
2mM orthophenyldiamine plus 3mM hydrogen peroxide in 0.02M citrate-
phosphate buffer at pH 5.0 at ambient temperature for up to 10 minutes. 
Reactions were stopped by the addition of 50J.Ll 1M H2S04 and the plates were 
read at 492nm on a Titertek Multiscan Plus II (Labsystems,Basingstoke,U.K.) 
utilising data storage software. 
Optimisation of the ELISA system also involved the use of blocking 
agents such as 1% w/v BSA or 5% w/v non-fat dried milk and the use of test 
plasma at 2% concentration in PBST,the concentration at which there was the 
least endogenous cross-rection caused by the presence of plasma,which was 
occasionally observed with plasma concentrations of over 10%. 
These studies lead to the subsequent use of the homologous ELISA 
system throughout the study to test the pooled,experimental,tilapia plasma using 
primary (coating) antisera at 1/4000 dilution,secondary (conjugate) antisera at 
1/2000,no protein blocking steps and a development time of approximately 6 
minutes. 
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4.2.7. STATISTICAL ANALYSES. 
All ELISA-derived data was analysed using one and two-way analyses of 
variance using the ANOVA programs on MJNITAB software. Briefly,analyses 
of variance are used to identify sources of variation between data groups eg if 
differences between data are truly due to experimental results or due to natural 
variability in the uptake of macromolecules by the test groups. 
Analyses of variance usually derive a final value of variance ratio (F-
statistic) that can be tabulated and significance derived from a follow up test 
(Wardlaw, 1987). The follow-up test involves the use of the pooled standard 
deviations (PSD) derived from the ANOV A program in the following equation 
Least significant difference (LSD) = 
.[Pii52x2 
xt., ·• N 
t., ·• ~[(2xN)-2] 
where t a .. = the degrees of freedom. The t-distribution of the LSD is then 
checked for significance at p = 0.025. This is the system for the determination 
of LSD's with groups of data of equal numbers. 
Unequally sized groups have LSD's determined by : 
Standard error of means (SEM's) were derived by: 
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which equivelates to a 75% confidence limit. 95% confidence limits were 
derived by: 95% limit = SEM x t-statistic. 
The derived absorbance readings were statistically treated and the 75% 
confidence limits added to the representative Figures 
4.3. RESULTS. 
4.3.1. ABSORPTION OF HGG. 
The standard curves typically obtained with the homologous antisera 
ELISA are shown in Figure 4.2.a. The titration of an antibody response over 
such a wide range of antigen concentrations is shown,with a typical optimal 
range of sensitivity from approximately l.6J.Lg/ml to 2.5ng/ml and an end point 
of an absorbance value of approximately 1.5 units generally being chosen. 
Figure 4.3 (a-d) shows typical ELISA systems on microtitre plates with the 
titration of test plasma in several columns. 
The dose response to orally and anally delivered HGG was investigated 
after 1 hour in order to optimise both the amounts of HGG absorbed and 
minimise the levels of HGG that are voided by regurgitation and excretion. 
Figure 4.2.b shows the dose responses to HGG. There is a statistically 
significant increase (p < 0.025) in the amount of detectable HGG absorbed into 
the plasma 1 hour after anal delivery on comparison with levels detected after 
oral delivery,for all concentrations of HGG tested. Lower concentrations of 
anally delivered HGG (lmg/ml and 2mg/ml) resulted in lower absolute levels 
of uptake of antigen into the plasma and maximal absorption of HGG occurred 
with 20mg/ml concentrations of antigen though these levels were not 
significantly higher than those detected after lOmg/ml HGG intubation. 
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lOmg/ml HGG orally delivered was absorbed in significantly (p < 0.05) greater 
quantities than other concentrations but anally delivered antigen at 20mg/ml 
was only statistically significantly greater than 1mg/ml. Control delivery of PBS 
reulted in background levels of approximately 0.2t£g/ml (not shown). 
HGG was also voided 1 hour after oral and anal delivery (Figure 4.2.c). 
Orally delivered HGG was voided in greater quantities than anally delivered 
antigen with the greatest levels of antigen voiding occurring with the intubation 
of the higher HGG concentrations (20mg/ml and 50mg/ml). The maximal 
absolute values (in Figure 4.2.c) of voided antigen,however,did not correlate with 
the values as percentages of the delivered antigen dose (Table 4.1) eg the 
maximum percentage of voided antigen was approximately 30% of the orally 
delivered dose (0.2ml of the lmg/ml preparation) and only between 1.6% and 
3.75% of the delivered doses of the higher concentration preparations 
(10mg/ml,20mg/ml and 50mg/ml). 
As a result a dose of lOmg/ml HGG was chosen for the study in order 
to maximise levels of absorption after oral and anal delivery,to retain dose 
standardisation and to keep voided antigen to a minimum. 
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TABLE 4.1. VOIDED HGG AS A PERCENTAGE OF DELIVERED 
ANTIGEN DOSE. 
CONCENTRATION OF DELIVERED DOSE. PERCENTAGE OF 
ANTIGEN THE 
PREPARATION. DOSE VOIDED. 
1 mg/ml 200J.Lg Oral delivery = 30%. 
Anal delivery = 25%. 
2 mg/ml 400J.Lg Oral delivery = 25.8% 
Anal delivery = 7.5% 
10 mg/ml 2mg Oral delivery = 3.75% 
Anal delivery = 2.5% 
20 mg/ml 4mg Oral delivery = 1.6% 
Anal delivery = 2.4% 
50 mg/ml 12.5mg Oral delivery = 2.2% 
Anal delivery = 1.1% 
4.3.2. TEMPORAL ASPECTS OF HGG ABSORPTION. 
The absorption of HGG was observed to be temporally variable and 
significant differences in the levels of absorption at various times due to the 
route of antigen delivery were observed. Bars on Figures 4.4.a and 4.4.b 
represent the 95% confidence limits for these data points,all other bars on 
figures represent the SEM's. 
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Orally delivered antigen (Figure 4.4.a) was absorbed into the bloodstream 
after 15 minutes and two peaks of absorption were observed;after 30 minutes 
and,maximally,after 6 hours. The second absorptive event indicated levels of 
plasma HGG that were significantly greater than at other times and greater than 
background values obtained after PBS-intubated controls that resulted in 
approximate values of O.lJ.Lg/ml (not shown). 
Anally intubated antigen (Figure 4.4.b} was absorbed in a temporally 
different manner (compared to oral delivery) with the uptake being more rapid 
as shown by peaks of absorption 30 minutes after intubation and maximal 
absorption after 60 minutes. Both routes of antigen delivery show that the levels 
of HGG reaching the plasma rapidly decline after 6 to 12 hours resulting in 
very-low amounts of HGG from 24 to 48 hours. Anal delivery of HGG resulted 
in both a more rapid absorption and an earlier peak response than oral 
intubation,with significantly greater amounts detected after 1 hour and 
significantly less after 6 hours. 
4.3.1. ABSORPTION OF HGG 1 HOUR AFfER PRIOR 
INTUBATION OF QUIL-A. 
Quii-A was administered 1 hour pnor to delivery of antigen by a 
complementary route (ie orally or anally) at various concentrations in order to 
evaluate the dose effect of Quii-A on the absorption of optimised HGG. The 
optimal dose for the increase of absorption of antigen by both routes was 
100J.Lg/ml (Figure 4.4.c) with detectable levels in the plasma being significantly 
(p < 0.05) greater than control administration of HGG. However,outside this 
concentration,Quii-A appeared to have a negative effect on the absorption of 
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HGG with levels in the plasma being below control values,albeit not statistically 
significantly (for anally delivered antigen). 
Temporally,prior administration of Quii-A (Figure 4.4.d) altered the 
uptake kinetics of HGG absorption and the relative levels absorbed. The 
maximal uptake of anally delivered HGG (after 30 minutes) was significantly 
higher (p < O.OS,almost two-fold greater) than oral delivery (maximal absorption 
218J.Lg/ml,2 hours after delivery). Increased absorption due to prior Quii-A 
administration was observed up to 6 hours after delivery. 
4.3.3. ABSORPTION OF HGG WITH CONCURRENT 
ADMINISTRATION OF QUIL-A. 
Quii-A administered concurrently with HGG also caused a dose-
dependent increase in the amounts of antigen absorbed into the plasma (Figure 
4.5.a),1 hour after intubation. The adjuvant effect of Quii-A administered in this 
system was observed with concentrations of Quii-A from 1mg/ml to 1J.Lg/ml with 
the peak modification,occurring at lOJ.Lg/ml for both orally and anally delivered 
antigen. Oral antigen delivery with concurrent administration of adjuvant was 
increased above control values (HGG only) but was lower than the values 
detected for anally delivered antigen (approximately 700J.Lg/ml). Both routes of 
delivery showed no increase in the levels of antigen absorbed with 
concentrations of adjuvant below 100ng/ml. 
The administration of an optimised dose of Quii-A with HGG,orally and 
anally,yielded a temporal pattern of absorption that was similar to the temporal 
kinetics of HGG on its own, but had significantly elevated levels (Figure 4.5.b ). 
Anally administered HGG plus Quil-A was detected maximally after 1 hour;it 
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was increased 10-fold over control levels of anally intubated antigen and this 
peak of absorption was significantly {p < 0.025) greater than oral administration 
of antigen plus adjuvant. Oral delivery resulted in biphasic absorption peaks at 
1 and 6 hours of 220 and 250 J.'g/ml antigen,respectively,which,while being 
significantly higher than the control values,were not different from each other. 
4.3.4. ADMINISTRATION OF HGG IN DERIVED TERTIARY 
FORMATIONS WITH OUIL-A. 
The addition of Quil-A in tertiary conformations with HGG ie as 
ISCOMS caused an increase in the levels of antigen absorbed,l hour after 
administration, when compared to the control administration of HGG on its own 
or with LPS plus HGG (Figure 4.5.c) by 3-fold. Anal administration caused 
slightly greater absorption of HGG than oral delivery but these differences were 
not significant for each mode of absorption. Micelle delivery resulted in levels 
of absorbed HGG that were less-significantly higher than that observed with 
controls. Delivery of HGG plus LPS was not significantly greater than HGG on 
its own,but the differences between the two routes of absorption were more 
pronounced as the overall levels were lower. 
4.3.5. THE VOIDING OF HGG INTO THE TANK WATER. 
The pattern of voiding of HGG into the tank water was temporally 
variable with both anal and oral delivery (Figure 4.5.d). Delivered antigen 
appeared to be regurgitated into the water in greater amounts after oral 
administration. The peaks of voiding roughly correlated with the peaks of 
absorption into the plasma (ie 1 hour after anal delivery and 6 hours after oral 
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delivery). The levels of voided antigen decreased with time and were largely 
absent after 48 hours. 
Voiding also exhibited a dose response with the oral and anal delivery of 
the adjuvant Quii-A when given prior to (Figure 4.6.a) and concurrently with 
(Figure 4.6.c) HGG,at various concentrations,after 1 hour. Voiding of antigen 
was only significantly increased by the higher concentrations of Quii-A (1mg/ml 
and lOOJLg/ml),when given 1 hour prior to the antigen (Figure 4.6.a). 
Concentrations of Quii-A below 1JLg/ml did not cause an increase in the levels 
of HGG evacuated,above control anal administration of HGG. Concurrent 
administration of HGG plus antigen caused an increase in the levels of expelled 
antigen over a similarly narrow concentration range, below which levels were the 
same as controls (Figure 4.6.c). Absolute levels voided at 1mg/ml and lOJLg/ml 
administered orally with both systems were similar (approximately 73-75!-'g) but 
were disparate for anal administration (151-'g prior and 50!-'g concurrent). 
Voiding of antigen after the intubation of Quil-A (Figure 4.6.b) decreased 
over time with the greatest levels being voided rapidly after intubation. Levels 
of voiding were similar,except after 15 minutes where anal delivery resulted in 
approximately 140!-'g of antigen being voided. The voiding of HGG with the 
concurrent administration of Qui l-A was much more temporally complex (Figure 
4.6.d) with the expulsion of antigen paralleling its absorption into the plasma. 
However peak levels in both systems appeared to be consistent at approximately 
50JLg,for most time periods. 
4.4. DISCUSSION. 
Complex patterns of absorption after oral and anal delivery are evident 
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in tilapia,for HGG,which is absorbed into the plasma by mechanisms that can 
be altered by the action of the adjuvant Quil-A causing a direct increase in the 
levels of antigen taken into the plasma after its administration as a direct,soluble 
adjuvant and as a three-dimensional vehicle. 
The appearance of detectable HGG in the plasma is closely correlated 
with its appearance in the intestinal enterocytes as determined by 
immunocytochemistry. There was a clear dose-response of absorption of HGG 
into the plasma of tilapia 1 hour after the oral administration of antigen,with a 
maximum being detected after a single dose of 0.2ml of a lOmg/ml solution. A 
similar dose response was observed after the oral delivery of a single dose of 
HRP,in tilapia, with maximal absorption also occurring with a 10mg/ml antigen 
concentration (Doggett,l989). Dose responses to orally delivered antigen have 
also been noted in other species such as Oncorhynchus mykiss where peak 
intestinal absorption was observed after a single oral dose of 50mg/ml HRP 
(McLean, 1987) and there appeared to be a direct correlation between the 
quantity of antigen ingested and the quantity transferred to the blood in 
O.mykiss in another study employing HRP (Georgopoulou et a/.,1988). Such 
similarity in responses may indicate that the processes of absorption for these 
antigens are similar between these species and are indicative of saturation-type 
kinetics on coated-pits at the microvillous surface (McLean,1987). Multiple 
doses of antigen applied orally and anally to O.mossambicus did not increase the 
overall levels of antigens absorbed across the intestine (Doggett, 1989) and were 
deemed an ineffective strategy for the oral delivery of soluble proteins in tilapia 
(Doggett et a/.,1991 ). 
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HGG has been visualised being absorbed rapidly after oral and anal 
delivery across the intestinal enterocytes of Oreoclzromis mossambicus in 
antigenically recognisable forms,similar to the absorption of ferritin and HRP,in 
this species (Doggett,l989). Absorption occurrs by a process involving both 
transcellular pinocytosis by vesicles and cytoplasmic tubules in the intracellular 
transportation as described in other species (lida and Yamamoto,l985;Rombout 
et al.,1986;Rombout and van den Berg,1989;Georgopoulou et al.,1988). 
The pattern of absorption of HGG across the intestine is temporally 
complex and route dependent. Initial absorption of HGG into the plasma was 
very rapid,being detectable 15 minutes after administration. Maximal levels of 
HGG were detected in the plasma 6 hours after oral delivery and 60 minutes 
after anal delivery. Such absorptive kinetics differ from those observed in other 
studies on the uptake of protein macromolecules by the intestine of tilapia. Oral 
delivery of ferritin resulted in maximal levels of approximately 300J.£g/ml in the 
plasma after 60 minutes (Doggett,1989),whereas the time course of absorption 
of HRP was remarkably similar to HGG ie was detectable after 15 minutes. 
However maximal peaks of HRP absorption occurred after 60 minutes and were 
7-fold greater than the peak levels of HGG absorption at 6 hours (700J.£g/ml 
HRP compared to 100J.£g/ml HGG;Doggett,1989). Anally administered HGG 
was absorbed in greater quantities,more rapidly,in tilapia,than orally delivered 
antigen,as was observed for ferritin absorption (Doggett,1989) but in contrast to 
the results of anal delivery of HRP,the levels of which were almost 2-fold lower 
anally than orally (Doggett,1989). Increased absorption of anally delivered 
antigen,through the circumvention of the gastric conditions of the stomach (in 
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gastric species),is generally regarded as,possibly,the maJor reason for the 
increased efficacy of this route for immunisation (Johnson and 
Amend,1983a,1983b;Ellis,l988). The stomach also has a complex series of 
physiological interactions controlling its rate of activity,including its emptying 
(Jobling,1988,Dabrowski,1985),the mechanics of which are generally regarded 
to be biphasic in nature (Hofer and Newrkla, 1983). Such physiological functions 
will have a large effect on the temporal patterns of absorption of orally 
delivered antigens and are also,theoretically,influenced by factors such as the 
nutritional state of the organism (Soothill, 1976),which may be more important 
in some species than others (McLean,1987;Doggett,1989). Absorption of orally 
delivered macromolecules is temporally variable in other species. HGG 
absorption in O.mykiss first occurs 10 hours after administration in vivo and 90 
minutes in vitro in isolated enterocytes,and is first observed absorbed 5 hours 
after anal delivery (Georgopoulou et a/.,1986). Reports of studies on absorption 
of other antigens have been conflicting,with HRP being reported as being 
detectable in the plasma of O.mykiss after 15 minutes and maximally after 1 
hour (McLean,1987;Doggett,1989) and 7-8 hours after oral intubation in a third 
study (Georgopoulou et al., 1988). Such differences may possibly be due to 
variations in the experimental protocol or assay techniques used with some 
studies (M cLean, 1987;Doggett, 1989),relying on either an antigen-capture ELISA 
(McLean,1987) and yet others on a combination of ELISA and 
chemiluminescence (Arrio,Lecuyer,Dupaix, Volfin,Jousset and 
Carrette,1980;Georgopoulou et a/.,1988). In agastric species the absorption of 
antigen appears to be equally as rapid,with ferritin being detectable in the 
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intestinal tissues (Rombout et a/.,1986;Rombout and van den Berg,1989) and 
plasma (Doggett, 1989) after 60 minutes. There are also disparities in the 
detectable levels of various antigens after oral and anal delivery in several 
species with absorbed values from ng (HRP,O.myldss) to 11-g levels (HRP and 
ferritin,O.my/dss,carp Cyprinus carpio and tilapia). Quantitatively,almost 1000 
times the amount of antigen was absorbed across the intestine of tilapia than in 
other species such as rainbow trout and carp 
(McLean,1987;Doggett,1989;Georgopoulou et a/.,1986,1988). In mammals,oral 
delivery of protein macromolecules results in detectable levels of intact proteins 
and antigenic fragments of those proteins in the blood (Walker,1981). 0.1% 
BSA solution administered to rabbits in drinking water resulted in approximately 
60ng of detectable protein being observed m the circulating 
plasma,approximately 0.01% of the administered dose. In vitro studies in 
mammals indicated that 0.1% of human serum albumin,used as antigen,was 
recoverable from the plasma in definable form 2 hours after oral delivery 
(Hemmings,1978). It appears that the levels of protein absorption are 
approximately 0.02% of the ingested dose in humans and 0.01%-0.1% in other 
mammals whereas fish show a much greater percentage absorption of 
proteins,with levels of approximately 4% absorbed in this study. Direct 
comparisons of antigenic levels must be made with caution as different antigens 
are likely to be processed in different manners (intra and interspecifically) and 
fragmentation of antigen can be envisaged where certain macromolecules are 
split into a variety of potentially antigenic (and immunogenic) portions eg a 
possibility in the processing of ferritin which is made up of 24 identical sub-units 
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(Rombout and van den Berg,1989). 
HGG,like other antigens delivered to the intestines of fish,is likely to be 
primarily absorbed to the plasma via a transcapillary route rather than through 
any lymphatic system (McLean,l987) and this is further suggested by the fact 
that it is visualised near the intestinal capillary beds rapidly after absorption 
(Chapter 3) in tilapia. The intestinal capillaries of both mammals and fish are 
thought to be permeable to macromolecules as up to 60% of their surface area 
is fenestrated which may facilitate the rapid transport of small macromolecules 
through open fenestrae and incomplete intracellular junctions (Hemmings,1978). 
Indeed in mammals studies indicated that of the total of 2% of plasma absorbed 
BSA 1.1% was transported through the capillary systems underlying the 
epithelium and 0.8% through the lymphatics. 
HGG was detected in the plasma 48 hours after oral and anal delivery 
but the direct quantitative level decreased after 6-12 hours. This is likely to be 
an indirect measure of the ongoing antigenic clearance systems which include 
the transfer of delivered antigen to major organs such as the kidney,liver and 
spleen (Georgopoulou et a/.,1988) which appear to act as repositories for orally 
and anally delivered HRP and ferritin in tilapia (Doggett,1989),HRP in rainbow 
trout and carp (McLean,1987) and immune-complexes of BSA and antibody in 
plaice,P/euronectes platessa (Ellis,1981). Direct tissue clearance patterns were 
not measured in this study due to the levels of cross-reactivity obtained with 
whole body organs in ELISA microtitre systems. Temporally the decrease in the 
plasma levels of HGG in this study correlate with other studies where most 
antigen was absent at 24 hours post-delivery (Georgopoulou et a/.,1988). The 
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exact mechanics of plasma clearance of antigen are unclear but have been 
surmised as involving macrophage activity in the venous sinusoids,especially in 
the pronephros (Smedsrud,Dannevig,Tolleshaug and 
Berg,1984),melanomacrophage centres in the spleen,kidney and liver 
(Ellis, 1981 ). Indirect stimulation of macrophages,by bacterial challenge, increases 
plasma clearance mechanisms (Grayson et a/.,1987) thus highlighting the 
probable importance of these cells. The clearance kinetics of antigen from 
plasma are not fully determined and are described as both monophasic and 
biphasic for HRP orally delivered to rainbow trout (McLean,1987;Georgopoulou 
et a/.,1988),but are probably antigen dependent. There was a considerable 
visual increase in the amounts of HGG absorbed across the intestine on 
administration after,or concurrently with,the saponin adjuvant,Quil-A (Chapter 
3). This increase in the intestinal accumulation of HGG was paralleled by a 
substantial increase in the amount of antigen in the plasma. There was a 
distinct dose response to the oral and anal administration of Quil-A 1 hour prior 
to HGG by a complementary route. Maximum increase in absorbance was 
observed with the prior delivery of lOOJ.Lg/ml Quil-A with the amounts of HGG 
being absorbed being increased by 66%,orally,and 33%,anally over control 
levels. Outside this concentration,Quil-A had a negative effect on absorption. 
Quil-A at this optimal concentration caused a more rapid absorption of anally 
and orally delivered HGG,in significantly greater levels (10-fold,anally and 5-
fold,orally) up to 6 hours post-delivery. A similar pattern of modification was 
observed on rabies antigen administered to mice after oral treatment with Quit-
A (Maharaj et a/.,1986),the level of which increased with time up to 16 hours. 
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In mammals,oral and anal delivery of saponins can increase the absorption of 
macromolecules such as BSA (Udall et a/.,1984) by up to 60% in rats treated 
with aprotinin (Seifert,Sass and Dreyer,1984;Telemo et al., 1982). 
Concurrent administration of Quil-A with HGG also potentiated the 
absorption of antigen to the plasma over a narrow concentration range 
(lOJLg/ml),after 1 hour. Peak oral and anal levels were increased by 6-7-times 
and 15-times respectively. The temporal patterns of HGG appeared to be 
unaffected by this mode of delivery but the overall levels were increased for up 
to 12 hours after intubation,in contrast to the production of a peak of absorption 
2 hours after delivery in mice. Optimal doses of orally delivered Quii-A with 
rabies antigen,in mice was much higher,lOmg,though potentiation of the immune 
response was achieved with 125JLg of saponin (Maharaj et a/.,1986;Campbell et 
a/.,1985). 
Administration of antigen as ISCOMS or micelles allows unique 
properties and adjuvant effects to be imparted to orally delivered antigens. Both 
ISCOM and micellar delivery of antigens increased the level of absorbed antigen 
in the plasma but not greater than that observed with other forms of Quii-A 
administration. However,ISCOMS impart a well-defined (cage-like) three-
dimensional structure on the normally soluble HGG which would give it aspects 
of a particulate antigen as well as inherent adjuvant effects from Quil-A 
(Dalsgaard,1987;Morein et a/.,1984;Morein,1987). Particulate antigens appear 
to be more suited to initiating a mucosal immune response in both fish (Mughal 
et al.,1986;Rombout et al.,1989b) and mammals (Mestecky,1987) and HGG 
administered in these forms was observed accumulated and possibly retained in 
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the lamina propria of the intestine. Micelles are less-well defined structures that 
probably act by partially enclosing the antigen and acting as a protective vesicle 
as well as an adjuvant. The presence of LPS,a known B-cell mitogen did not 
appear to increase HGG absorption appreciably possibly due to its low 
concentration or inappropriate mode of delivery. 
The absorptive and adjuvant effects of Quil-A are likely to occur by a 
combination of direct effects on the permeability of the intestine itself 
(Bangham and Home, 1962),effects on GALT cells such as macrophages 
(Campbell and Bede, 1989),direct modification of the antigen ("depot effect") and 
inhibitory effects on digestive enzymes such as trypsin,pepsin and chymotrypsin 
that are considered to be the major abrogators of useful oral delivery of antigen. 
The various modes of delivery of antigen with Quil-A are probably enhanced by 
most of these systems acting synergistically although the primary relevance of 
each form of action may alter eg prior delivery may have a greater effect by 
reducing digestion on antigens by enzymes as it contacts them prior to the 
delivery of antigen. 
Orally and anally administered HGG was found to be voided into the 
water by regurgitation (observable after oral delivery) or excretion (after anal 
delivery),one of the few instances in which this observation has been recognised 
and quantified. HGG was voided in a dose dependent and temporally complex 
manner with larger absolute amounts being expelled with greater concentrations 
of HGG delivered and over shorter time periods (15 minutes to 1 hour). More 
antigen was voided after oral delivery and this contrasted with the expulsion of 
HRP in tilapia with levels of up to 30% of the intubated dose of HGG 
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compared to 3.32% HRP being voided (Doggett,1989). It is likely that it is the 
absolute levels of voided antigen that is relevant in the possibility of initiation 
of an immune reaction via introduction into the organism through another route. 
Generally,the presence of Quil-A in the delivery system increased the levels of 
voided antigen. Such demonstrations of expelled antigen through oral and anal 
delivery into the surrounding tank water lends itself to the possibility of the 
antigen being absorbed via an immersion form of delivery,being subsequently re-
swallowed or having a direct effect on the gills or integument. Immersion 
vaccines have been found to be substantially protective in certain cases 
(Eilis,1988) although their major mode of stimulation has been recently 
postulated as being through swallowing of the vaccine (Tytler,Tatner and 
Findlay,1990) and subsequent stimulation of the GALT. Therefore substantial 
evacuation of intubated antigen into the immediate surroundings may have 
unique repercussions on the overall uptake of antigen,its route of introduction 
and hence on overall antigen delivery strategies. 
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FIGURE 4.2. 
Figure 4.2. 4.2.a shows two standard curves,after HGG titration,from the 
homologous-antiserum ELISA. 4.2.b is the dose response levels of HGG in the 
plasma after oral and anal delivery ( ~ ;oral delivery; !7.:1 ;anal delivery). 
4.2.c is the dose response of levels of HGG in the tank water after oral and anal 
delivery ( ~;oral delivery; 17.:1 ;anal delivery). 
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FIGURE 4.3 
ELISA MICROTITRE PLATES SHOWING TYPICAL TITRATION 
PATTERNS FROM THE HGG ANTIGEN-CAPTURE ELISA.. 
4.3a,4.3b and 4.3c show the absorption of HGG (0.2rnl of a lOmg/rnl 
solution) into the plasma after oral delivery of a range of concentrations of Quil-
A from lmg/ml to lOOpg/ml,by a complementary route. 
4.3a,shows the titration of plasma-borne HGG after intubation of lmg/rnl 
(A),100J.£g/ml (B) and 10J.£g/ml (C) Quil-A prior to HGG,with controls of 
negative plasma (NP,no HGG) and no plasma (-P). Standards (STDS) are 
HGG titrated 1:5 in PBST from 40J.£g/rnl to 500ng/ml. Antibody controls are 
with the absence of primary antibody (1 ° c) and secondary antibody (2 ° c) which 
are also negative in the assay. 
4.3b,sirnilar plate layout to 4.3a with the concentrations of Quil-A 1J.£g/rnl 
(A),lOOng/ml (B) and lOng/m! (C). Other columns are the same as A). 
Asterisk (*) shows an anomalous result in the negative plasma column. 
4.3c,similar to 4.3a with concentrations of Quil-A at 2ng/rnl (A),lng/ml 
(B) and lOOpg/ml (C) with other columns being the equivalents of A). 
4.3d,shows the titration of voided water samples (plus voided HGG) from 
the same ELISA as 4.3a,with orally administered Quil-A followed by HGG. 
Quil-A concentrations are lmg/ml (A),l00J.£g/ml (B) and 10J.£g/rnl (C). Plate 
protocol is as previously with normal water (NW) from controls and columns 
lacking water (-W). Antisera controls are as previously (loc and 2oc). 
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FIGURE 4.4. 
Figure 4.4. Figure 4.4.a is the temporal absorption of HGG into the 
plasma after oral delivery. 4.4.b is the temporal absorption of HGG after anal 
delivery. Controls are delivery of PBS by a complimentary route (not shown). 
4.4.c is the dose-response absorption of HGG 1 hour after the prior intubation 
of Quit-A from 1mg/ml to 1pg/ml ( oral delivery; anal delivery and 
;control anal delivery of HGG). 4.4.d is the temporal absorption of HGG 1 
hour after the prior intubation of lOOJ.Lg/ml Quit-A (Legend as in 4.4.c). 
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FIGURE 4.4. 
Figure 4.4. Figure 4.4.a is the temporal absorption of HGG into the 
plasma after oral delivery. 4.4.b is the temporal absorption of HGG after anal 
delivery. Controls are delivery of PBS by a complimentary route (not shown). 
4.4.c is the dose-response absorption of HGG 1 hour after the prior intubation 
of Quii-A from lmg/ml to lpg/ml ( 0 oral delivery; 6. anal delivery and 0 
;control anal delivery of HGG). 4.4.d is the temporal absorption of HGG 
hour after the prior intubation of 100~-Lg/ml Quii-A (Legend as in 4.4.c). 
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FIGURE 4.5. 
Figure 4.5. Figure 4.5.a is the dose-response absorption of 1-IGG with the 
concurrent administration of Quii-A,from lmg/ml to IOOpg/ml ( 0 oral 
delivery; 6 anal delivery; 0 control anal delivery of HGG). 4.5.b is the 
temporal absorption of HGG with the concurrent administration of IOJ..Lg/ml 
Quit-A (Legend as in 4.S.a). 4.S.c is the absorption of HGG into the plasma I 
hour after the oral and anal delivery of Qui l-A as ISCOMS and micelles and the 
control delivery of HGG + LPS and HGG on its own ( ~oral delivery; EZl 
anal delivery). 4.5.d is the temporal voiding of HGG into the tank water in 
J..Lg/tank ( 0 oral delivery; 6 anal delivery). 
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FIGURE 4.6. 
Figure 4.6. Figure 4.6 (a-d) shows the level of voiding of HGG into the 
tank water (J.Lg/tank). 4.6.a is the dose-response voiding of HGG,into the tank 
water, I hour after the prior intubation of Quii-A from lmg/ml to IOOpg/ml 
( 0 oral delivery; !::, anal delivery and D control anal delivery of HGG ). 
4.6.b is the temporal voiding of HGG after the prior intubation of IOOJ.Lg/ml 
Quit-A (Legend as in 4.6.a). 4.6.c is the dose-response voiding of HGG with the 
concurrent administration of Quii-A ( 0 oral delivery: 6. anal delivery; 
0 control anal delivery of HGG). 4.6.d is the temporal voiding of HGG with 
the concurrent administration of 10!-ig/ml Quii-A (Legend as in 4.6.c). 
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CHAPTER 5. THE OUALHATIVE PROCESSING AND 
ABSORPTION OF PR011EIN MACROMOLECULES AND THE 
EFFECTS OF ENHANCED ENTERIC DELIVERY SYSTEMS. 
5..1... INTRODUCfiON. 
The normal physiological function of the alimentary tract in mammals 
and fish acts to rapidly degrade the majority of antigen after the bulk oral 
administration·of protein (Job ling, 1988; M cLean, 1987;Georgopoulou et al., 1988). 
Such degradative activity is (qualitatively) species-specific and is dependent on 
a variety of factors including the nature of the antigen delivered and both the 
mode and state of nutrition of the organism (Hofer,1982). The oral delivery of 
protein macromolecules,such as BSA,to mammals results in the uptake of a 
small percentage (approximately 0.01%-0.1% ):of serologically intact proteins and 
a larger percentage of antigenic breakdown products. These are generated by 
proteolytic conditions in the stomach and intestine and also by post-absorptive 
intracellular enzymatic degradation (Warshaw, Walker,Cornell and 
Isselbacher,1971;Walker et a/.,1972). Such breakdown products may contain 
degraded fractions that may be non-reactive with antisera to the native whole 
molecule btit still be capable of eliciting an immune response 
(Hemmings,1978;Morris and Morris,1978). Similar fragmentation of proteins 
has been observed after the oral administration of protein antigens to fish 
(Georgopoulou et al.,1986,1988) together with subsequent intracellular release 
and contact With GALT cells, This may have immunological implications with 
the eventual induction of a local immune response (Rombout et 
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al.,l985;Georgopoulou et a/.,1988). 
However,the production ·Of fragments after the oral delivery of protein 
antigens may result in the revelation of protein conformations that can act as 
tolerogenic epitopes (Michael, 1989). Thus, the relatively lower immune 
responses to orally delivered soluble protein antigens (by comparison with 
injection) may be due to the decreased amounts of antigen available for 
absorption across the intestine or the revelation and subsequent presence of 
tolerogenic epitopes of the antigen. The incorporation of the saponin adjuvant 
Quil-A may allow the use of protein antigens,orally,that would otherWise be non-
irnmunogenic and possibly induce tolerance (Mowat et al., 1991). Quil-A has 
been found to substantially increase both the levels of absorbed orally delivered 
antigens (Maharaj et a/.,1986) and the resultant cellular and humoral immune 
responses (Mowat et al.,l991). 
The present study was carr:ied out in order to examine the antigenic 
fragmentation of orally and anally delivered HGG,the quantitative and temporal 
aspects of the passage of these fragments to the plasma and any modifying 
effects that various modes of delivery of the saponin adjuvant Quil"A on these 
systems. 
5.2. MATERIALS AND METHODS. 
5.2. 1. ANIMALS. 
Adult tilapia,Oreoclzromis mossambicus of both sexes,weighing 30-50g 
were held,as previously {Chapter 3),in a freshwater recircuiating system at 24-
26 • C,until use. 
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5.2.2. THE ADMINISTRATION OF HGG AND OUIL-A. 
Optimised doses of human gamma globulin (HGG MW 150kDa,Crohn 
fraction li,Sigma;10mg/ml,0.2ml dose) were administered to groups of fish 
(n=5) orally and anally over a structured time course,as previously (as in 3.2.2.). 
Control groups (n=5) were sham intubated with PBS pH 7.2. 
The effect of administration of the purified saponin adjuvant,Quil-A on 
the qualitative absorption of HGG was also investigated at previously optimised 
doses (Chapter 4) prior to and concurrently with the antigen,over a structured 
time course. Quil-A was also administered with the antigen as ISCOMS (as in 
3.2.3.) and micelles (as in 3.2.5.). 
Control groups of fish were immunised with HGG orally and anally or 
with a mixture of HGG plus E.coli L:026:B6 LPS (Sigma),for the ISCOM and 
micelle study. 
Fish were sacrificed by a sharp blow to the head and blood obtained in 
heparinised (10 units heparin (Sigma)/ml saline) microcapillary (25J.Ll volumes) 
and microhaematocrit tubes (100J.LI volumes). Blood was centrifuged at 4000rpm 
for 4 minutes and the plasma removed,pooled for each test group,and stored at -
20"C until required. 
~SOS-PAGE ELECTROPHORESIS. 
All reagents,including the 6H,7H and pre-stained molecular weight 
markers were composed as in Appendix I (Sigma,Poole,Dorset,U.K.). 
A discontinuous sodium dodecyl-sulphate (SOS) polyacrylamide gel 
electrophoresis (PAGE) system was used throughout the study to analyse plasma 
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samples from the test and control groups of fish. Discontinuous polyacrylamide 
gels were used,based on the method of Laemmli (1970) utilising a Mini Protean 
II electrophoresis system (Bio-Rad,Watford,U.K.) or a LKB 2001 system 
(LKB,Bromma,Sweden). 
SOS-PAGE was carried out on plasma under reducing (ie. sample buffer 
plus 2-B mercaptoethanol) and non-reducing (ie. without 2-B mercaptoethanol) 
conditions. Various percentage gels were prepared according to Table 5.1 and 
polymerisation was carried out using an ammonium persulphate/TEMED system 
(Hames and Rickwood,1990). 
TABLE 5.1. THE COMPOSITION OF SOME STACKING AND 
RESOLVING GELS FOR SOS-PAGE. 
11% SEPARATING 7% SEPARATING GEL. 3% STACKING GEL. 
GEL 
3rnl Separating gel buffer. 3ml Separating gel buffer. 1ml Stacking gel buffer. 
9.5rnl Separating gel 6ml Separating gel 2ml Stacking gel solution. 
solution. solution. 4ml SOS. 
11.5ml SOS solution 11.5ml SOS solution lml water containing 
containing 17mg containing 17mg Bmg ammonium 
ammonium persulphate. ammonium persulphate. persulphate. 
3.5ml water. 
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Other percentage gels may be made by alteration of the above 
compositions by manipulation of the following formula: 
%gel(%1)- g.acrylamide+g.bis xlOO 
total.acrylamide 
Gel sandwiches were assembled on a levelling table. The desired 
concentration of separating gel was prepared and de-gassed for 15 minutes 
without the ammonium persulphate. The de-gassed separating gel had the 
ammonium persulphate added to it and was poured into the gel former and 
overlaid with water-saturated n-butanol,to exclude air,and left to polymerise for 
45 minutes. 
The overlay solution was rinsed off completely with distilled water and 
the stacking gel prepared by degassing and poured onto the separating gel in the 
presence of a 10-well comb. The stacking gel was left for 45 minutes to 
polymerise. 
Plasma samples were added to the wells,at various concentrations,each 
optimized for the particular staining or blotting technique employed (see 
below),in reducing or non-reducing sample buffer. Various preparations of 
molecular weight markers were used, 6H for high molecular weight protein 
determination,7H for low molecular weight determination or pre-stained 
standards for determinations on immunoblots. Varying quantities of sample 
were loaded onto the gels - 10J.Ll per well for the Mini-Protean 11 system and 
50J.LI per well for the LKB 2001 system. Electrophoresis was carried out at a 
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constant voltage of 200V for 45 minutes (Mini-Protean 11) or 300V for 3-4 hours 
(LKB 2001). Gels were removed and were directly stained or immunoblotted. 
5.2.3.1. COOMASSIE BLUE STAINING. 
Gels were fixed in Coomassie brilliant blue-R stain overnight at ambient 
temperature on an orbital shaker and subsequently destained for 4-5 hours with 
several changes of destain. The sensitivity of detection of this staining system 
was 0.1-0.5J.£g of protein per lane (Harlow and Lane,1988). The optimal 
concentration of plasma for this form of detection system was found to be 5%. 
Coomassie brilliant blue-G staining was carried by fixation of the gel in 
a trichloroacetic acid-salicylic acid fixative followed by staining in the Coomassie 
working solution (Appendix I) for 1-2 hours. Destaining was carried out in 10% 
acetic acid plus 25% methanol for 60 seconds followed by immersion in a 25% 
methanol solution for 24 hours. Maximal detection sensitivity was 0.05-0.1J.,£g of 
protein per lane. 
5.2.3.2. NEUTRAL SILVER STAINING. 
Plasma concentrations were optimised at 2% for this method of detection. 
Gels were fixed for 30 seconds,washed and equilibrated in an appropriate 
volume of silver solution for 30 minutes. The silver stain was developed,stopped 
and a reduction of the stain carried out for 10-30 seconds if necessary. 
Detection limits were 1-10ng of protein per lane. 
5.2.4. IMMUNOBLOTTING (WESTERN BLOTTING). 
Electrophoresed plasma proteins were transferred,in Trans-Blot apparatus 
(Bio-Rad),onto 0.45J.,£m or 0.2J.£m pore nitrocellulose membranes 
(Sigma;Schleicher and Schuli,Anderman and Co.,Kingston-Upon-Thames,U.K.) 
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according to the method of Towbin,Staehelin and Gordon (1979) in 0.025M 
Tris,0.192M glycine plus 20% v/v methanol at pH 8.3 for 18-20 hours at a 
constant current of 30mA. 
5.2.4.1. STAINING OF IMMUNOBLOTS FOR TOTAL PROTEIN. 
Initial imunoblots were stained for total protein content to ascertain 
whether the general pattern of the transferred protein resembled that of 
equivalent gels. Total protein staining was carried out by 2 methods: the first 
involving the use of amido black and the second the use of India ink staining. 
Amido black staining was carried out by sequentially washing of the 
immunoblot with PBST (Appendix I) and immersion in Amido black solution 
for 5 minutes followed by destaining. India ink staining was similarly carried out 
on a washed blot and was compatible with further immunostaining (Harlow and 
Lane,1988). 
5.2.4.2. IMMUNOSTAINING. 
Western blotting was optimised with respect to blocking protocol,antisera 
concentrations and incubation times for the detection of absorbed fragments of 
HGG. Blots were washed in Tris-saline pH 7.5 for 20 minutes and subsequently 
blocked,for 2 hours,in Tris-saline plus 5% low fat skimmed milk (Tris-saline-
milk,TSM),on an orbital shaker at ambient temperature. All antisera were 
diluted in TSM for incubations and each incubation was preceded by thorough 
washing of the membranes for 3x3 minutes in Tris-saline and 2x3 minutes in 
TSM. Blots were incubated in primary antiserum (rabbit anti-HGG) at 1/1500 
for 6 hours at ambient temperature. For peroxidase conjugate-labelling, the blots 
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were incubated with secondary antiserum (swine anti-rabbit IgG peroxidase 
conjugate) at 1/2000 for 2 hours at ambient temperature. Blots were developed 
in Tris-saline plus 0.5% w /v 3'3' diaminobenzidine-tetrahydrachloride (DAB) 
substrate plus 0.03% v /v H20 2 for 4-5 minutes and the reaction was terminated 
by thorough washing in Tris-saline. 
For immunogold-silver staining,the blots were treated as above until 
incubation in secondary antiserum. The secondary antiserum was goat anti-
rabbit IgG 5nm gold conjugate in PBS pH 7.2 plus 1:20 porcine gelatin 
(Sigma),for 2 hours at ambient temperature. The blots were washed for 2x5 
minutes in PBS and subsequently for 2x1 minute in distilled water and 
developed with silver enhancing solution as per manufacturers instructions 
(Amersham Ltd,Amersham,Herts.,U.K.) for 10-15 minutes and the reaction 
terminated by washing with PBS pH 7.2. 
Blots were also analysed for the molecular origin of the absorbed HGG 
fragments. Blots were incubated with either goat anti-human lgG F.b or goat 
anti-human Fe region antiserum at 1/250 in TSM for 4 hours followed by rabbit 
anti-goat peroxidase conjugate at 1/2500 in TSM for 1 hour and developed as 
above. 
5.2.5. OUANTIFICATION OF GELS AND BLOTS. 
All gels and blots were run in the presence of appropriate molecular 
weight markers. This allowed the accurate estimation of the molecular weights 
of the HGG fragments by interpolation from log weight versus relative mobility 
curves. For fragments that appeared to be differentially mobile with the %T of 
the gels (often apparent for glycoproteins) an asymptotic minimum was 
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calculated from several gels. Gels and blots were analysed by laser densitometry 
with a LKB Ultroscan XL densitometer equipped with a helium-neon laser,at 
633nm. Densitometry scans were compared to blots directly and a relative 
quantification of protein bands was carefully made. 
5.2.6. STATISTICAL ANALYSES. 
All densitometry derived data were analysed using one-way analyses of 
variance with the incorporated follow-up test that allows derivation of 75% and 
95% confidence limits (see Chapter 4). 
5.3. RESULTS. 
Tilapia plasma is,de facto, very complex and contains a large number of 
proteins of variable size (molecular weight) and structure (Figure 5.1.a). Figure 
5.1.a shows the optimisation of plasma at 5% for Coomassie-blue detection 
(Lanes c and d) with overloaded plasma in two lanes (at 25%(a) and 
15 %(b ),respectively). 
Administration of HGG altered the observable plasma protein profile, in 
gels, in a temporal and route dependent manner. Reducing gels of plasma after 
the oral and anal administration of HGG,had noticeable alterations in the 
overall band patterns (Figures 5.1.b and 5.1.c). Immunoblotting of similar gels 
and subsequent probing for the antigenic determinants of HGG with specific 
rabbit antisera revealed a wide range of antigenic fragments of HGG in the 
plasma (Figures 5.4.a and 5.4.b ). These bands were first detectable after 15 
minutes and remained,at some level, throughout the study. Table 5.2 shows the 
apparent molecular weights (Mw's) of the antigenic fragments of HGG detected 
in the plasma as derived after curve interpolation. 
143 
TABLE 5.2. THE APPARENT MOLECULAR WEIGHTS (kDa) OF 
THE ANTIGENIC FRAGMENTS OF HGG. 
HIE MODE OF ADMINISTRATION OF HGG. 
HGG PRIOR QUI L-A CONCURRENT QUIL-A ISCOMS 
ORAL ANAL ORAL ANAL ORAL ANAL ORAL 
15.1' 15.1' 27.o' 27.ol 
-
26.5 18.1' 
37.7 37.7 30.2 30.2 29.6 29.6 21.2 
-
42.9§ 36.1 36.1 33.gl -- 23.7 
48.8 48.8 41.0 - -- 36.2 27.0 
59.9 59.9 47.2 47.2 37.9 - 36.8 
70.3 70.3 - 52.8 46.4 46.4 38.5 
79.8 79.8 - 59.ol 51.9 51.9 43.0 
-
92.5 64.5 64.5 59.3§ 59.31 48.1 
93.8 93.8 73.8' 73.8' 66.3 66.3 91.4 
99.7 99.7 73.4 73.4 109.2 
119.9 119.9 75.C}I -- 127.5 
130.9'1 130.9'1 
-
81.2 1393 
83.0 
-
90.8 90.8 
nu1 111.11 
124.2 124.2 
ANAL 
18.1' 
21.2 
23.7 
27.0 
36.8 
38.5 
43.0 
48.1 
91.4 
109.2 
127.5 
139.3 
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Tim MODE OF ADMINISl'RATION OF HGG 
HGG I'RIOR QUII~A CONCURRENT QUIL-A JSCOMS 
ORAL ANAL ORAL ANAL ORAL ANAL ORAL 
141.2 -
145.3 145.3 
149.9'1 
-
• denotes the fragments that are identified by Western blotting as having 
determinants identified with anti-Fab antisera. 
§ denotes the fragments that are identified with anti-Fc antisera. 
TABLE 5.3. CORRELATION OF RELATIVE LEYELS OF 
FRAGMENTS OF HGG WITH ELISA MAXIMA. 
DELNERY SYSfEM FRAGMENT Mw (kDa) REI.ATIVE LEVEL(%) MEAN PLASMA 
LEVELOFHGG 
(by ELISA;Ilgjml) 
HGG (ORAL) 59.9 46.4 96.1 
70.3 25 
79.8 28.7 
HGG (ANAL) 59.9 31.3 74.1 
119.9 31.3 
PRIOR QA. (ORAL) 645 31 218.6 
PRIOR Q.A. (ANAL) 645 38.3 407.6 
CONC. Q.A. (ORAL) 51.9 415 251.8 
CONC. Q.A. (ANAL) 51.9 24.2 687.3 
ANAL 
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DELIVERY SYSffiM FRAGMENT Mw (kDa) RELATIVE LEVEL(%) MEAN PLASMA 
LEVEL OF HOG 
(by ELISA;Ilg/ml) 
ISCOMS (ORAL) 36.8 46 1455 
-
ISCOMS (ANAL) 36.8 46 1555 
MICELLES (ORAL) 27 SI 65.6 
MICELLES (ANAL) 27 49.7 64.3 
Several of the fragments are positive for determinants associated with the 
Fe and/or F.b regions of the molecule (Table 5.2). There appears to be less 
fragments with complete Fab determinants present on comparison with fragments 
with Fe epitopes and the fragments that are Fab positive are in the Mw size-
range that is suggestive of the presence of the whole molecule or the intact Fab 
portion itself. The data for the Fe is more complex and suggests the presence 
of determinants on intact immunoglobulin heavy chains. 
There was an overall difference in the numbers of fragments derived after 
oral (10 fragments) and anal (12 fragments) administration of HGG. The 
apparent Mw's of the fragments derived from unreduced immunoblots were 
remarkably similar for both routes of administration. Extensive laser 
densitometry was carried out on immunoblots of plasma after delivery of HGG 
and the differences highlighted using this technique correlated with the 
observable differences on the immunoblots. Figures 5.7 to 5.12 show the 
quantified levels of each antigenic fragment as a relative percentage of the total 
detectable HGG level. Such data was derived from scans as exemplified in 
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Figures 5.5 and 5.6. Figure 5.5 shows an immunoblot (5.5.c) of an orally 
delivered ISCOM preparation and the corresponding laser scan (5.5.a) and 
quantification (5.5.b) of detected bands and Plate 5.6 shows similar data for a 
scan of a 7H molecular weight standard protein sample after Coomassie 
staining. Typical differences may be noticed between the two scans (5.5.a and 
5.6.a),showing the complexity of antigenic fragments in the plasma in contrast 
to the relative simplicity and homogeneity of a predetermined protein sample. 
From such laser scans of immunoblotted and probed HOG-containing 
plasma it was observed that there were temporally variable patterns of 
absorption or production of antigenic fragments from HGG,from small portions 
of the molecule to its almost entirely intact structure (Figures 5.7-5.12). There 
appeared to be several fragments that had a similar pattern of appearance in the 
plasma ,with time,after oral and anal delivery. 
Antigenic fragments of 15.1kDa,37.7kDa,99.7kDa and the largely intact 
130.9kDa were processed in a route-independent manner after delivery. The 
levels of the two low Mw fragments, 15.1 kDa and 37. 7kDa,decreased rapidly with 
time and were at 5% levels 6 hours after intubation. In contrast,the higher MW 
fragments,99.7kDa and 130.9kDa, increased with time after delivery making up 
70-80% of the detectable antigen after 12-48 hours. The other fragments of 
HGG,while being present at the same weights after both routes of 
delivery,were,quantitatively,different in their patterns of appearance in the 
plasma. Anal delivery of HGG resulted in the production of two more 
fragments than oral delivery,one of 42.9kDa and another of 92.5kDa. 
Prior administration of Quii-A,in various concentrations ranging from 
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1mg/ml to 100pg/ml,1 hour before HGG delivery resulted in detectable 
differences in the numbers and apparent quantities of the plasma protein 
profiles after electrophoresis and neutral silver staining (Figure 5.2). Prior 
administration of Quii-A reduced the number of bands produced,and their 
apparent Mw's (Table 5.2,Figures 5.3.c and 5.3.d) with no fragments of over 
73.8kDa being detectable. The quantitative processing of the fragments was 
route-dependent (Figure 5.13) with the apparently preferential production 
(approximately 30-40% of the total detectable protein) of a fragment of 64.5kDa 
after both oral and anal delivery (Table 5.3). Anal administration resulted in 
the production of more bands than oral delivery but there was a significant 
similarity between the relative levels of the common fragments produced. 
Concurrent administration of Quii-A with HGG resulted in an observable 
alteration in the plasma protein profiles derived after oral and anal delivery 
(Figure 5.3.a and 5.3.b ). Delivery of HGG with Qui l-A in this manner appeared 
to cause a greater degree of division of the antigen into fragments than the 
other modes of delivery. Orally and anally delivered antigen was processed into 
a number of fragments that were unique to each route,with only 10 of the 18 
bands sharing a common approximate apparent Mw (Figure 5.14). Comparison 
of immunoblots (Figure 5.3.c lanes 4 and 5) shows that the production of 
fragments after this form of delivery differed from prior administration of Quii-
A (Figure 5.3.c lanes 1,2 and 3). The lower molecular weight (below 75kDa) 
bands appeared to be produced in similar levels after both oral and anal 
administration,whereas route differences were most apparent in the levels of 
higher molecular weight fragments (90.8kDa,l11.lkDa and 124.2kDa) and the 
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intact molecule. Greater relative levels of intact proteins were produced by this 
mode of delivery than any other. 
There appeared to be an antigenic fragment of similar Mw 59kDa 
produced with the oral and anal adminstration of HGG on its own, with or after 
the administration of Quil-A. 
Oral and anal delivery of ISCOMS and micelles resulted in the 
production of fragments that were similar to each other but unlike those from 
other modes of delivery (Figure 5.4.c). There was little route variation in the 
levels of production of each fragment (Figures 5.15 and 5.16) and maximal 
levels of antigen represented as a 36.8kDa antigen (Table 5.3). 
The maximal relative levels of certain fragments of HGG appeared to 
correlate with the overall peak levels of HGG as detected by ELISA (Table 5.3). 
M DISCUSSION. 
The oral and anal administration of HGG to O.mossambicus resulted in 
the absorption of a number of antigenic fragments,of various sizes,being 
absorbed in various quantities across the intestine to the plasma as well as the 
largely intact protein. The antigenic fragments ranged from small (18kDa in 
molecular weight) to almost intact protein (130.9kDa in molecular weight). 
Analysis revealed that the absorption and qualitative processing of orally and 
anally delivered HGG varied with time with respect to the relative levels of the 
fragments detectable in the plasma. More antigenic fragments were derived 
after anal intubation of HGG than oral delivery,possibly due to the anally 
administered protein bypassing the stomach and its degradative milieu and 
hence having an increased retention of detectable fragments. Fragmentation of 
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orally delivered HGG in O.mossambicus resulted in the production of several 
fragments that were associated with the Fe and/or F.b regions of the molecule. 
The levels of the Fab positive fragments generally decreased with time possibly 
indicating that this region of the molecule was more susceptible to degradation. 
The oral delivery of HGG in other species such as rainbow trout also resulted 
in the rapid production of antigenic fragments that could be specifically 
identified as belonging to the Fe and F.b portions of human lgG (Georgopoulou 
et a/.,1986). However this study revealed contrasting results where the Fe region 
of the molecule was primarily degraded,utilising an everted gut-sac model. 
Some fragments,of similar molecular weight, were present after oral and 
anal delivery of HGG and two fragments,one of 59.9kDa and the other of 
70.3kDa, had peaks of relative abundance that correlated with the maximal 
levels of HGG,as quantified by ELISA. The production of highly antigenic 
epitopes from orally delivered proteins has been documented for other protein 
antigens in teleosts,such as BSA (Doggett,l989;Doggett et a/.,1991) and ferritin 
and antigens from Vibrio anguillarum (Rombout and van den Berg,1989) and is 
correlated with increased overall levels of plasma-borne antigen. Partially 
degraded antigenic fragments from BSA ,of approximately 40kDa,were detected 
after oral administration in tilapia (Doggett, 1989). In mammals small fragments 
and complexes of higher molecular weight,thought to be indicative of BSA in 
imrnune-complexes,contributed to the overall plasma levels of the antigen 
(Schreiber and Walker,1988). Up to 5% of the total delivered dose of BSA,and 
between 57.7% and 68.8% of the total absorbed antigen appeared as breakdown 
products,of between 20-50kDa in mammals (Hemmings, 1978). 
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Qualitative and quantitative fragmentation of antigen is also dependent 
on its inherent structure eg macromolecules such as ferritin are likely to be 
fragmentable into immunologically recognisable epitopes as it is composed of 
24 identical subunits (Rombout and van den Berg,1989) whereas BSA is 
composed of three non-identical domains. Fragmentation of orally delivered 
antigen is mostly caused by the normal physiological functioning of the stomach 
and other areas of the alimentary tract where primary degradative events occur. 
The complex temporal patterns of antigen appearance in the plasma may be due 
to the mechanisms of fluid retention and gastric emptying that operate in the 
alimentary tract of teleosts as well as species specific nutritional functions 
(Jobling,1988). The direct intubation of relatively large volumes of oral 
antigens,may alter gut retention times,the absolute level of degradation on the 
antigen and the size and peptide composition of the fragments obtained,as 
compared to intra-ileal delivery in fish and mammals (Michael,1989). 
Intact HGG and fragments of higher molecular weights appeared m 
increasing amounts 24 to 48 hours after delivery both with and without Quil-A 
adjuvant,when the overall detectable level of plasma antigen was decreasing. 
Such an absorptive pattern could be due to the retention of intact antigens in 
the intestinal tissue. The differential absorption and the retention of intact 
antigen, in association with GAL T cells and the supranuclear vacuoles of the 
enterocytes,was observed for HGG (Chapter 3),HRP and ferritin in tilapia 
(Doggett,l989) for ferritin and V.anguillamm in carp,C.carpio (Rombout and van 
den Berg,1989) and HRP in Rainbow trout (Georgopoulou et a/.,1988) for up 
to 48 hours whereas antigenic fragments appeared to be more rapidly directed 
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to the plasma (Rombout and van den Berg,1989). Another possibility is that low 
Mw breakdown products are more rapidly cleared from the vasculature resulting 
in an apparent accumulation of intact HGG,in the plasma,with time. 
Administration of Quit-A prior to and concurrently with HGG altered the 
numbers of fragments, their molecular weights and the temporal pattern of their 
appearance in the plasma on comparison with the absence of adjuvant. Prior 
Quit-A delivery resulted in the preferential production of detectable fragments 
of HGG of low molecular weight,after both oral and anal delivery,(the largest 
fragment weighing 73.8kDa). Such a process has also been observed for the oral 
administration of rabies antigen preparations after the delivery of Quit-A 
(Campbell et al., 1985;Maharaj et al., 1986) where a rapid absorption of fragments 
of low molecular weight occurred after 2 hours. Concurrent administration of 
Quil-A with HGG resulted in the widest size range of fragments in the study 
and the highest levels of absorbed antigen,quantitatively. The level of intact 
proteins absorbed after 1 hour into the plasma increased. Such differences in 
the antigen fragment profiles in the plasma can be directly attributed to the 
adjuvant effects of the saponin Quit-A on the degradative enzymes of the gut, the 
absorptive capacity of the enterocytes and also on the antigen itself which may 
include direct structural changes,as noted for the complex rabies G antigen when 
orally delivered to mice in the presence of Quit-A (Maharaj et a/.,1986). 
Administration of ISCOMS and micelles resulted in altered HGG antigen 
patterns in the plasma probably via the mechanisms outlined above and also due 
to the addition of a defined three-dimensional structure to the antigen. 
(Dalsgaard, 1987;Morein,1987). Particulate antigens are processed and retained 
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in a different manner by teleost alimentary tracts and can expect to arrive in the 
plasma altered in comparison to the administration of the same antigen by other 
mechanisms. This appeared to be the case in tilapia where the fragmentation 
profile was different to all others obtained. 
Protein fragments derived after the oral and anal delivery of antigen in 
fish and mammals retain the potential to act as both antigens 
(Hemmings,1978;Rombout et al.,1989b) and immunogens (Morris and 
Morris,1978). Orally delivered ferritin and V.anguillarum,after fragmentation in 
the enterocytes of the hindgut of carp C.carpio produced detectable serum and 
mucosal antibody titres that appeared to be protective (for V.anguillarum) after 
subsequent challenge (Rombout et al., 1989b ). However,oral delivery of antigens 
such as BSA to mice and the subsequent action of the stomach caused the 
revelation of epitopal conformations that preferentially induced a tolerogenic 
response to the subsequent administration of the antigen (Michael,1989). 
The production of breakdown products from delivered proteins and the 
resultant facilitation of an immune response is enhanced by the use of the 
saponin adjuvant Quii-A,as observed in mammals on the administration of rabies 
G antigen in mice (Campbell et a/.,1985;Maharaj,et a/.,1986). It appears that the 
immune responses to orally delivered antigens in mammals and fish may be 
directly influenced by the epitopes of the breakdown products that are formed 
by both intra and extracellular degradation .. 
This study did not address itself to the immunological consequences of 
the fragmentation of HGG ie. whether the direct production of specific 
fragments could specifically act as tolerogens or immunogens. The current study 
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did,however,show that the enteric delivery of HGG results in the production of 
fragments of the antigen and that the relative levels of the fragments could be 
differentially altered by various modes of delivery of Quii-A in a complex and 
specific manner. 
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FIGURE 5.1. 
SOS-PAGE GELS OF TILAPIA PLASMA AFfER THE 
ADMINISTRATION OF HGG ORALLY AND ANALLY. 
5.1.a) A 7% reducing SOS-PAGE gel showing various dilutions of 
normal tilapia plasma from 25% (a),15% (b) and 5% (c and d) showing the 
overloading of bands (a&b) and an optimal protein concentration (c&d). 
Molecular weight markers (6H) show protein distributions from 205kDa to 
29kDa. Coomassie blue stain. 
5.1.b) A 6% reducing gel of 5% tilapia plasma after the oral 
administration of HGG (0.2ml of lOmg/ml) at various times: 15 minutes (1),30 
minutes (2),60 minutes (3),2 hours (4),6 hours (5),12 hours (6),24 hours (7) and 
48 hours (9). Control HGG is shown in lane 8. Molecular weight markers (6H) 
are as in 1. Coomassie blue staining. 
5.1.c) A 6% reducing gel of plasma after the oral and anal 
administration of HGG after 15 minutes (2),30 minutes (3),60 minutes (4),2 
hours (5),6 hours (6),12 hours (7),24 hours (8) and 48 hours (9). Molecular 
weight markers (6H,lane 1) are as in 1. Coomassie blue staining. 
Figure 5.1 155 
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FIGURE 5.2. 
SDS-PAGE GELS SHOWING THE PLASMA PROTEINS AFTER 
PRIOR ORAL AND ANAL ADMINISTRATION OF QUIL-A 
FOLLOWED BY HGG. 
5.2.a) A 11% reducing SDS-PAGE gel showing plasma,optimised at 2%, 
after the oral administration of Quii-A at various concentrations ,1 hour prior 
to the delivery of HGG (0.2ml of 10mg/ml). The concentrations of 
administered Quii-A were lmgjml (1),100~.£g/ml (2),10~.£g/ml (3),1~.£g/ml 
(4),100ng/ml (5),10ng/ml (6),1ng/ml (7) and lOOpg/ml (8). Low molecular 
weight markers (7H) are as in 2. Neutral silver staining. 
5.2.b) A 11% reducing SOS-PAGE gel of 2% plasma after the anal 
administration of Quii-A,at various concentrations, 1 hour prior to the 
administration of HGG. The Quii-A concentrations were the same as 1) except 
lane 7 being a 2mg/ml solution. Low molecular weight markers (7H). Neutral 
silver staining. 
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FIGURE 5.3. 
SOS-PAGE GELS AND IMMUNOBLOTS SHOWING THE PLASMA 
PROTEINS AND ANTIGENIC FRAGMENTS OF HGG WITH THE 
ADMINISTRATION OF OUIL-A. 
5.3.a) A 8% SOS-PAGE reducing gel showing plasma after the delivery 
of 100!-'g/ml Quil-A concurrently with HGG,with oral intubation (0) and anal 
intubation (A) after 15 minutes (1),30 minutes (2) and 60 minutes (3). 
Molecular weight markers (6H) are shown with the same weights as in Plate 
10.1 and as shown in Appendix 1. Coomassie blue stain. 
5.3.b) A 12% reducing SOS-PAGE gel of plasma showing the 
distribution of proteins after the administration of 10J.Lg/ml Quit-A concurrently 
with HGG orally (0) and anally (A) after 15 minutes (1) and 30 minutes (2). 
Neutral silver staining. 
5.3.c) An immunoblot of a non-reducing 11% SOS-PAGE gel showing 
the distribution of the absorbed HGG fragments 1 hour after the administration 
of 100J.Lg/ml Quil-A orally (1&3) and anally (2) and with the concurrent 
administration of 10!-'g/ml Quil-A orally (4) and anally (5). Pre-stained 
molecular weight markers (PS) have weights as shown. lmmunogold-silver 
staining. 
5.3.d) An immunoblot of a non-reducing 7% SOS-PAGE gel showing the 
fragmentation of absorbed HGG 1 hour after the administration of lOOJ.~g/rnl 
delivered orally (1&3) and anally (2&4) after 60 minutes (1&2) and 2 hours 
(3&4 ). Pre-stained molecular weight markers (ps) are as in 3. DAB staining of 
peroxidase conjugate antisera. 
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FIGURE 5.4. 
IMMUNOBLOTS SHOWING THE PRESENCE OF ANTIGENIC 
FRAGMENTS OF HGG AFTER ORAL AND ANAL DELIVERY. 
5.4.a) An immunoblot of a non-reducing 7% SDS-PAGE gel with 2% 
tilapia plasma after the oral (lanes 1,3&5) and anal (lanes 2&4) delivery of 
HGG after 15 minutes (1&2),30 minutes (3&4) and 60 minutes (5) after oral 
delivery. Pre-stained molecular weight markers (PS) are as in 2). Immunogold-
silver staining. 
5.4.b) A higher magnification of 1) with the same lane protocol showing 
observable differences in the band patterns of HGG fragments after oral (1) and 
anal (2) delivery,with respect to both their numbers and intensity of staining. 
Molecular weight markers (PS) have weights (kD) as shown. Immunogold-silver 
staining. 
5.4.c) An immunoblot of a 7% reducing SDS-PAGE gel of plasma after 
the oral and anal administration of ISCOMS and micelles containing HGG. 
ISCOMS are shown in 3 (anally administered) and 4 (orally administered) and 
micelles in 1 (anally administered) and 2 (orally administered). Pre-stained 
molecular weight markers (PS) are as previously. DAB staining of peroxidase-
conjugate antisera. 
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ATYPICA£·t.ASER11DENSTIF0METRiY SCAN rF0R TlHE: PRESENCE 
OF ANTIGENICFRAGMENTtS GF ABS0~BEID HGG. 
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FIGURE 5....6. 
A TYPICAL LASER DENSITOMETRY SCAN FOR THE 
MOLECULAR WEIGHT MARKERS (7H) OF A SDS-PAGE GEL. 
Figure 5.6 shows a typical laser scan of the 7H molecular weight markers 
on a 11% reducing SDS-PAGE gel. The composition of the markers is shown 
in Appendix I. The laser scan (5.6.a) is from the bottom of the gel (5.6.c) in the 
direction shown (arrows). The subsequent quantitative output is shown in 5.6.b. 
The scan of such a standard protein mixture is much more easily relatable to its 
appearance compared to the fragments of HGG derived on an immunoblot 
(Figure 5.5). Coomassie blue staining of a gel. Standards at 10%. 
2 
1 tlb~-Jrbiir.ce 
! 
I 
•. tL "'-il.:!~) '1.00 N.B.! CLAi1f'!D l I ~-~~in = ? "" ~  ~ . 
uot· -------- _______________ _ : ::1· . .. - --- ---·- -· ·- ------- - -.-- -- . - - -------- t 
j, )IJ j+ , \ ; . 
::J . . . . . . . . . . . . .. . . . \ ' .•. //. 
, ,~ ~·~\ . . . ··\.  . . r·,\ 
,Jo .. \,.,~0 I ... ! .. , ..... I l . '''' '' ·'' • J · 
' - ' ; I j .. '\" ' .. . ,\ I . 
.... ' I \ .. ,rJ \ I \ ! 
/ 
' I 
I 
I 
i 
I 
I 
,_., / \t' \ i \ : r' \J. 
I . . I \ 
·, , I ...... ::.'vC\J. 
'---...... I 
. .._/, 
I" 
3 
........, 
.,_, 
===t 
.,. 
/ 
7h 
I~ 
I" 
I 
166 
'FIGUJRE;5.7. 
li'HE ~ELATJiVE PROCESSING· OF A' lS.'lkDa AND1 37.7kDa• 
' A•N'FIGEN FRAGMENT AFTER' 'ORAL AND ANAL 
.:ADMINISifRAlilON :OF HGG. 
The processing of orally intubated HGG: 
the appearance of a 15.1kDa antigen in the pl~sma. 
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FIGURE 5.8. 
THE RELATIVE PROCESSING OF A 48.8kDa ANTIGEN 
FRAGMENTSAFTERORALANDANALADMINISTRATION AND 
A 42.9kDa ANTIGEN FRAGMENT AFTER ANAL 
ADMINISTRATION OF HGG. 
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The processing of orally intubated HGG: The processing of anally intubated HGG: 
the appearance of a 48.8kDa antigen in the plasma. the appearance of a 48.8kDa antigen in the plasma. 
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. FIGUJRE.512.. 
'FHE RELATtiVE PROCESSING OF S9.9kba' AND, 70l3kba 
,~ ; 
A:N1liGEN 'FRAGMENTS AFTER 0R'AI!.. AND ANAL 
AI>MINiSfRA'ifiON 0FHGG. 
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The processing of orally intubated HGG: The processing of anally intubated HGG: 
the appearance of a 59.9k0a antigen in the plasma. the appearance of a 59.9kDa antigen in the plasma. 
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FIGURE 5.10. 
THE RELATIVE PROCESSING OF A 79.8kDa ANTIGEN 
FRAGMENT AFTER ORAL AND ANAL ADMINISTRATION AND 
OF A 92.6kDa ANTIGEN FRAGMENT AFfER ANAL 
ADMINISTRATION OF HGG. 
The processing of orally intubated HGG: The processing or anally intubated HGG: 
the appearance of a 79.8kDa antigen in the plasma. the appearance of a 79.8kDa antigen in the plasma. 
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:FIGUR'E 5.14. 
'FHEU·RELATtlVE PROE:ES.SING OF ANU'IGEN 1FRAGMENTS 
AFIIER _ •ORAIL AND ANM!. .. AlDMINISTRAIT'I0N :OF iQUIL-A 
CON€l:JRRENIThY WlllH HGG. 
- -
30 
25 
20 
IS 
10 
-
0 
The proceuing of HGC olfor oral 
admin. concurrently •lrh Ouii-A, 
level of antigen In ploamo (llro HGC) 
- F 
F 
F 
F 
F 
F 
F hnn = . Fllf l~ llm1inJ 
Molecular "Weight of antigen (kOo). 
The procusing of HGC after lhe anal 
odmJn. coi'\Currenlty •ith Ouii-A. 
lowel of antigen In plasma (7. HGG). 50~~~~~~==~~~---------------. 
40 
30 
20 
26.5 29.6 36.2 .. 6.4 51.9 59.J 66 . .3 1.5.4 81.:? 90.8111.1124.2U5.J 
MolecukJr •eight of antigen (liDo). 
181 
' 
I 
' 
'. 
1. 
:i 
' 
'fHE 'R'ELAl'IV:E PROCESSING OF ANT<IGEN FRAGMEN'FS 
' ' 
MTERI ORAL M-.IID ANAL ADMINiSTR·A1'IGN OF' HGG AS, 
·lSCOMS. 
50 
40 
30 
20 
10 
The proceulng of HGG after the Otol 
odmlnislrotton of ISCOMS. 
L•••l of anligon In plosmo (~ HGC). 
18 . 1 21.2 23.7 27.0 36.8 38.5 H .O 48 .1 91.~ 109.2127 .5139. 3 
Molecular weight of antigen (kOa). 
The processir\9 of HCC orter rhe onol 
odminis rrotion of ISCOMS. 
Level of ont;gen in plosmo ( ?. HGG). 
18 . 1 2 1.2 23.7 27.0 36.8 38.5 • 3.0 • 8 .1 91.• 109.2 127 .5139. 3 
~oleculor weight of antigen (kOa) 
183 
f 
I 
I 
,• 
FIGliRH 5.16. 
'FHE RELATIVE PROCESSING OF AN['IGEN !fRAGMENTS 
AF'tER ORAL ANB. ,J\NAL AIDMINISifRATION• OF HGG AS 
MICELLES. 
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CHAPTER 6. TilE ANTIBODY RESPONSES TO ORAL AND ANAL 
DELIVERY OF PROTEIN ANTIGEN IN ENHANCED ENTERIC 
DELIVERY SYSTEMS. 
6.1 INTRODUCTION. 
The absorption of antigens from the gastrointestinal tract, in mammals, can 
lead to the stimulation of specific antibodies locally,systemically and also in 
secretions at mucosal sites "remote",anatomically,from the site of antigen 
delivery (Mestecky,1987;Nicklin, 1987). The oral delivery of a wide range of 
antigens to mammals can result in their subsequent absorption and a specific 
immune response that can be protective against infectious agents such as 
Salmonella typhi (Black et al.,l990;Forrest et a/.,1990) that gain access to the 
host organism via the gastrointestinal tract. The repeated oral delivery of 
standard antigens such as bovine serum albumin (BSA) has been reported in 
mammals,to result in a serum immunoglobulin response that is comparable to 
parenteral immunisation with respect to titre and antibody isotype production 
(Rothberg et a/.,1970;Nicklin,1987) and to the generation of antibody-secretory 
cells in the plasma (Kantele,1991). The antibody response generated at mucosal 
sites,especially the intestine,largely consists of dimeric secretory IgA (slgA),an 
isotype that is uniquely adapted to secretion across epithelial surfaces and to 
resistance against lumenal proteolysis (Brandtzaeg et al., 1988;Mestecky,McGhee 
and Elson,1988). Fish have been reported as only having one major isotype of 
immunoglobulin,a tetrameric IgM-Iike molecule,although the systemic and 
mucosal forms may have some structural differences and indeed recent evidence 
187 
lends itself to the possibility of more widespread differences in immunoglobulin 
structure than was previously presumed (Lobb and Clem,1981a-d;Kobayashi and 
Tomonaga,l988;Davidson,1991). Similar studies have resulted in the observation 
that the oral delivery of some proteins,especially dietary and standard,T-
dependent,antigens cause a specific systemic hyporesponsiveness (tolerogenesis) 
that is possibly mediated by the induction of specific T-suppressor cells 
(Elson, 1985;Nicklin, 1987;Michael, 1989). Mammalian studies therefore indicate 
that the immune response to orally delivered antigen is variable and dependent 
on a series of interrelated factors including the nature of the antigen 
delivered,the dose,timing and frequency of its administration and the nutritive 
status and genotype of the recipient organism (Ad a, 1990;Peng et al.,1990). 
The oral and anal delivery of a variety of protein antigens has been 
reported to elicit systemic and/or mucosal immune responses,both of a humoral 
and cellular type m fish (Davina et al., 1980;1 ohnson and 
Amend, 1983a, 1983b;Ellis,1988;Rombout et al.,1989b;Doggett, 1989;McLean and 
Donaldson,1990). The oral delivery of protein antigens to fish has shown that 
it is possible to immunise enterically with both soluble and particulate antigens 
(Georgopoulou et al.,1986;Doggett,1989;Rombout et al.,1989b),and for such 
immunisation to be effective in generating a protective immune response in 
secretions anatomically separated from the alimentary tract. This may indicate 
the existence of a common mucosal immune system in fish (Kawai,Kusuda and 
Itami,1981;Kawai and Kusuda,l983;Rombout et al.,1985;Rombout et 
al.,1989b;Davidson,1991),similar to that in mammals (Arya,1990). However 
studies also show similar variation to oral stimulation in mammals,with the 
188 
induction of an appropriate immune response being variable,at best. Oral 
immunisation of teleosts has been found to induce protective immunity against 
subsequent bacterial challenge (Kawai et al.,1981;Rombout et al.,1989b),but to 
also possibly result in a route-dependent tolerogenic response to soluble protein 
antigens (Whiskovsky and Avtalion, 1982;Mughal et al., 1986;Davidson,1991) and 
especially to those characterised as thymus-dependent (Rombout et al., 1989b ). 
The abrogation of potential oral tolerance,and the possible enhancement 
of any resultant immune responses,may be facilitated by the use of specific 
adjuvants in oral delivery systems. The saponin adjuvant Quii-A has been 
reported in several studies in mammals,as being highly effective in enhancing the 
immune response to both the oral and parenteral delivery of protein antigens 
(Dalsgaard,1987;Kensil et al.,l991;Mowat et al.,l991). The delivery of Quii-A 
has been reported to increase the absorption of standard protein antigens and 
to increase the systemic antibody titre to molecules such as BSA,by lOO-fold 
(Kensil et a/.,1991). Quii-A can also be manipulated to form specialised 
immune-stimulatory complexes (ISCOMS) that can be used to impart a degree 
of immunogenicity (by their three-dimensional nature) on proteins that are 
otherwise tolerogenic when administered orally,in their native state (Mowat et 
al.,l991). The delivery of soluble protein macromolecules to Oreochromis 
mossambicus perorally or peranally has been shown to be enterically absorbed 
in amounts that are potentially immunologically significant (see Chapter 4) and 
that the quantitative levels of the proteins,their qualitative nature and their 
absorption kinetics may all be significantly altered by the incorporation of the 
saponin adjuvant Quii-A in the delivery system (see Chapter 5). 
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The aims of the current study were to monitor one aspect of the immune 
response notably antibody production to an enterically delivered standard 
protein antigen (HGG). The current study also investigated the results of the 
use of the saponin adjuvant Quit-A in the enhancement of any specific immune 
responses obtained following its oral and anal delivery in a variety of forms with 
the antigen. 
The test of the efficacy of the delivery methods was the initiation of an 
antigen-specific antibody response,both systemically and mucosally. 
However,this imposes a certain degree of limitation to the investigation with 
respect that this is only one indicator of an efficient,specific,immune response 
(albeit that it is the parameter most often measured in investigations of this type 
and that the formation of an antibody response,at a minimum,requires cellular 
interactions in the form of antigen presentation and appropriate T-cell 
involvement)(Sanderson and Walker,1991}. There are other assay systems that 
can potentially be employed to monitor the efficacy of oral 
immunisation,especially with respect to the direct induction of an observable 
cellular immune response. This study tests the efficacy of the delivery systems 
employed,coupled with the analysis of mucosal secretions which may give an 
indication of the possibility of the induction of a specific adaptive immune 
response at mucosae distanced from the delivery site,through the operation of 
a common mucosal immune system. Immunisation studies employing different 
antigens may require emphasis on the enhancement of a different aspect of the 
Immune response. 
6.2. MATERIALS AND METHODS. 
6.2.1. ANIMALS. 
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Adult tilapia, Oreochromis mossambicus, of both sexes, weighing 50-lOOg, 
were held in a recirculating freshwater system at 24-26 ° C throughout the study. 
6.2.2. IMMUNISATION PROTOCOLS. 
Groups of fish (n=S) were immunised once (on day 0) with HGG with 
or without optimalised concentrations of Quil-A (see Chapter 4), as follows: 
1) HGG immunisation: orally,anally or intraperitoneally with 0.2ml HGG 
solution (10mg/ml in 0.85% saline). 
2) Prior administration of Quit-A with HGG: orally or anally with 0.2ml 
Quil-A (10J.&g/ml in 0.85% saline) followed after 1 hour by 0.2ml HGG solution 
(lOmg/ml in 0.85% saline. 
3) Concurrent administration of Quit-A with HGG: orally or anally with 
0.2ml HGG solution (10mg/ml in 0.85% saline) plus 1J.&g/ml Quil-A. 
4) Quit-A used as vehicles for HGG: orally or anally with ISCOMS or 
micelles prepared as in 3.2.2. 
5) Control immunisation: orally or anally with 0.2ml 0.85% saline in lieu 
of antigen and/or adjuvant,to act as an experimental control. 
6.2.3. COLLECTION OF SERUM.BILE AND MUCUS. 
Fish were bled from the caudal sinus 0,7,14,21,28 and 35 days after 
immunisation using heparinised (10 units heparin (Sigma)/ml saline) syringes 
(Luckham,Watford,U.K.) with 19g needles. The blood was pooled, centrifuged 
at 4000rpm for 5-6 minutes and the plasma removed and stored at -20 ° C prior 
to their assay for specific antibody via ELISA. 
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Bile was removed,by syringe, from the gall bladder and dialysed against 
O.OSM Tris O.lSM NaCI pH 7.5 (Tris-saline) overnight at 4"C,with stirring,to 
remove the bile salts. The resultant solution was further dialysed against flake 
polyethylene glycol (Aquacide III,Calbiochem,Behring Diagnostics Ltd,U.K.) 
until volumetrically similar to the original sample. 
Cutaneous mucus was removed using a method based on the protocol of 
Burgess (1988). Briefly, mucus (in aliquots of approximately 120J.£1) was 
collected by the use of absorbent cotton wool buds (Boots,Ltd) and subsequently 
eluted by washing and squeezing with approximately 680J,£1 PBS (pH 7.2). The 
resultant solution was dialysed against O.OSM Tris O.lSM NaCI pH 7.5 (as above) 
and subsequently dialysed against flake polyethylene glycol until volumetrically 
similar to the original sample. The cutaneous mucus was stored at -20 • C until 
use. 
6.2.4. ELISA FOR THE DETECTION OF ANTI-HGG ANTIBODIES. 
6.2.4.1. PRODUCTION OF RABBIT ANTI-TILAPIA IgM 
ANTISERUM. 
Large adult tilapia,150-200g were initially immunised intraperitoneally 
with a 0.2ml solution of sheep red blood cells (SRBC) emulsified in an equal 
volume of Freunds Complete Adjuvant (FCA). The fish were boosted by 
repeated immunisation (as above) three times at two-weekly intervals with 
antigen (SRBC) emulsified in Freunds Incomplete Adjuvant (FIA). 
Fish were bled,using non-heparinised syringes and needles, via the caudal 
sinus and the blood centrifuged at 4000rpm for 5-6 minutes. The serum was 
removed and subjected to haemagglutination against a 2% solution of SRBC. 
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The tilapia IgM-SRBC agglutinate was harvested and emulsified in an equal 
volume of FCA and 1ml injected into Dutch rabbits at two sites subcutaneously 
(SC). The rabbits were boosted by two SC injections of antigen,with FIA,at 6-
weekly intervals. Rabbits were bled via the marginal ear vein,the blood stored 
at 4 • C overnight and serum collected following centrifugation for 5-6 minutes 
at 4000rpm. The serum was then tested for its specificity for tilapia lgM by 
immunoelectrophoresis. 
Immunoelectrophoresis was carried out using the method outlined by 
Hudson and Hay (1989). Briefly,microscope slides (75 x 21 x 1 mm) were 
cleaned in methanol and coated with a thin gel of 1% (w /v) agar in 0.08M 
barbitone buffer pH 8.2. Electrophoresis templates were cut in the agar and 
10J.Ll of fish serum placed in the side wells with specific rabbit antiserum in the 
central trough. Serum was electrophoresed at 30mA constant current for 
approximately 2 hours with bromophenol blue dye as a front marker. 
Electrophoresed gels were left overnight for development of precipitin 
arcs,washed in PBS,thoroughly dried and stained with Coomassie blue. 
A single precipitin arc was produced corresponding to the specific 
reaction of the rabbit antiserum with the tilapia lgM. 
This rabbit anti-tilapia lgM antiserum was aliquoted and stored at -70 • C 
until use. 
6.2.4.2. SPECIFIC ELISA FOR THE DETECTION OF ANTI-HGG 
ANTIBODIES. 
Tilapia plasma,bile and cutaneous mucus were assayed for the presence 
of anti-HGG antibodies using a specific,indirect,enzyme-linked immunosorbent 
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assay (ELISA) employing heterologous antisera,based on the method of Voller 
et a/.,(1979). 
Samples and reagents were added at lOOp.l per well to 96-well flat 
bottomed polystyrene microtitre plates (Falcon,Ltd,Becton Dickinson,New 
Jersey,U.S.A.) unless stated. Extensive studies were carried out to optimise the 
coating dilution of HGG on the plates, the initial dilution of the plasma,bile and 
cutaneous mucus added to the plate and the dilution of the rabbit anti-tilapia 
IgM (by checkerboard titration). 
Plates were coated with 20p.g/well HGG in carbonate/bicarbonate buffer 
pH 9.6 overnight at 4' C. Plates were subsequently washed ( 4x3 minutes) after 
each incubation with approximately 150p.l phosphate-buffered saline plus 0.5% 
Tween (PBST) by aspiration,using a Titertek Handiwash 110 
(Labsystems,Basingstoke,U.K.) and then patted dry on paper towels. 
Test tilapia plasma was optimised at an initial dilution of 10% (in PBST 
and also in non-immune tilapia serum),bile at 10% (in PBST) and cutaneous 
mucus at 2.5% (in PBST). Plasma,bile and cutaneous mucus were doubly 
diluted,from these initial dilutions,down the plate and incubated for 2 hours at 
ambient temperature in a humid environment. 
The system employed for the detection of the captured anti-HGG 
antiserum involved the use of the rabbit anti-tilapia IgM ( optimised at 1/500,in 
PBST) for 1 hour at ambient temperature followed by swine anti-rabbit 
immunoglobulin peroxidase conjugated antiserum ( optimised at 1/1000,in PBST) 
for 1 hour at ambient temperature. 
All reactions were developed using 2mM ortho-phenyldiamine plus 3mM 
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hydrogen peroxide (OPD-H20 2) substrate solution in 0.02M citrate-phosphate 
buffer at pH 5.0 at ambient temperature for up to 10 minutes. 
The reactions were terminated by the addition of 50J-£11M H2S04 to each 
well of the plate. Absorbances were read at 492nm on a Multiscan Mk 11 
microplate reader (Labsysterns,Basingstoke,U.K.) utilising data handling and 
storage software. 
6.2.3.3. CONTROLS. 
The experimental controls were as outlined in 6.2.2. Technical controls 
involved the omission of the test solutions (plasma,bile and cutaneous 
mucus),the primary antiserum and the secondary antiserum,independently,to test 
for residual binding and background activity in the test assay. 
6.2.4. STATISTICAL ANALYSES. 
Statistical analyses were carried out on the derived antibody titres. The 
degree of significance of difference between specific antibody titres was 
determined using the chi-squared test (Wardlaw,1987). 
~RESULTS. 
A typical standard curve derived from the ELISA assay for the presence 
of anti-HGG antibodies in tilapia plasma,bile and cutaneous mucus is shown in 
Figure 6.1. 
Figure 6.1. specifically shows the antiserum titration from the ELISA 
assay of plasma,14 days after the oral and anal immunisation of HGG with the 
concurrent delivery of 10J-£g/ml Quii-A. Control immunisation of saline resulted 
in background absorbances of approximately 0.1 absorbance units (Figure 6.1) 
throughout the study. The control levels were mathematically removed from the 
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derivation of the antibody titres with the use of the ELISA-hardware data 
storage software,and are not shown on the remaining figures. 
6.3.1. HGG IMMUNISATION WITHOUT OUIL-A. 
The results of oral,anal and intraperitoneal (lP) HGG immunisation are 
shown in Figures 6.2 (a-c),respectively. lP immunisation of HGG resulted in 
peak titres of specific plasma anti-HGG antibodies that were significantly 
greater (p < 0.05) than the maximal titres obtained after oral and anal delivery 
(Figure 6.2). Plasma antibody responses to lP immunisation were significantly 
greater (p < 0.05) than mucosal antibody titres, in the bile and cutaneous mucus. 
lP delivery of HGG resulted in rapid initial antibody responses in the plasma 
(after 7 days),which peaked after 30-35 days. lP mucosal titres were also 
significantly greater than those obtained after oral and anal immunisation 
(Figures 6.2.b and 6.2.c). The antibody response in the cutaneous mucus 
was,after lP immunisation,lower than the response in the plasma and bile. 
Oral and anal delivery of HGG resulted in lower antibody titres in the 
plasma,bile and mucus than after lP immunisation. Anal immunisation resulted 
in higher antibody titres,in the plasma and bile (Figures 6.2.a and 6.2.c) than 
oral immunisation,albeit not statistically significantly. Anal immunisation 
resulted in a more rapid peak in plasma and biliary antibody responses than 
after lP or oral delivery. Oral immunisation consistently resulted in longer peak 
antibody generation times (Figures 6.2.b and 6.2.c). There were very low 
antibody responses generated in the cutaneous mucus after either oral or anal 
immunisation of HGG. 
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6.3.2. THE ADMINISTRATION OF QUIL-A PRIOR TO HGG 
IMMUN1SATION. 
The administration of 100J.£g/ml Quii-A 1 hour prior to the delivery of 
HGG (by a complementary route) resulted in a significant alteration in the 
temporal kinetics and levels of the antibody response (Figures 6.3 (a-c)) by 
comparison with HGG administered alone. Quii-A was not administered via the 
lP route due to the toxicity of saponins delivered to fish in this manner 
(Lindbland, 1985) 
Oral immunisation of HGG,with the prior delivery of Quii-A (Figure 
6.3.a),resulted in a rapid peak plasma antibody response (after 14 days) which 
was approximately 15-fold greater than that after immunisation with HGG 
alone. Similarly,mucosal responses after oral immunisation were initiated more 
rapidly (Figures 6.3.b and 6.3.c) and were of greater peak levels than their non-
adjuvanated counterparts and in the case of the biliary response, by almost 2-fold. 
Significant levels of antibodies were detectable in the cutaneous mucus after this 
form of delivery (Figure 6.3.c). 
Anal HGG administration ,with the prior delivery of Quil-A,resulted in 
a very rapid antibody response in the plasma (often after < 7 days),which 
declined more rapidly than that observed after oral delivery but which was of an 
equal magnitude (Figure 6.3.a). However anal immunisation resulted in a more 
rapidly initiated response,and greater peak levels of antibodies in bile and 
cutaneous mucus than after oral delivery (Figures 6.3.b and 6.3.c). 
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6.3.3. THE IMMUNISATION OF OUIL-A CONCURRENTLY WITH 
HGG. 
The concurrent administration of lOJLg/rnl Quil-A with HGG orally and 
anally resulted in generation of antibody responses in the plasma (Figure 6.4.a) 
that were lower by comparison with those obtained after immunisation of HGG 
following prior administration of Quil-A. 
Oral immunisation resulted in peak antibody levels in the plasma (after 
28 days) (Figure 6.4.a) that were approximately 4-fold less than those obtained 
after oral immunization with prior Quil-A delivery but significantly greater than 
those obtained with the oral delivery of HGG alone. Biliary and cutaneous 
mucus antibody levels after oral immunisation (Figures 6.4.b and 6.4.c) were 
similar to those achieved with antigen delivered after Quil-A treatment. Peak 
plasma and mucus antibody levels were similar after oral and anal delivery,after 
14-28 days (Figures 6.4.a and 6.4.c) but peak biliary levels were greater after 
anal delivery (Figure 6.4.b). Mucosal antibody titres (in the bile and cutaneous 
mucus) were considerably higher than obtained after HGG immunisation on its 
own. 
6.3.4. THE IMMUNISATION OF OUIL-A WITH HGG AS ISCOMS. 
The delivery of HGG as ISCOMS resulted in antibody responses in the 
plasma,bile and cutaneous mucus that were quantitatively very similar (Figures 
6.5. (a-c)). Plasma antibody levels paralleled each other after oral and anal 
immunisation with ISCOMS but resulted in lower titres (Figure 6.5.a) than with 
either delivery of Quil-A prior to or concurrently with HGG. However,plasma 
antibody levels after the oral and anal delivery of ISCOMS were greater than 
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with HGG,alone. 
Mucosal antibody responses were higher in the bile than the cutaneous 
mucus after both oral and anal HGG delivery as ISCOMS (Figures 6.5.b and 
6.5.c). However the mucosal responses after the oral and anal delivery of 
ISCOMS (Figures 6.5.b and 6.5.c) were not significantly different than after 
other methods of immunisation. Peak responses in the bile and cutaneous 
mucus occurred 14 days after anal delivery whereas they occurred 21 and 28 
days after oral delivery,respectively. Plasma, bile and mucus antibody titres were 
considerably elevated above those observed after the oral and anal delivery of 
HGG alone. 
6.3.5. THE IMMUNISATION OF OUIL-A WITH HGG AS MICELLES. 
The antibody responses to the oral and anal immunisation with micellar 
HGG in the plasma and cutaneous mucus (Figures 6.6.a and 6.6.c) were 
temporally and quantitatively similar to those observed after the corresponding 
immunisation with ISCOMS. The biliary antibody response with micellar HGG 
immunisation resulted in marginally higher peak titres after oral immunisation 
by comparison with anal immunisation (Figure 6.6.b);however the overall levels 
of both were lower than the corresponding biliary antibody responses after 
immunisation with ISCOMS. 
Table 6.1 is a table showing the peak levels of antibody production in the 
plasma,bile and cutaneous mucus after the various modes of delivery of HGG 
and the time taken for the generation of this response,post-immunisation. 
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TABLE 6.1. ILLUSTRATING TilE PEAK LEVELS OF 
ANTIBODY PRODUCTION (AND THEIR TIMES OF 
GENERATION POST-IMMUNISATION). 
ROUTE OF ADMINISTRATION. 
Intraperitoneal Oral Anal 
Analyte P. B. CM. P. B. CM. P. B. CM 
HGG 5.42 2.11 1.5 1.2 0.9 0.6 1.2 1.7 0.6 
(28) (35) (28) (28) (35) (28) (21) (21) (28) 
QA> HGG . . . 3.31 1.81 1.2 3.31 2.11 1.75 
(14) (28) (28) (7) (21) (14) 
HGG+Q.A . . . 2.71 1.5 1.2 2.71 2.11 1.2 
(28) (28) (28) (14) (21) (14) 
ISCOMS . . . 2.41 1.5 1.2 2.71 1.81 1.2 
(14) (21) (28) (14) (14) (14) 
MICELLES . . 2.41 1.5 1.2 2.41 1.2 1.5 
(21) (21) (21) (14) (14) (21) 
Key: Unparenthesised numbers refer to the maximal HGG-specific titres 
observed (1/- Log10 antibody titre) and the numbers in parenthesis refer to the 
time of generation of the titres,post immunisation (Days). 
Analyte refers to the fluid analysed,where Pis plasma,B is bile and CM 
is cutaneous mucus. 
Columns marked - indicate that this particular test was not carried out. 
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The nomenclature in the left hand column refers to the mode of delivery 
of HGG where: HGG equals delivery without adjuvant;Q.A. < HGG refers to 
the delivery of Quii-A prior to HGG;HGG + Q.A refers to the delivery of HGG 
plus Quii-A;ISCOMS refers to the delivery of HGG as immune stimulating 
complexes; MICELLES refers to the delivery of HGG as a micellar package with 
HGG. 
6.4. DISCUSSION. 
The present study shows that the oral,anal and intraperitoneal delivery 
of a single,standard dose of HGG to O.mossambicus results in a primary 
immune response evidenced by considerable levels of antigen-specific antibodies 
in the plasma,bile and cutaneous mucus. The production of specific 
antibodies,was monitored by the utilisation of a specific ELISA system which 
quantified levels of specific antibodies rather than overall immunoglobulin (Ig) 
levels. Detection of specific antibodies rather than overall lg levels is extremely 
valuable m comparing the relative immunogenicity of antigens 
(Ellis,198S;Burgess,1988) and in the determination of any possible induction of 
specific immunity in secretions anatomically remote from the intestine ,and 
hence in determining the potential existence of a common mucosal immune 
system. Intraperitoneal injection of HGG resulted in significantly higher titres 
of antibodies in the plasma than by oral or anal immunisation. A similar route-
dependent increase in the plasma levels of antibodies was observed after 
intraperitoneal injection of BSA in O.mossambicus by comparison with oral and 
anal immunisation (Doggett, 1989). In this study intraperitoneal immunisation 
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of BSA resulted in specific titres of 1/209600 and oral and anal immunisation 
in titres of only 1/32 and 1/16,respectively. Administration of HGG 
intraperitoneally to carp,Cyprinus cwpio,resulted in similar levels of antibody 
production by comparison with those seen in the current study,when a specific 
indirect haemagglutination assay was used;with peak antibody titres of log2 14-20 
and log2 7-8 being produced after the administration of HGG and antigens from 
Aeromonas salmonicida,respectively (Mughal et al., 1986) although the ELISA 
system is generally regarded to be more sensitive than haemagglutination. 
Anal administration of HGG generated greater levels of plasma 
antibodies than oral delivery in tilapia but less than those achieved by 
intraperitoneal injection. The efficacy of anal immunisation has also been 
observed in carp where the repeated anal delivery of ferritin resulted in antibody 
responses that approximated to the levels achieved with intramuscular injection 
(Rombout et al.,1989b). The delivery of ferritin (associated with food) per 
diem,for a period of 8 days,resulted in antibody titres that were at least 2-fold 
greater than those achieved against HGG in this study (Rombout et a/.,1989b). 
The delivery of HGG orally (per diem,for 5 or 10 days) in rainbow 
trout,Oncorhyncus mykiss,resulted in detectable antibody responses in the plasma 
which were approximately 6-fold greater than the plasma antibody titre 
generated after a single intraperitoneal injection of the antigen (Davidson, 1991). 
However,in contrast,multiple doses of antigen did not result in an increase in the 
levels of antigen absorbed from the intestine or in the resultant antibody 
response in O.mossambicus (Doggett,1989). 
The oral and anal delivery of HGG also resulted m lower titres of 
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antibodies in the bile and cutaneous mucus by comparison with intraperitoneal 
injection,although the disparity was not as great as that evidenced between the 
respective plasma responses. Several other studies have identified antibodies in 
the secretions of fish including the bile of channel catfish Ictalurus punctatus 
(Lobb and Clem.1981d),sheepshead,Arc/wsatgUS probatoceplzalus (Lobb and 
Clem,1981c),dogfish, Scy/iorhinus canicula (Hart, 1987),carp,Cyprinus carpio 
(Rombout et a/.,1986) and rainbow trout Oncorhyncus mykiss (Davidson,1991). 
BSA administered orally and anally also resulted in low,but specific, titres of 
antibodies in the cutaneous mucus and bile of O.mossambicus (Doggett,1989). 
Soluble antigens such HGG and ferritin have been reported as being poor 
immunogens,at least for the stimulation of specific mucosal antibodies in fish. 
No specific cutaneous mucus antibodies were found after the oral administration 
of ferritin in carp (Rombout et al., 1989b ),and very low levels of antibodies were 
found in the bile and cutaneous mucus of rainbow trout after immunisation with 
HGG (Burgess,l988). However antibodies have been generated in the 
cutaneous mucus of channel catfish,lctalums punctatus,after bath immunisation 
(Lobb,1987) and antibodies have been detected in the cutaneous mucus of both 
rainbow trout Oncorhyncus mykiss (Harrell et al.,1976;St Louis Cormier et 
a/.,1984;Davidson,1991) and the sheepshead A.probatoceplzalus (Lobb and 
Cl em, 1981b ). The oral delivery of particulate,T-independent bacterial antigens 
such as those from Vibrio anguillamm resulted in relatively high levels of 
specific,protective,antibodies in the cutaneous mucus with no detectable systemic 
titres (Rombout et a/.,1989b). Such results may lend some explanation to the 
observation that protection against bacterial challenge,after vaccination,is very 
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often correlated with a definite lack of specific,systemic antibodies (Bienenstock 
and Befus,1980;Kawai et al.,1981;Kawai and Kusuda,1983;EIIis,1988;Davidson, 
1991) and can also be efficiently initiated by the enteric delivery of suitable 
antigens (Johnson and Arnend,l983a,1983b). 
The kinetics of the primary immune response to HGG generated after 
oral,anal and intraperitoneal immunisation of tilapia,was monitored for up to 35 
days post-immunisation. The antibody generation curves show that the immune 
responses to HGG in the plasma,bile and cutaneous mucus all paralleled each 
other,with the antibody response after oral and anal immunisation being largely 
short-lived (of approximately 21 days duration) after a single HGG dose. Anal 
immunisation appeared to elicit slightly greater levels of antibodies more rapidly 
than oral immunisation. Intraperitoneal immunisation generated a plasma 
response with a short latent period,that appeared to be tenable past 35 days. A 
transient antibody response was also observed after single oral,anal and 
intraperitoneal immunising doses of BSA in tilapia (Doggett,l989),resulting in 
plasma antibody kinetics that were very similar to those observed here after 
immunisation with HGG. Anti-HGG antibody titres generated in the serum and 
bile peaked after 28-35 days and after 21-28 days in the mucus and the 
persistence of these antibody titres were shorter than those generated in 
carp,after boosted,oral and anal administration of ferritin and V.anguillarnm 
(Rombout et al., 1989b ). In this study the antibody responses after oral 
immunisation appeared to be tenable for approximately 28 days,after which time 
a boosting immunisation was required to maintain the levels of antibody 
(Rombout et al.,1989b). This study also confirmed the observation that 
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protection against bacterial infection is often not correlated with the levels of 
plasma antibodies but may be associated with mucosal titres or other factors. 
Other studies have also shown that oral and anal delivery of antigens can 
generate an antibody response that can be remarkably long-lived (Ourth,1980) 
and maintained so that it can be almost totally protective against subsequent 
bacterial challenge for up to 1 year post-immunisation (Fryer,Rohovec and 
Garrison,1978). Mucosal antibody titres have also been shown to be specifically 
elevated for extended periods of time,after oral and anal immunisation;for 
example up to 63 days in carp (Rombout et a/.,1986) and for up to 96 days after 
bath immunisation,in channel catfish (Lobb,1987). 
The current study therefore provides further evidence for the existence 
of a common mucosal immune system in fish as the enteric delivery of antigens 
is clearly able to generate substantial levels of specific antibodies in mucosal 
tissues divergent from the intestine. Specific antibodies have also been reported 
as being variably inducible in the intestinal mucus,after oral stimulation 
(Fletcher and White,1973;Davidson,1991). Oral immunisation in the plaice 
Pleuronectes platessa resulted in antibody levels that were maintained for up to 
1 year after delivery of the antigen possibly indicating that there was a 
significant memory component in the lymphoid tissue responsible for the 
generation of this population of antibodies (Fletcher and White, 1973). Specific 
antibodies have also been induced in the intestinal mucus after immunisation in 
carp (Rombout et a/.,1986). However,conflicting evidence has been shown 
where chub experimentally infected with the Acanthocephalan,Pomphorhyncus 
laevis,failed to produce any discernable antibodies in the intestinal mucus 
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(Harris, 1972) and more recently no intestinal antibody could be induced,after 
the delivery of HGG and aKLH,in the rainbow trout O.mykiss despite 
considerable levels of specific antibodies generated in other secretions,such as 
the bile and cutaneous mucus (Davidson,l991). Parenteral immunisation has 
also been reported to be able to induce specific antibodies in mucosae such as 
the female genital tract of the dogfish,Scyliorhinus canicula (Hart,l987). 
Mammalian studies have also indicated that local and generalized immune 
responses,manifested by the parallel appearance of slgA,in mucosal secretions 
distant from the site of immunisation,can be induced after the enteric delivery 
of antigens (Mestecky et al., 1985;Mestecky, 1987). Oral immunisation in 
mammals has led to the observation that antibodies can be induced in milk after 
natural infections,or immunisation,with enteric pathogens such as Salmonella 
typhimurum (Montgomery,Lemaitre-Coelho and Vaerman, 1980;Sheldrake et 
a/.,1984;Mestecky,1987) and that enteric stimulation of GAL T triggered antibody 
responses in saliva,bronchial,biliary and intestinal secretions often with only 
minimal serum antibody titres (Montgomery et al.,1980;Gyure,Hall,Hobbs and 
Jackson,1991). 
There appears to be a general consensus in both fish and mammalian 
studies that the enteric,and especially the oral,delivery of antigens is less 
efficacious in producing systemic antibody titres than parenteral immunisation 
(Mestecky, 1987;Nicklin, 1987;Rombout et al.,l989b;Davidson, 1991) but are still 
capable of eliciting considerable levels of mucosal antibodies. One of the major 
factors that may cause such observed disparities in the levels of antibodies 
generated after enteric and parenteral immunisation is the decreased levels of 
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antigen encountering target lymphoid tissue,after enteric immunisation and the 
resultant requirement for a greater antigen dose to generate equivalent immune 
responses to those obtained after parenteral immunisation (Ell is, 1988). 
However the present study shows that the oral and anal delivery of human 
gamma globulins (HGG),which consists,mostly,of the active lgG 
component,results in the absorption of detectable amounts of antigen across the 
intestinal enterocytes of O.mossambicus over a wide range of time. HGG is 
rapidly absorbed and transcytosed,in a complex manner,across the enterocytes 
and is exocytosed into the lamina propria where it comes into contact with a 
variety of lamina) cells including GALT cells. HGG was observed in contact 
with GAL T cells apparently of the macrophage lineage and also with non-
granular lymphocyte-like cells. Immunoreactivity of these cells was thought to 
parallel similar results in carp (Rombout and van den Berg,1989) where it was 
considered to be indicative of active antigen presentation processes and it has 
also been established in mammals that such cells are an a priori requirement for 
the initiation of local immune responses (Chain et a/.,1988). 
Other studies have also indicated that the oral and anal immunisation 
with soluble protein antigens can result in measurable levels of absorbed 
antigens and subsequent interactions of such antigen with the local immune cells 
of the GALT (Davina et al.,1980;Georgopoulou et al.,1986,1988;Rombout et 
a/.,1986;Davidson, 1991). Such interactions of absorbed antigen with 
immunocompetent cells at the site of absorption may be a major factor in the 
observation that enterically delivered antigens can elicit relatively high local 
immune responses and the eventual generation of immune responses at other 
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mucosae. Absorbed antigen has been observed interacting with GAL T cells in 
O.mossambicus (Doggett,1989;see Chapter 3),rosy barb,Barbus conclwnius 
(Davina et a/.,1980) and carp (Rombout et al.,l986;Rombout and van den 
Berg,1989) and antigen-specific antibody secreting cells have been detected and 
enumerated in the disaggregated intestine of rainbow trout,O.my/dss,after oral 
immunisation with HGG (Davidson,1991) but the eventual fate of the released 
antibody in such cells could not be apportioned,with any degree of certainty,to 
the lumenal or serosal compartments of the intestine (Davidson,1991). 
Surface-immunoglobulin positive cells (Ig+) cells have also been observed 
in the intraepithelium of the intestine of the carp (Rombout et al.,1989a),where 
they comprise approximately 10% of the cells;in the lamina propria of the rosy 
barb (Davina et a/.,1980) and histochemically in the intestinal lymphoid tissue 
of the dogfish (Hart,1987;Hart et a/.,1988). The production of a mucosal 
immune response in secretions such as the cutaneous mucus is not thought to 
be due to the sequestration of serum antibodies (Lobb and Clem,1981d) as a 
poor transport system is believed to exist,in fish,for the transport of 
immunoglobulins from the serum to mucosae such as the skin epidermis (Harrell 
et al.,1976;Lobb and Clem,1981c;Rombout et al.,1989b). 
The generation of mucosal antibodies,such as those observed in this 
study,are thought to be initiated,after oral immunisation,at a local level by either 
direct antigen stimulation of resident lymphoid tissue at each respective mucosal 
surface or that antigen specific Iymphocytes (both of Band T cell lineage) are 
generated in the GAL T and eventually migrate and seed the relevant mucosal 
surfaces (Rombout et a/.,1989b;Davidson,1991). 
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The results of mammalian studies vary as to the generation of a mucosal 
immune response. Some mammals,such as humans,directly derive 
approximately 50% of their biliary slgA and 2% of their intestinal slgA from the 
serum (Delacroix et a/.,1982a,1982b) whereas in other mammals these values are 
considerably elevated (Vaerman and Delacroix,1984;Mestecky and 
McGhee,1987). Other studies have indicated that the GALT can be stimulated 
to preferentially produce antigen-specific antibody secreting cells after the oral 
immunisation of ovalbumin (van der Heijden,Bianchi,Bokhout,Dol,Scholten and 
Stok,1989) and that populations of such antibody-secreting cells in the intestinal 
mucosa can seed other mucosal surfaces (Kagnoff,1987;Mowat,1987;Nicklin, 
1987). The relatively low levels of antibodies generated after oral and anal 
immunisation of HGG in O.mossambicus may be due to the initiation of 
systemic hyporesponsiveness (tolerance) that appears to be observed after the 
oral delivery of soluble protein antigens in fish (Whiskovsky and 
Avtalion,1982;Mughal et al., 1986;Rombout et al., 1989b;Davidson, 1991) and 
mammals (Andrew and Hali,1982;Mowat et a/.,1991). Tolerogenesis is usually 
manifested as the reduced efficacy of the generation of a secondary immune 
response,and although secondary immune responses were not investigated in this 
study,intestinally mediated immunosuppression of circulating antibody titres has 
been reported in carp (Mughal et al.,1986;Rombout et al.,1989b) to a variety of 
antigens such as ferritin and soluble and particulate HGG and also in rainbow 
trout, where the simultaneous administration of HGG orally and intraperitoneally 
caused a dose-dependent tolerance (Davidson, 1991 ). Such systemic vulnerability 
to a decrease in antibody titre may be dependent on the form of the antigen and 
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its degree ofT-dependency (Davidson,1991). 
The enteric delivery of HGG to O.mossambicus results in its detectable 
fragmentation (see Chapter S),and the serum appearance of such fragments may 
also be partly responsible for any systemic hyporesponsiveness after oral antigen 
delivery. The absorption of soluble protein antigens across the mammalian 
gastrointestinal tract results in the revelation of epitopes of the molecule that 
are stimulatory for T-suppressor cells and also in the corresponding loss of 
determinants specific forT-helper cells (Kay and Ferguson,1989a,1989b) both 
of which result in immune tolerance to the antigen and subsequently to minimal 
antibody responses (Bruce and Ferguson,1986a,1986b;Michael,1989). 
The delivery of the saponin adjuvant Quil-A has been reported,in 
mammals,to be an efficient adjuvant and to also allow generation of specific 
immune responses to orally delivered antigens that otherwise induce tolerance 
(Maharaj et a/.,1986;Mowat et a/.,1991). The oral and anal administration of 
Quil-A in combination with HGG to O.mossambicus,in a variety of delivery 
systems,resulted in a substantial increase in the primary immune response (as 
monitored by an increase in HOG-specific antibody titres in the plasma,bile and 
cutaneous mucus) compared to the levels achieved after immunisation without 
adjuvant. The current study records the first demonstration of Quil-A as an 
enteric adjuvant and its effectiveness in increasing both mucosal and systemic 
antibody responses in these animals. 
The oral and anal administration of Quil-A,prior to the delivery of HGG 
by a complementary route,resulted in the generation of similar antibody titres 
in the plasma and bile. However anal immunisation resulted in greater antibody 
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titres in the cutaneous mucus. Immunisation with HGG,orally and anally,after 
Quil-A resulted in an approximately lOO-fold increase in the plasma and a 2-3-
fold increase in the biliary antibody levels over those achieved after HGG 
immunisation on its own,but were still not of a comparable level to those 
following the lP administration of the antigen (1/2048 titres generated after oral 
delivery of Quii-A followed by antigen compared to 1/64 and 1/300000 titres 
raised after oral and lP administration of HGG on its own). Antibody titres in 
the cutaneous mucus after delivery of HGG,preceded by Quii-A,were elevated 
to approximately the same levels as those derived after the intraperitoneal 
injection of HGG on its own. These adjuvant-modified antibody titres were 
initiated more rapidly than the direct delivery of HGG but their persistence was 
not increased. The antibody titres achieved after the enteric delivery of HGG,in 
combination with Quii-A in this manner,were comparatively higher than those 
obtained after the oral,anal and intramuscular immunisation of carp with ferritin 
or V.anguillarum (Rombout et a/.,1986,1989b) without adjuvant. 
The oral and anal delivery of HGG concurrently with Quil-A elicited 
raised antibody titres above those observed with the comparable non-
adjuvanated immunisations but were slightly lower than those with HGG 
delivered after Quil-A. Similarly, the mucosal antibody titres were raised 4-6 fold 
over their non-adjuvanated counterparts. 
The oral and anal immunisation of O.mossambicus with HGG plus Quil-
A in the form of ISCOMS and micelles resulted in elevated antibody titres 
compared to oral and anal HGG immunisation. ISCOMS yielded slightly 
greater antibody responses than micelles in all the secretions studied and the 
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temporal disparity between the antibody generation curves was greatest in the 
mucosal immune responses after oral and anal immunisation with ISCOMS. 
The addition of Quil-A,prior to or concurrently with HGG significantly 
raised the levels of antigen that were absorbed after oral and anal delivery 
(Chapter 4). The amounts of HGG absorbed and retained in the intestine of 
O.mossambicus were greatly increased by the oral and anal administration of the 
antigen with the saponin adjuvant Quit-A. Quil-A also increased the levels of 
antigen absorbed into the plasma. Any potential immune response to orally or 
anally delivered antigen is influenced by both the level of antigen present in the 
intestine and its qualitative nature ie if it is intact or fragmented,the nature of 
the fragments produced, whether it is soluble or particulate and its degree ofT-
dependency (Whiskovsky and Avtalion,1982;Mughal et a/.,1986). The delivery 
of Quil-A,enterically,also has a direct effect on the intestinal enterocytes of 
O.mossambicus (Chapter 3),such as increasing the intestinal 
permeability,shortening and damaging the villi and causing pinocytosis of 
coincident lumenal material. The oral delivery of Quil-A,in combination with 
both soluble protein antigens and more complex glycoproteins derived from 
micro-organisms,was reported to elicit and increase both the levels of antigen 
absorbed from the mammalian gastrointestinal tract and to cause a resultant 
increase in the immune response to the antigen (Maharaj et a/.,1986;Kersten et 
a/.,1988a,1988b;Mowat et a/.,1991) in some studies but to be ineffective via the 
oral route in others (Trudel,Nadon,Seguin,Boulay and Lussier, 1987). The use 
of Quil-A,in fish,to date is limited to its incorporation in an immersion vaccine 
against Yersinia ruckeri (Grayson et a/.,1987) and to its administration with 
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Aeromonas salmonicida antigen preparations (Cossarini-Dunier,198S),both of 
which were ineffective and indeed the latter appeared to have a negative effect 
on the generation of antibody titres (Cossarini-Dunier,1985). 
The increased antibody responses with prior and concurrent Quit-A 
delivery with HGG may reflect the increase in antigen absorption observed with 
these delivery systems,but Quit-A administration also greatly alters the patterns 
of antigen fragmentation observed and also the temporal appearance of these 
fragments in the plasma (Chapter 4). The immune response to oral delivery of 
antigen may possibly be tolerogenic for some soluble antigens,as outlined 
previously,with gastric degradation playing an important role in the production 
of the epitopes responsible. Thus,as Quit-A alters the profile of degraded 
antigens appreciably in both a qualitative and quantitative manner, the reduction 
of tolerogenic protein conformations and/or the increase in the revelation of 
epitopes specific for T-helper cells may be as important as the direct increase 
in antigen absorption in the production of the observed increased antibody 
response to orally and anally delivered antigen. The delivery of HGG as 
ISCOMS and micelles also increase the antibody titres generated to levels 
approximating those observed with prior and concurrent Quit-A administration 
with HGG,which would not be expected if the sole adjuvant effect of Quit-A was 
its direct ability to increase antigen absorption,as the delivery of ISCOMS and 
micelles caused significantly lower peak levels of antigen absorption. The 
implications of this are that the alterations in the plasma antigen fragmentation 
patterns observed are indeed immunologically relevant and that Quit-A has a 
direct effect on the lymphoid tissue it encounters (primarily the GALT) in some 
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manner that causes an increased immune response or that,specifically,the 
delivery of HGG as ISCOMS and micelles imparts a degree of "particularity" to 
the antigen due to their intrinsic three-dimensional natures. All these factors 
have received a degree of support in recent investigations where the derivation 
of specific fragments of soluble protein are highly linked to immunosuppression 
and oral tolerance (Kay and Ferguson,1989a,1989b). Quii-A has been observed 
as being able to increase the production and release of immunomodulators such 
as cytokines and monokines (Campbell and Bede,l989) and that particulate 
antigens may be more immunogenic at mucosal surfaces than,unmodified,soluble 
ones (Rombout et a/.,1989b) and that ISCOM delivery in particular can 
preferentially cause a greater increase in mucosal immune responses (Mowat et 
a/.,1991). The production of a delivery system that allows the generation of a 
relevant and protective immune response with a single immunising dose is likely 
to be a requirement for any oral vaccination regime,considering the various 
problems encountered with oral tolerance and immune response variability 
observed in both mammals and fish. 
In conclusion,the present study shows that the oral,anal and 
intraperitoneal delivery of a single dose of HGG results in the generation of 
considerable levels of antibodies in the plasma,bile and cutaneous mucus of 
O.mossambicus and that the enteric delivery of the antigen in combination with 
the saponin adjuvant Quii-A in a variety of delivery systems can cause a 
significant increase in the specific antibody responses elicited,both systemically 
and mucosally. 
214 
FIGURE 6.1. 
Figure 6.1 shows the plasma antiserum titration 14 days after the oral and 
anal delivery of 10mg/ml (0.2ml intubated) HGG concurrently with or after 
Quil-A. HGG + Q.A. (0) is the oral delivery of HGG concurrently with Quii-A; 
Q.A. > HGG (0) is the oral delivery of HGG after the delivery of Quii-A; 
HGG + Q.A (A) is the anal delivery of HGG concurrently with Quii-A; 
Q.A. > HGG (A) is the anal delivery of HGG after the delivery of Quit-A; the 
control is the anal delivery of saline. 
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FIGURE 6.2. 
Figure 6.2.a shows the temporal antibody response in the plasma after the 
oral,anal and intraperitoneal (lP) immunisation with lOmg/ml (0.2ml dose) 
without adjuvant. Figure 6.2.b shows the temporal antibody response in the bile 
after the oral,anal and intraperitoneal (IP) immunisation with lOmg/ml (0.2ml 
dose) without adjuvant. Figure 6.2.c shows the temporal antibody response in 
the cutaneous mucus after the oral,anal and intraperitoneal (lP) immunisation 
with lOmg/ml (0.2ml dose) without adjuvant. 
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FIGURE 6.3. 
Figure 6.3.a shows the temporal antibody response in the plasma after the 
oral and anal immunisation with lOmg/ml HGG (0.2ml dose) after the prior 
administration of lOO~g/ml Quil-A. Figure 6.3.b shows the temporal antibody 
response in the bile after the oral and anal immunisation with lOmg/ml HGG 
(0.2ml dose) after the prior administration of lOO~g/ml Quil-A. Figure 6.3.c 
shows the temporal antibody response in the cutaneous mucus after the oral and 
anal immunisation with lOmg/ml HGG (0.2ml dose) after the prior 
administration of lOO~g/ml Quil-A. 
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FIGURE 6.4. 
Figure 6.4.a shows the temporal antibody response in the plasma after the 
oral and anal immunisation with lOmg/ml HGG (0.2ml dose) with the 
concurrent administration of lOJ.'g/ml Quil-A,by a complementary route. Figure 
6.4.b shows the temporal antibody response in the bile after the oral and anal 
immunisation with lOmg/ml HGG (0.2ml dose) with the concurrent 
administration of 101-'g/ml Quil-A,by a complementary route. Figure 6.4.c shows 
the temporal antibody response in the cutaneous mucus after the oral and anal 
immunisation with lOmg/ml HGG (0.2ml dose) with the concurrent 
administration of 101-'g/ml Quil-A.by a complementary route. 
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FIGURE 6.5. 
Figure 6.5.a shows the temporal antibody response in the plasma after the 
oral and anal immunisation with lOmg/rnl HGG (0.2ml dose) with Quit-A as 
immune-stimulatory complexes (ISCOMS). Figure 6.5.b shows the temporal 
antibody response in the bile after the oral and anal immunisation with lOmg/ml 
HGG (0.2ml dose) with Quit-A as immune-stimulatory complexes (ISCOMS). 
Figure 6.5.c shows the temporal antibody response in the cutaneous mucus after 
the oral and anal immunisation with lOmg/ml HGG (0.2ml dose) with Quit-A 
as immune-stimulatory complexes (ISCOMS). 
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FIGURE 6.6. 
Figure 6.6.a shows the temporal antibody response in the plasma after the 
oral and anal immunisation with lOmg/ml HGG (0.2ml dose) with Quil-A as 
micelles. Figure 6.6.b shows the temporal antibody response in the bile after the 
oral and anal immunisation with lOmg/ml HGG (0.2ml dose) with Quil-A as 
micelles. Figure 6.6.c shows the temporal antibody response in the cutaneous 
mucus after the oral and anal immunisation with lOmg/ml HGG (0.2ml dose) 
with Quil-A as micelles. 
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CHAPTER 7. 
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CHAPTER 7. PRELIMINARY STUDIES ON THE USE OF 
TARGETING AGENTS AND ADJUVANTS IN POTENTIAL 
DELIVERY SYSTEMS TO O.mossambjcus. 
7.1. INTRODUCTION. 
The oral administration of soluble,T-dependent antigens has produced 
variable results in attempts to generate a specific,protective,immune response. 
The delivery of protein antigens,orally,often results in the conversion of the 
protein, by the normal physiological processes of the gastrointestinal tract,into a 
form that results in immunological hyporesponsiveness and eventually specific 
immunosuppression to the protein (Bruce and Ferguson,1986a,1986b). This 
mode of administration often requires a larger immunising dose than that 
required on systemic injection of the same protein,to elicit an immune 
response,and may reflect both the degradative processing of the gastrointestinal 
tract and/or the trans-lumenal processing effects of the intestinal enterocytes 
(Mayer,1991;Sanderson and Walker,1991). The enteric delivery of protein 
antigens,in mammalian systems,can also result in the generation of an antigen 
specific immune response locally in the intestine that can be recognised in 
mucosal sites distanced from the intestine which comprises the common mucosal 
immune system (Befus and Bienenstock,1980;Mestecky,1987;van der Heijden et 
al., 1989;Arya, 1990;van der Heijden,Bianchii,Dol,Pals,Stok and Bokhout, 1991 ). 
Lymphocytes of the gastrointestinal tract,stimulated with antigen,are induced to 
express immunoglobulin that is evolutionarily designed for mucosal translocation 
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to local secretions (slgA,in mammals). Antigens delivered orally to the lumen 
are absorbed and interact with resident T and B cells and accessory cells. 
Antigen sensitized B-cells enter the general blood and lymphatic circulations 
until they lodge in mucosae-associated tissue where terminal differentiation into 
secretory plasma cells occurs ~Bockman,Boydston and Beezhold, 1983). From 
this it can be observed that the oral immunisation of non-replicating,protein 
antigens may have a variable effect on the potential generation of an immune 
response with a spectrum of possible responses from hyporesponsiveness to a 
specific immune response (van der Heijden et al., 1989;Davidson,1991). 
It has also been reported that the prolonged feeding of protein 
antigens,in mammals;can similarly result in either specific local and inducible 
secretory immune responses (Mestecky,1987;Kantele,1991) or in systemic 
hyporesponsiveness (Bruce·and Ferguson,l986a,1986b). The oral administration 
of protein antigens over several days, in repeated doses, in teleosts, can also result 
in a measurable antibody response in both the mucosal and systemic immune 
compartments (Rombout et a/.;1986,1989b;Davidson,1991). However,as in 
mammalian systems, the oral administration of soluble protein antigens, to fish, 
has also been reported to result in a form of systemic immunosuppression that 
may be similar to tolerance (Harrell et al.,1976;Whlskovsky and 
Avtalion,1982;Rombout et a/.,1989b;Davidson,1991). Analysis of the resident 
gut-associated lymphoid tissue (GALT) in the intestine of teleosts appears to 
show that the mechanisms responsible for the induction of a common network 
of immunologically-interlinked mucosae,in the form of an inducible antibody-
secreting cell population exists (Davidson,1991),and in a manner analogous to 
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that observed in mammals (Czerkinsky,Prince,Michaelek,Jackson,Russell, 
Moldoveanu,McGhee and Mestecky, 1987;Lycke,Bromander and 
Holmgren, 1989;Lycke,Bromander,Ekman,Karlsson and Holmgren, 1989; 
Czerkinsky,Svennerholm,Quiding,Jonsson and Holmgren,1991;van der Heijden 
et a/.,1991). However it also appears that the cellular phenotypes required for 
the generation of a mammalian-type tolerogenic response that is antigen-specific 
(intraepithelial T-cells of the suppressor phenotype) is possibly also present in 
the teleost gastrointestinal tract (Miller et a/.,1986,1987). 
Recent studies have evaluated the requirement for adjuvants,targeting 
agents and carrier molecules that will allow the oral delivery of protein 
macromolecules in a manner that will avoid tolerogenesis (Mestecky, 1987;Mowat 
et al.,1991;van der Heijden et al., 1991). One potential delivery vehicle, that has 
received considerable attention in mammalian studies,is the use of Vibrio 
clzolerae toxin or its purified B-subunit (McKenzie and Halsey,1984;Lycke and 
Holmgren, 1986;Kay and Ferguson,1989a, 1989b;Lycke et al., 1989a, 1989b;van der 
Heijden et a/.,1991). Cholera holotoxin is composed of er and B sub-units with 
the er subunit (approximately 30 kDa in molecular weight) being the primary 
causative agent for the clinical symptoms of cholera in mammals via its 
activation of adenylate cyclase resulting in raised intracellular levels of cAMP 
in the intestinal enterocytes and in the active efflux of electrolytes and fluid 
(Liang,Lamm and Nedrud,l988). The B-subunit is a pentamer (each monomer 
being approximately 10.6kDa in molecular weight) which adheres to the GMl 
gangliosides on the intestinal enterocytes and allows the active translocation of 
the holotoxin in vivo (Liang et a/.,1988). Both the holotoxin (CT)(Lycke and 
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Holmgren,1986,1989;Lycke et a/.,1989a,1989b) and its B-subunit (McKenzie and 
Halsey,1984;Liang et a/.,1988) have been reported as being able to increase the 
local (intestinal} and systemic immune responses and to alter the isotyope 
profile of the antibody response (Jetborn,1988) to antigens when delivered 
mixed together or conjugated with them (by a variety of mechanisms) (Liang et 
a/.,1988}. Cholera toxin and its B-subunit have not,as yet,been used as adjuvants 
or carriers for the oral delivery of protein macromolecules in fish although the 
potential usefulness of this procedure has been noted (EIIis,1988). 
Aluminium hydroxide (AIOH3) is one of the most commonly used clinical 
adjuvants and is currently the only adjuvant licensed for widespread commercial 
and veterinary use (Warren et a/.,1986;Jolivet,1989;Lise and Audibert,1989}. 
AIOH3 has been reported to be an efficient inducer of humoral immune 
responses through its ability to specifically induce the T-cell subset Th2,in 
mammals,and the resulting B-cell stimulation (Lise and Audibert,l989). AIOH3 
has been variously reported as a slow-release ("depot") type adjuvant (Warren 
and Chedid,1988} that allows a continuous trickle of antigen at the site of 
delivery,and as an immunopotentiating agent (Lise and Audibert,1989} by 
causing an inflammatory focus that attracts immunocompetent cells to the 
vicinity of the antigen. 
Al0H3 has been used in injection,immersion and oral vaccination regimes 
m fish,with a variety of antigens,to little beneficial effect (Agius et 
al., 1983;Tatner and Home, 1983;Cossarini-Dunier, 1985). 
Ammonium chloride (NH4CI) has been reported as acting as a 
lysosomotrophic agent when delivered to fish cells in vivo and in vitro 
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(McLean,1987). Immersion of rainbow trout in quaternary ammonium 
compound ,{QAC),a presumptive analogue,prior to Aeromonas salmonicida 
bacterin caused an increase in the resultant immune response observed,although 
apparently largely by acting as an non-specific immunostimulant (Jeney and 
Anderson,199l,in press). 
The aims of the current study were to carry out preliminary investigations 
into the applicability of the use of cholera toxin B-subunit as a targeting agent 
and adjuvant,AIOH3 and NH4Cl as adjuvants and immunostimulants in enteric 
delivery systems in O.mossambicus. The study represents the first use of cholera 
toxin B-subunit in oral delivery systems in fish and represents one of the few 
reports to use AIOH3 and NH4CI as enteric adjuvants. Furthermore it is 
designed to make preliminary observations of the effects of these substances on 
the absorption of HGG and on a single measurable parameter of any resultant 
immune response -the systemic antibody levels specifically raised against the 
antigen. Thus this investigation is not designed as an exhaustive study on the 
mechanisms of action of any of the substances studied or on the affects they may 
have on all the parameters of an immune response in vivo. 
1...1. MATERIALS AND METHODS. 
7.2.1. ANIMALS. 
Tilapia,Oreochromis mossambicus,of both sexes, weighing between 30-50g 
were maintained in a recirculating freshwater system at 24-26 • C until required. 
7.2.2. PREPARATION OF ADJUV ANT-ANTIGEN COMBINATIONS. 
a) Cholera toxin B-subunit: (containing approximately 20ng cholera 
231 
holotoxin,Sigma,Poole,Dorset,U.K.) was prepared in 0.05M Tris,0.2M NaCl 
buffer plus 3mM NaN3 and 1mM Na2EDTA (ethylene diamino tetracetic acid) 
at pH 7.5. 50J,Ag of cholera toxin B-subunit solution was mixed,by thorough 
vortexing,with 2mg human gamma globulin (HGG) in 0.2ml 50mM Tris,0.2M 
NaCl buffer and stored at 4 ° C until required. 
b) Aluminium hydroxide: (AIOH3;Aldrich Chemical Company,Gillingharn, 
Dorset,U.K.) was added at a 1:1 w\w ratio with 10mg/ml HGG and mixed by 
thorough vortexing,in saline. The mixed antigen and adjuvant was adsorbed for 
8 hours at ambient temperature and subsequently stored at 4 o C,until required. 
c) Ammonium chloride: (NH4Cl;BDH,Poole,Dorset,U.K.) was added at 
a 1:1 w\w ratio with lOmg/ml HGG and mixed by thorough vortexing,in saline. 
The antigen-adjuvant mixture was stored at 4 o C until required. 
7.2.3. INTUBATION AND IMMUNISATION PROCEDURES. 
7.2,3.1. INTUBATION PROCEDURES. 
For the antigen absorption study groups of fish were intubated perorally 
and peranally with 0.2ml of a 10mg/ml solution of HGG,as a positive control, the 
fish sacrificed,and the plasma tested over a structured time course as follows: 
after 15 minutes,1,2,6,12 and 24 hours. 
Test groups of fish (n=3) were intubated perorally and peranally with 
0.2ml of each of the adjuvant-antigen mixtures,prepared as outlined above 
(cholera B-subunit/ AIOH3/NH4CI plus HGG) and sampled over the same 
structured time course as the positive control. Control fish (n=3) were 
intubated with 0.2ml PBS pH 7.2,by a complementary route under the same 
conditions. 
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7.2.3.2. IMMUNISATION PROCEDURES. 
Groups of fish (n = 3) were also immunised (for the antibody response 
study) perorally,peranally and intraperitoneally with 0.2ml of each antigen-
adjuvant mixture,solely with HGG (as a positive control) and with PBS pH 7.2 
as a negative control. The fish were marked subcutaneously,by panjetting,with 
an Alcian blue (Gurr stains,BDH,Bristol,U.K.) solution in ethanol to aid 
subsequent identification. 
7.2.4. SAMPLE COLLECTION. 
7.2.4.1. FOR THE ANTIGEN ABSORPTION STUDY 
Fish were sacrificed by a sharp blow to the head and blood was collected 
in heparinised (10 units of heparin (Sigma)/ml saline) microcapillary tubes (25J.Ll 
volumes) and microhaematocrit tubes (lOOJ.£1 volumes). Blood was pooled for 
each test group,centrifuged at 4000rpm for 5 minutes and the plasma removed 
and stored at -20' C,until required. 
7.2.4.2. FOR THE ANTIBODY RESPONSE STUDY. 
The test groups of fish were bled,at days 0,7,14,21,28, and 35 days post-
immunisation using 25g needles and heparinised (as previously) syringes from 
the caudal sinus. The plasma was removed,by centrifugation,as previously 
described and stored at -20' C until required. 
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7.2.5. THE DETECfiON OF HGG AND FISH ANTI-HGG 
ANTIBODIES USING AN ENZYME LINKED IMMUNOSORBENT 
ASSAY SYSTEM (ELISA). 
The procedures employed for both the detection of absorbed HGG and 
the production of HGG-specific antibodies in the plasma are identical to those 
developed and described in Chapters 4.2.5. and 6.2.5.,respectively. All ELISA 
assay results were subjected to statistical analyses. 
7.2.6. STATISTICAL ANALYSES. 
The ELISA derived data was analysed using one and two-way analyses 
of variance for the antigen absorption study (as in Chapter 4.2.7.) and the data 
form the antibody generation study was analysed using chi-squared tests (as in 
Chapter 6.2.7.) 
7.3. RESULTS. 
7.3.1. THE ABSORPTION OF HGG AFTER ORAL AND ANAL 
DELIVERY ANDTHEEFFECfOF ADJUVANTSADMINISTERED 
IN COMBINATION WITH THE ANTIGEN. 
The ELISA systems utilised in this investigation were largely based on 
those optimised in the earlier studies on HGG absorption after enteric delivery 
(see Chapter 4.2.5) and antigen-specific antibody responses to immunisation (see 
Chapter 6.2.5). The kinetics of the titration curves obtained with these systems 
were extremely similar to those obtained in the earlier assays and the control 
values were not significantly altered (approximately 0.1-0.15 absorbance units). 
The background absorbances were mathematically subtracted from the peak 
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absorbances in the ELISA systems using data storage software. 
7.3.1.1. ANTIGEN ABSORJYTION AFTER HGG DELIVERY 
WITHOUT ADJUV ANT. 
The absorption patterns obtained after the oral and anal delivery of 
HGG (Figure 7.1) were similar to those obtained previously and were used in 
this study as both a positive control and as a baseline against which to make 
comparisons of any effect of the adjuvants on the levels of antigen absorption. 
Differences in the levels of absorption of HGG from the intestine were 
temporally variable and route-dependent. HGG absorption appeared to be 
biphasic with peaks of absorption 1 hour and,maximally,6 hours after oral 
delivery (Figure 7.1). These maxima were significantly greater (p< 0.1) than the 
other levels of HGG detected in the plasma and was also significantly greater 
than background levels obtained (not shown). 
The temporal kinetics of absorption of anally delivered HGG were 
different from those seen after oral delivery with maximal absorption occurring 
after 1 hour. The levels of HGG reaching the plasma declined after 6-12 hours 
following either oral or anal delivery. 
7.3.1.2. ANTIGEN ABSORPTION AFTER THE DELIVERY OF HGG 
WITH CHOLERA TOXIN B-SUBUNIT. 
The oral and anal delivery of HGG with cholera toxin B-subunit (CTB) 
altered the levels and the pattern of absorption of HGG from the intestine. 
Oral delivery of HGG plus CTB resulted in peak levels of antigen absorption 
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(Figure 7.2) that were over 2-fold greater than those observed after the oral 
delivery of HGG alone (Figure 7.1). Similarly,anal delivery of HGG plus CTB 
caused an increase in the levels of antigen absorbed (Figure 7.2). The levels of 
HGG absorbed after enteric delivery with CTB substantially increased above 
those achieved with HGG delivery on its own from 6-12 hours after delivery. 
The temporal levels of absorption were also different with peak levels occurring 
12 hours after anal delivery,although the maximum uptake still occured 6 hours 
after oral delivery. 
7.3.1.3. ANTIGEN ABSORPTION AITER THE DELIVERY OF HGG 
WITH ALUMINIUM HYDROXIDE (AIOHJ. 
The oral and anal delivery of HGG plus aluminium hydroxide (AIOH3) 
resulted in the absorption of HGG in a similar manner (temporally and 
quantitatively) to that of HGG delivered without adjuvant. The oral delivery of 
HGG plus AIOH3 resulted in peak levels of antigen absorption 6 hours after 
delivery that were approximately 1/3-fold greater (Figure 7.3) than those 
observed after HGG delivery on its own. The kinetics of antigen absorption 
were similar to that of HGG delivered on its own although the plasma levels 
remained significantly greater (almost 2-fold) between 12 and 24 hours after 
administration. 
Anal delivery of HGG with AIOH3 (Figure 7.3) resulted in levels of 
antigen absorption that were statistically similar to those observed after oral 
delivery. Anal administration of HGG plus AlOH3 resulted in a biphasic 
pattern of absorption with peaks 15 minutes and 6 hours after administration. 
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The levels of plasma HGG declined more swiftly between 12-24 hours after anal 
delivery than those observed after the oral delivery of HGG plus AIOH3• 
7.3.1.4. ANTIGEN ABSORPTION AFfER TilE DELIVERY OF HGG 
WITII AMMONIUM CHLORIDE (NH1Cl). 
The oral and anal delivery of HGG plus NH4Cl resulted in significantly 
lower (p<O.l) peak levels of antigen absorption (Figure 7.4) by comparison with 
the peak levels observed after the delivery of HGG alone. The oral delivery of 
HGG plus NH4Cl resulted in peak levels of absorption (Figure 7.4) after 6 hours 
that were significantly greater than those observed after the anal delivery of 
HGG with NH4Cl. The temporal kinetics of HGG absorption after its oral. 
delivery with NH4Cl were similar to those observed after the delivery of the 
antigen plus AIOH3• Peak antigen levels were observed 6 hours after oral 
delivery and 15 minutes after anal delivery. Levels of antigen decreased 
between 6 and 24 hours after both oral and anal delivery. 
The anal delivery of HGG with NH4CI resulted in lower levels of antigen 
absorption,over the entire time course studied,by comparison with levels 
observed after oral delivery. Peak levels of antigen were detected 15 minutes 
after anal delivery and the levels of plasma antigen decreased after this time,in 
marked contrast to the trend observed after oral antigen delivery. The levels of 
antigen absorbed 1 to 24 hours after anal delivery of HGG with NH4Cl were 
significantly lower than those observed after oral delivery over the same time. 
The levels of HGG absorbed after the enteric delivery of antigen with NH4Cl 
were lower than those observed after the administration of HGG with 
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CfB,AJOH3 or alone. 
7.3.2. THE ANTIBODY RESPONSE IN THE PLASMA AFTER 
PARENTERAL AND ENTERIC IMMUNISATION WITH HGG. 
The presence of anti-HGG antibodies,in the plasma,was investigated 
following the immunisation of the antigen in combination with several adjuvants. 
The standard curves derived from the ELISA assay (developed in 
Chapter 6) are exemplified,by data derived from immunisation of HGG with 
CTB in Figure 7.5 and were similar to those obtained previously. Control 
immunisation of saline regularly resulted in background absorbances of 0.1-0.15 
absorbance units throughout the study. The control values are not illustrated on 
the figures as they were mathematically removed from the ELISA data utilising 
data storage software. 
Intraperitoneal (IP) immunisation with HGG resulted in an antigen-
specific antibody response (Figure 7.6). IP immunisation resulted in peak 
antibody titres that were significantly greater (p < 0.05) than those obtained after 
oral and anal delivery (Figure 7.6). IP immunisation of HGG resulted in the 
generation of detectable antibody titres 7 days post-immunisation that peaked 
28 days post-immunisation. 
The oral and anal delivery of HGG resulted in significantly lower 
antibody titres in the plasma than after JP immunisation. Oral and anal 
immunisation of HGG resulted in peak antibody titres that were quantitatively 
and temporally similar,peaking 21-28 days post-immunisation. The oral and anal 
delivery of HGG resulted in a longer latent period,prior to the generation of a 
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plasma antibody response,than after JP delivery. 
7.3.3. THE ANTIBODY RESPONSE IN THE PLASMA AFfER 
PARENTERAL AND ENTERIC IMMUNISATION WITH HGG AND 
CHOLERA TOXIN B-SUBUNIT. 
lP immunisation with HGG with CTB did not result in a statistically 
significant increase in the levels of antibodies (Figure 7.7) generated against 
HGG by comparison with HGG delivered without adjuvant. However,the 
delivery of HGG orally and anally in combination with CTB caused a moderate 
increase in the levels of antibodies generated in the plasma (Figure 7.7). The 
peak levels of antibodies generated were similar after both the oral and anal 
delivery of HGG plus CTB. 
Temporally,the delivery of HGG in combination with CTB stimulated 
different antibody generation curves by comparison with delivery of HGG alone. 
Peak level of antibody was observed 35 days after immunisation via the enteric 
route compared with 28 days after the JP delivery of HGG with CTB. The 
inclusion of CTB resulted in a decrease in the latent period between 
immunisation and the appearance of antibodies in the plasma after oral and 
anal administration,with peak responses 21-28 days after delivery (for both 
routes of immunisation) that appeared to be tenable beyond 35 days,in the case 
of the orally delivered immunogen. 
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7.3.4. TilE ANTIBODY RESPONSE IN THE PLASMA AFfER 
P ARENTERALAND ENTERIC IMMUNISATION WITII HGG PLUS 
ALUMINIUM HYDROXIDE (AIOHJ.. 
The lP immunisation of HGG plus AIOH3 resulted in the generation of 
a plasma antibody response with a peak titre (Figure 7.8) approximately 8-10 
fold less than the maximum titre observed after the lP immunisation with HGG 
alone. lP immunisation of HGG adsorbed to AIOH3 resulted in plasma 
antibody titres that were significantly (p < 0.05) greater than those detected after 
oral and anal delivery. 
The enteric (oral and anal) delivery of HGG adsorbed to AIOH3 resulted 
in peak titres that were slightly (but not statistically) greater than those observed 
after the enteric delivery of HGG alone. 
lP immunisation of antigen with AIOH3 caused a peak antibody response 
35 days post-immunisation and a more rapid generation of the antibody response 
(as evidenced by a steeper curve over the early points in the time course) than 
the antibody generation curve stimulated by HGG alone (Figure 7.6). 
The oral and anal delivery of HGG adsorbed to AIOH3 resulted in 
similar antibody generation curves with oral delivery causing a peak after 28 
days and anal delivery a peak after 35 days. The oral delivery of HGG plus 
AIOH3 resulted in plasma antibody titres that were of a comparable magnitude 
to those obtained after the equivalent immunisation with HGG and 
CTB,whereas for immunisation via the anal and intraperitoneal routes the 
antibody response was considerably reduced. 
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7.3.5. THE ANTIBODY RESPONSE IN THE PLASMA AFfER 
PARENTERAL AND ENTERIC IMMUNISATION WITH HGG AND 
NH1CI. 
The immunisation with HGG and NH4Cl,by both the parenteral and 
enteric routes,resulted in both quantitative and temporal differences in the 
antibody generation curves by comparison with immunisation of HGG,alone. 
lP immunisation resulted in peak specific antibody titres that were lower 
(Figure 7.9) than those observed after the lP immunisation with HGG on its 
own or in combination with CTB (by approximately 10-fold) but were 
approximately equal to the levels observed after the lP delivery of HGG 
adsorbed to AIOH3• Oral and anal delivery of HGG with NH4Cl resulted in 
lower antibody titres by comparison with JP immunisation (Figure 7.9). Oral 
delivery resulted in detectable higher antibody titres than anal delivery. The 
enteric delivery of HGG with NH4Cl resulted in lower levels of specific 
antibodies than any of the other immunisation protocols (Figures 7.6,7.7 and 
7.8). Maximal antibody titres occurred 35 days after lP immunisation and 28 
days after the enteric delivery of HGG plus NH4CI. 
7.3.6. A TABLE SUMMARISING THE PEAK ANTIBODY 
RESPONSES GENERATED IN THE STUDY. 
Table 7.1 is a tabulated summary of the peak antibody titres achieved 
with the various modes of antigen delivery with or without adjuvant and the 
times these levels were detected post-immunisation. 
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TABLE 7.1. ILLUSTRATING THE PEAK LEVELS OF 
ANTIBODY PRODUCTION (AND THEIR TIMES OF 
GENERATION POST-IMMUNISATION). 
ROUTE OF ADMINISTRATION. 
Intraperitoneal Oral Anal 
Analyte Plasma Plasma Plasma 
HOG 4.82 (28) 1.81 (28) 1.81 (21-28) 
HGG+Cholcra 5.12 (35) 2.71 (21-28) 2.71 (21-28) 
toxR. 
HGG+AIOH3. 4.21 (35) 2.71 (28) 2.41 (35) 
HGG+NH40 4.21 (21) 2.11 (28) 1.5 (28) 
Key: Unparenthesised numbers refer to the maximal HOG-specific titres 
observed (1/- Log10 antibody titre) and the numbers in parenthesis refer to the 
time of generation of those titres,post immunisation (Days). 
Analyte refers to the immunogen analysed. 
The nomenclature in the left hand column refers to the mode of delivery 
of HGG where: HGG equals delivery without adjuvant;Cholera toxB refers to 
the delivery of the B-subunit of cholera toxin in combination with HGG;AIOH3 
refers to the delivery of HGG adsorbed to aluminium hydroxide;NH4Cl refers 
to the delivery of HGG with ammonium chloride. 
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M... DISCUSSION. 
The present study is one of the first demonstrations of the viability of the 
use,in fish,of a variety of adjuvants on the absorption of enterically delivered 
antigen. It is also the first study to demonstrate a potential use of the B-subunit 
from cholera toxin (Cf) as an adjuvant and targeting agent in the delivery of 
antigen to the gastro-intestinal tract of fish. 
HGG delivered enterically without adjuvant resulted in detectable levels 
of absorbed antigen in the plasma 15 minutes after oral or anal delivery. The 
appearance of HGG in the plasma correlated with similar temporal patterns of 
absorption as observed in earlier studies (Chapters 4 and 5) using the same 
optimised dose of 10mg/ml (0.2ml intubated dose). This rapid absorption,as 
outlined earlier,is also observed for optimised doses of other orally and anally 
delivered soluble protein antigens such as bovine serum albumin (BSA) m 
O.mossambicus (Doggett,1989),horseradish peroxidase (HRP) and HGG in 
rainbow trout Oncorhynchus mykiss (McLean,1987;Lavelle,unpbl.obs). 
The absorption of HGG in O.mossambicus delivered enterically without 
adjuvant was rapid,temporally complex and also dependent on route of 
administration. The initial absorption of anally delivered HGG was rapid with 
anal delivery resulting in maximal levels of absorption into the plasma after 1 
hour. The levels of plasma HGG observed at this time were greater than those 
observed after oral delivery at this time. Oral delivery resulted in peak levels 
of plasma antigen absorption after 6 hours that were approximately equal to the 
peak levels of plasma antigen after anal delivery. Levels of plasma antigen 
appeared to decrease from 6-12 hours after both oral and anal delivery. The 
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temporal patterns and quantitative levels of HGG absorption into the 
plasma,after oral and anal delivery,were largely similar to those observed earlier 
(Chapter 4). The oral and anal delivery of other protein macromolecules,such 
as ferritin and HRP,to O.mossambicus (Doggett,1989) resulted in similar times 
of appearance of these antigens in the plasma but at considerably elevated levels 
by comparison with the levels of absorbed HGG in this study. The maximal 
levels of absorbed ferritin were 4-5 fold greater and maximal levels of HRP 7-
fold greater (Doggett,1989) than the peak levels of absorbed HGG 6 hours after 
oral delivery. The anal delivery of these antigens resulted in variable patterns 
of absorption,ferritin being absorbed in a similar manner to HGG and HRP in 
a distinctly different mode. Studies of the absorption of enterically delivered 
antigens in other species such as O.mykiss have shown that the temporal patterns 
of antigen absorption may be related both to the nature of the antigen 
administered and to the detection method used (Georgopoulou et 
a/.,1986;McLean,1987;Doggett,1989). 
The enteric delivery of HGG alone,in this study,is assumed to result in 
absorption across the intestinal epithelium in a similar manner to that observed 
earlier (Chapter 3) with the bulk of antigen being absorbed across the 
enterocytes transcellularly. HGG enterically delivered to O.mossambicus was 
also observed interacting with cells of the gut-associated lymphoid tissue 
(GALT). Such interactions,with both the enterocytes and GALT cells,will 
profoundly affect the temporal patterns of antigen absorption from the intestine 
as well as the quantitative levels of antigen observed in the plasma. The oral 
delivery of growth hormone was shown to have considerable interactions with 
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granular cells in the intestine of O.mykiss that affected overall absorption into 
the plasma (Le Bail et a/.,1989). Levels of antigen reaching the intestinal 
enterocytes are further influenced by a variety of other factors associated with 
both the nutritive functions of the gastrointestinal tract and overall gut 
physiology (Jobling,1988) and in the case of orally delivered proteins,the gastric 
pH may also be especially important (Smith,l989). 
The enteric delivery of HGG in combination with a standard dose of 
cholera toxin B-subunit resulted in an increase in the overall levels of antigen 
absorbed into the plasma,over the time course studied. Oral delivery of cholera 
toxin B-subunit mixed with HGG resulted in more rapid absorption of HGG into 
the plasma;the levels of orally administered antigen reaching the plasma after 
15 minutes being significantly greater (by almost 2-fold) than those observed 15 
minutes after the delivery of HGG without adjuvant. Oral administration of 
HGG plus cholera toxin B-subunit altered the temporal patterns of antigen 
absorption such that peak absorption was still observed 6 hours after antigen 
delivery but the biphasicity of the absorption curve was absent. Peak levels of 
HGG absorption were also 2-fold greater than the peak levels of antigen 
absorbed when delivered alone. 
Anally delivered HGG plus cholera toxin B-subunit also caused an 
increase in the levels of HGG absorbed into the plasma. Temporally,the anal 
administration of HGG plus cholera toxin B-subunit caused an alteration in the 
pattern of absorption of antigen into the plasma, with the levels of absorption up 
to 1 hour being similar to that of HGG alone and less than that observed after 
oral delivery without adjuvant. Between 1 and 6 hours the levels of HGG 
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absorbed into the plasma was similar to that observed after oral delivery. Peak 
levels of anally administered antigen were reached 12 hours after delivery. By 
comparison with HGG delivery without adjuvant the duration of antigen 
absorption was increased,with levels only declining 12 hours after either oral or 
anal delivery. The levels of antigen absorbed after the enteric delivery of HGG 
in combination with cholera toxin B-subunit were generally lower (by up to 5-
fold) than those observed after the delivery of Quii-A prior to or concurrently 
with HGG. Peak levels of antigen absorbed were similar to the peak levels 
observed after the delivery of HGG with Quii-A as ISCOMS or micelles 
(Chapter 4). 
The current study represents the first recorded practical use of cholera 
toxin B-subunit as an adjuvant in oral delivery systems in fish although the 
potential use of cholera toxin B-subunit for enhanced delivery of enteric antigens 
(in vaccination regimes) has recently been theoretically discussed 
(EIIis,1988;Davidson,1991) as it is known that the primary mechanism of cellular 
recognition for the B-subunit -the GM1 gangliosides- are probably present on 
most, if not all,eukaryotic cells (Kay and Ferguson, 1989a). Most of the 
information concerning the applicability of the use of cholera toxin (CT) or the 
B-subunit (CTB) as an adjuvant for enteric delivery studies and resultant 
immune responses has been observed from investigations on mammals,and 
frequently,humans (McKenzie and Halsey, 1984;Lycke and Holmgren, 1986;Liang 
et a/.,1988;Kay and Ferguson, 1989a, 1989b;van der Heijden et a/.1989;Clarke et 
a/.,1991;Lycke,Karlsson and Magnusson,1991;van der Heijden et a/.,1991). The 
enteric delivery of antigens mixed with cholera toxin was found to be efficacious 
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in increasing antigen absorption (and specific resultant immune responses) in 
mammals (McKenzie and Halsey,1984). The delivery of HRP in combination 
with cm was found to cause increased binding of the adjuvant/antigen to the 
GMl gangliosides,and hence an increased uptake of the antigen by M-cells and 
enterocytes. This was coupled with an increased active processing of the antigen 
by the intestinal lymphocytes and macrophages,possibly caused by increased 
cytokine release,including raised levels of interleukin-1 and gamma-interferon 
(Quiding,Nordstrom,Kilander,Andersson,Hanson,Holmgren and Czerkinsky,1991) 
that were not mediated by a rise in the intracellular levels of cAMP (Lycke and 
Strober,1989). 
Delivery of cholera toxin B-subunit mixed with Sendai virus also resulted 
in an increase in antigen absorption by direct conjugation of the B-subunit to the 
virus (Liang et al., 1988),which was thought to cause increased binding of the 
antigen-CTB complex to the GMl gangliosides and further increase the resultant 
immune response (van der Heijden et al.,l991). 
In contrast,other studies have suggested that delivery of antigen plus free 
cm does not increase the immunogenicity of the administered antigen ie. does 
not act as an adjuvant (Kay and Ferguson,1989a,1989b;Lycke et al.,1991;van der 
Heijden et al.,1991). These studies have suggested that the overall permeability 
of the gut is one of the vital factors in determining the levels of orally 
administered macromolecules absorbed and their relative immunogenicity 
(Lycke et al.,I991) and that both cholera toxin and its B-subunit are required for 
increasing the intestinal permeability and that the cooperation between the two 
components to achieve this is synergistic (Clarke et al., 1991 ). The delivery of 
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CfB in this study may,to some extent,be influenced by such factors as those 
outlined above as commercial preparations of cholera toxin B-subunit (such as 
the one used in this study) generally have cholera toxin contaminants (equivalent 
to approximately 20ng per dose in the preparation used in this study) and as 
little as lOOng of er is required to generate a strong immune response to an 
antigen (Lycke and Holmgren,1986). It is therefore likely that the increase in 
the absorption of HGG enterically delivered with cholera toxin B-subunit in 
O.mossambicus is due to a multiplicity of factors including an increase in the 
binding of the antigen to the intestinal enterocyte surface (via the GMl 
ganglioside),a possible increase in the permeability of the intestinal epithelium 
and also an alteration in the pattern of antigen passage and processing in the 
enterocytes via increases in soluble immunological mediators (IL's and IFN's) 
which may influence functions of the enterocytes (Bland and 
Warren,1986a, 1986b;Mayer, 1991). 
The oral and anal absorption of HGG adsorbed to aluminium hydroxide 
resulted in increased levels of antigen absorption into the plasma over a limited 
period which occurred towards the end of the time course studied in this 
investigation. 
Oral administration of HGG adsorbed with aluminium hydroxide did not 
result in increased levels of absorption of antigen to the plasma until at least 6 
hours after delivery,where peak levels were approximately 1/3 greater than the 
peak levels detected after the delivery of HGG on its own. Levels of plasma 
HGG decreased rapidly 12 hours after oral delivery of antigen. Anal delivery 
of HGG adsorbed to aluminium hydroxide also resulted in an increase in the 
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levels of HGG absorbed into the plasma. However,this increase was only 
observed between 2 to 6 hours after administration. Levels of adsorbed HGG 
were not increased significantly outside this time period,by comparison with 
delivery of HGG alone. The levels of HGG absorbed after the enteric delivery 
of the antigen adsorbed with aluminium hydroxide were lower than those 
observed after the delivery of the antigen with cholera toxin B-subunit at any 
time. 
Aluminium hydroxide has been widely used as an adjuvant in clinical 
situations (Warren et a/.,1986) and has been found to act as a "depot" for 
antigen,where the delivery of antigen in situ is delayed (Warren and 
Chedid,1988) resulting in prolonged interaction between the absorbed antigen 
and immunocompetent cells at the area of introduction (Warren et a/.,1986). 
Mammalian studies also show that precise conditions of antigen-adjuvant 
adsorption are required for the complete efficacy of aluminium compounds as 
depots for antigen (Edelman,1980) and deviations from these conditions may 
result in the subsequent loss of adjuvant activity. The current study represents 
the first use of alurninium hydroxide as an enteric adjuvant for the delivery of 
protein antigens in fish. Related compounds,such as potassium aluminium 
sulphate,have been shown to significantly increase the uptake of Vibrio 
anguillarum bacterin in rainbow trout O.mykiss,in an immersion vaccination 
regime (Tatner and Horne,1983). Such an increase in antigen absorption may 
also be partially attributed to the action of the antigen-adjuvant complex in the 
gastrointestinal tract,through the drinking of the bath vaccine and the 
subsequent passage of the antigen across the intestine (Tytler et a/.,1990). The 
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increase in the levels of antigen absorbed were specifically observed between 6 
to 12 hours after enteric administration and may correlate with the protraction 
of antigen release ("depot" effect) as evidenced in mammalian studies 
(Edelman,1980;Warren et a/.,1986). 
The oral and anal delivery of HGG in combination with ammonium 
chloride generally resulted in significantly lower peak levels of antigen 
absorption by comparison with either enterically delivered HGG alone or HGG 
delivered with cholera toxin B-subunit or adsorbed to aluminium hydroxide. 
Orally administered HGG in combination with ammonium chloride 
resulted in peak levels of antigen absorption into the plasma 6 hours after 
delivery,at levels that were approximately 2-fold greater than those observed 
after the anal delivery of HGG plus simultaneous ammonium chloride. 
Administration of HGG plus ammonium chloride,orally,resulted in a 
rapid,biphasic,pattern of absorption that,although quantitatively lower than that 
observed after the delivery of HGG on its own,was temporally similar. 
The anal administration of HGG in combination with ammonium 
chloride resulted in peak levels of absorption after 15 minutes and levels of 
antigen absorbed into the plasma rapidly declined after this time. Levels of 
enterically administered HGG plus ammonium chloride declined to very low 
levels after 12 hours. 
This study again represents the first attempt to enhance the levels of 
antigen absorption with the use of ammonium chloride,enterically in an in vivo 
situation in fish. The levels of absorbed antigen,however,indicate that 
ammonium chloride acts in vivo in O.mossambicus in such a manner as to 
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actively reduce the levels of antigen absorption. In contrast to this,ammonium 
chloride has been reported to function as an efficient agent for the prevention 
of proteolysis of antigen in vitro in fish (Smedsrud et a/.,1984). The use of 
ammonium chloride in vitro in whole kidney homogenates of arctic 
char,Salvelinus a/pinus,resulted in the reduction of proteolysis of delivered 1125-
HSA (human serum albumin),mediated by intracellular cathepsins,by its direct 
lysosomotrophic action (Smedsrud et a/.,1984). As a consequence the potential 
use of ammonium chloride to increase the absorption of and/or the resultant 
immunogenicity of enterically delivered antigen,in fish,has recently been 
postulated by McLean (1987). 
Recent mammalian studies have indicated that enterocytes (and possibly 
the majority of cell types) can,under certain circumstances,express MHC 11 
molecules on their surfaces and in the case of the intestinal enterocytes may 
have considerable antigen processing capabilities and an antigen presenting role 
(Bland and Warren,1986a;l986b;Bland and Whiting,l990;Mayer,1991). The 
administration of ammonium chloride to isolated mammalian enterocytes,in 
combination with ovalbumin,significantly reduced their ability to process the 
antigen and effectively blocked antigen presentation to T-cells (Bland and 
Whiting, 1990). 
It is possible that ammomum chloride has similar functions on the 
lysosomal/endosomal pathways in vivo,in fish,and hence on the overall levels and 
rates of transcytosis of antigen as well as on antigen processing/presentation to 
which such factors are inextricably linked (Chain et al., 1988;Bland and 
Whiting, 1990). Such mechanisms of action could partially explain the lowering 
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of the overall levels of antigen absorption of HGG into the plasma after its 
enteric delivery with ammonium chloride,as HGG appears to be absorbed across 
the intestine largely by a transcellular route that is partially dependent on 
pinocytotic vesicles. The prevention of endocytosis,the intracellular 
processing,presentation and exocytosis of enterically delivered antigens,by 
ammonium chloride,may also account for the decrease in the resultant levels of 
antibodies after immunisation involving this adjuvant. If ammonium chloride 
acts in such a manner then the greater decrease in the absorption of anally 
delivered antigen,by comparison with orally delivered antigen,is explainable. 
The anal route,by bypassing the denaturing conditions of the 
stomach,theoretically allows more active substances (in this case adjuvant) to 
reach and interact with the intestine. 
The current study represents the first in vivo use of ammonium chloride 
as an enteric adjuvant,in fish. Related ammonium compounds,termed 
quaternary ammonium compounds (QAC) (of indeterminate nature,and which 
may or may not contain ammonium chloride) have been used in bath immersion 
regimes (Jeney and Anderson,1991,in press). QAC's have been reported to 
increase neutrophil activity and phagocytosis,by non-specific mechanisms but 
have also been reported to be largely inefficient in increasing protection to 
challenge with Vibrio anguillarum in this regime (Jeney and Anderson,1991,in 
press). 
The immune responses to the various parenteral and enteric delivery 
systems was measured by the direct quantitation of the plasma antibody levels,at 
selected times post-immunisation,after the administration of HGG with and 
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without adjuvant. The direct quantification of plasma antibody titres is the 
parameter most often studied in determining the efficacy of antigen delivery 
systems enterically and parenterally,in mammals and fish (Warren et 
al.,1986;Mestecky,1987;EIIis,1988) and presupposes specific cellular interactions 
for its generation (Sanderson and Walker,1991). 
The immunisation of O.mossambicus with HGG,in the absence of 
adjuvant,by the enteric (oral and anal) or parenteral routes (lP) resulted in 
plasma antibody generation curves that were very similar to those observed after 
the immunisation of the same antigen in an earlier study (see Chapter 6). 
Intraperitoneal (JP) immunisation with HGG,alone,resulted in levels of 
antigen specific antibodies in the plasma that were significantly greater than 
those achieved after the enteric delivery of the same immunising dose. lP 
immunisation resulted in peak levels of plasma antibodies 28 days post-
immunisation that were similar to those achieved earlier (see Chapter 6). JP 
immunisation of other soluble protein antigens in O.mossambicus also resulted 
in similar levels of antibodies to those observed in this study (Doggett,1989) and 
to those achieved after immunisation in other teleost species (Mughal et 
al., 1986;Davidson, 1991 ). 
The oral and anal delivery of HGG alone also resulted in similar levels 
of antibodies to those observed earlier (see Chapter 6),that were lower by 
comparison with those achieved after JP immunisation. As discussed in detail 
previously (Chapter 6) the enteric delivery of immunising doses of protein 
antigens in teleost fish generally results in lower plasma antibody titres than the 
lP immunisation of the same antigen (Doggett, 1989;Rombout et 
253 
a/.,1989b;Davidson, 1991). Conflicting evidence exists for the efficacy of the 
repeated enteric delivery of protein antigens. Thus,either the elevation of the 
resultant antibody response to levels approximating those achieved after 
parenteral immunisation occurs (Rombout et a/.,1989b;Davidson,1991) or no 
increased response is demonstrated (Doggett, 1989). 
The immunisation of HGG in combination with cholera toxin B-subunit 
resulted in an increase in the peak antibody levels observed after JP 
immunisation and an overall increase in the levels of plasma antibodies after 
oral and anal delivery. The parenteral delivery of HGG with cholera toxin B-
subunit resulted in the peak levels of plasma antibodies beimg detected 21-28 
days after both oral and anal delivery which were of a similar magnitude. The 
antibody generation responses detected after enteric delivery of HGG plus 
cholera toxin B-subunit were similar to those observed without adjuvant but 
appeared to be tenable at least 35 days post-immunisation. 
The delivery of cholera toxin B-subunit mixed or conjugated to soluble 
protein antigens,such as HRP,is reported to cause an increase in the antigen-
specific antibody response in the bile,intestinal mucus and serum (if delivered 
enterically),in humans (Langevin-Perriat,Lafont,Vincent,Revillard,Mazert, 
Gerfaux and Tron,1988) and other mammals (Mckenzie and Halsey,1984; 
Czerkinsky et a/.,1987;Czerkinsky et a/.,1991). The delivery of cholera toxin B-
subunit (or cholera holotoxin) mixed with Sendai virus primed for increased 
mucosal immunity as evidenced by increased levels of slgA in the gastro-
intestinal tract and increased levels of IgA,IgM and IgG in the serum but did not 
induce protective immunity in the upper respiratory tract of mammals (Liang et 
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a/.,1988). In contrast,the oral delivery of Streptococcus mutans protein I and Il 
with cholera toxin 8-subunit resulted in good mucosal responses (in the salivary 
glands) in the form of antibody titres and populations of antibody-secreting cells 
in the spleen,mesenteric lymph nodes,salivary glands and circulating in the blood 
(Czerkinsky et al.,1987;Czerkinsky et a/.,1991). 
The enteric delivery of cholera toxin 8-subunit has several direct 
immunological effects that may have consequences for both the quantitative 
(magnitude) and qualitative (type) resultant immune response (Lycke and 
Holmgren,1986;Kay and Ferguson, 1989a, 1989b;Lycke et al., 1989a, 1989b;van der 
Heijden et al., 1989;Ciarke et al.,1991;Lycke et a/.,1991;Quiding et al.,1991;van der 
Heijden et a/.,1991). The oral delivery of cholera toxin and cholera toxin 8-
subunit causes an increase in gut-permeability and specifically influences the T 
and B lymphocytes and antigen presenting cells in the intestine. It also affects 
the immune regulatory pathways via its action on cAMP levels,IL-1 and cell-
associated IL-1,early B-cell isotype differentiation (Lycke et al.,1991) and its 
inhibition of some T-cell functions (Clarke et al.,1991). Similar increases in 
antigen-specific local immunity were observed in humans,with increases in 
specific IgA,IgG and gamma-interferon levels and exhibited a classical secondary 
response (on antigen boosting) that was attributed to either natural killer or T-
cells (Guiding et al.,1991). 
The oral and anal delivery of antigen plus cholera toxin or its 8-subunit 
may also result in the generation of antibody-secreting cells that are migratory 
and eventually seed distant mucosae (van der Heijden et al.,1991) and 
furthermore may be associated with efficient immunological memory induction 
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(Lycke and Holmgren,1986). 
In the current study it appears that the increase in the antibody response 
observed after parenteral,and especially the enteric delivery of HGG with 
cholera toxin B-subunit is not exclusively due to the increased levels of antigen 
absorption in this delivery regime. It is likely that cholera toxin and its B-
subunit act,as they appear to do in mammals,in a manner such that they directly 
influence the immune regulatory pathways and enhance the immune response 
(Wilson,Ciarke and Stokes, 1989). It is also likely that such profound influences 
in antigen absorption,antigen presentation and general immune status will also 
manifest itself in the configuration of the antigen that reaches the plasma, which 
as evidenced earlier (see Chapter 5),may be important in the generation of an 
immune response and the abrogation of tolerance (as discussed in Chapter 6). 
The adjuvant effect of cholera toxin B-subunit on (the increase of) specific 
antibody levels is less by comparison with the increases in the plasma antibody 
levels after the delivery of HGG in various forms with Quii-A (see Chapter 6). 
However,several factors must be taken into account when making such direct 
comparisons including the increased detail and optimisation of the delivery 
systems in the Quii-A study and the possible substantial modification of aspects 
of the immune response by cholera toxin that were not monitored in this 
preliminary investigation (e.g. mucosal antibody responses,antibody-secretory cell 
responses,potential immunological memory induction and broad range 
alterations in cytokine levels). Further studies on the potential use of cholera 
toxin and cholera toxin B-subunit as adjuvants/targeting agents for enteric 
delivery systems in fish are merited,on the basis of the moderate enhancement 
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effects observed in this study. 
The parenteral immunisation of HGG adsorbed with aluminium 
hydroxide did not result m an increase in the levels of antibodies elicited. 
Antibody titres peaked after 35 days post-immunisation and were not 
significantly different from those observed after the lP immunisation of HGG 
without adjuvant. 
The oral delivery of HGG adsorbed with aluminium hydroxide resulted 
in peak levels of antibodies in the plasma after 28 days that were slightly greater 
than those achieved with HGG alone. Anal administration of HGG adsorbed 
with aluminum hydroxide resulted in peak levels of antibodies 35 days post-
immunisation that were greater than those obtained after immunisation with 
HGG alone,but levels did not differ between these two groups until this time. 
The antibody response after parenteral and enteric immunisation with HGG 
adsorbed with aluminium hydroxide were lower than the comparable groups 
immunised with cholera toxin B-subunit. The levels of antibodies generated 
were lower after enteric immunisation than expected if there was a direct 
correlation between the levels of antigen absorbed and the eventual immune 
response. 
Mammalian studies indicate that aluminium hydroxide is a moderate 
enhancer of humoral immune responses when adsorbed with the delivered 
antigen correctly (Edelman,1980;Warren et al.,l986;Warren and 
Chedid,1988;Lise and Audibert,1989). Aluminium hydroxide causes slow release 
of antigen at the site of delivery,the subsequent attraction of immunocompetent 
cells to the site of introduction of the antigen and the eventual stimulation of 
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production of both antibody forming cells in the regional lymph nodes (for 
subsequent dissemination throughout the body) and local plasma cell containing 
granulomas (Edelman,1980). Primary clinical immunisation with tetanus and 
diphtheria toxoid preparations is considerably enhanced by adsorption of these 
antigens to aluminium hydroxide (Aprile and Wardlaw,1966). Similarly the use 
of aluminium hydroxide was found to significantly increase the antibody response 
and clinical protection to disease for Salk polio vaccine preparations,rabies 
vaccme preparations and subunit influenza vaccines (consisting of 
haemmaglutinin and neuraminidase) (Potter,Jennings,McLaren,Edey,Stuart-
Harris and Brady, 1975;Saroso,Bahrawi, Witjaksono,Budiarso,Bencic,Dewitt and 
Gomez,1978;Kuwert,Menzei,Marcus and Majer,1978). They were 
effective,however,in vaccines that are likely to rely on a mucosally directed 
1mmune response to achieve significant clinical protection (Cvejtanovic and 
Uemura, 1965). 
It seems likely from the relatively moderate increases in the antibody 
titres after the enteric delivery of HGG adsorbed with aluminium hydroxide that 
this mode of delivery is not optimised in this study with respect to the ratio of 
the antigen to the adjuvant. There remains considerable scope for future 
analysis of aluminium hydroxide or the new generation of aluminium based 
adjuvants such as algammulin (Cooper and Steele, 1991) in enteric or parenteral 
antigen delivery systems in fish. 
The parenteral immunisation of HGG in combination with ammonium 
chloride resulted in an antibody response in the plasma that peaked 21 days 
post-immunisation with titres that were lower by comparison with the peak 
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specific titres achieved using cholera toxin B-subunit or without adjuvant. 
However it was similar to the response after the lP immunisation with HGG 
adsorbed to aluminium hydroxide. 
The oral delivery of HGG plus ammonium chloride resulted in levels that 
were statistically unchanged from control levels but were lower than the 
antibody titres generated after the oral delivery of HGG with either cholera 
toxin B-subunit or aluminium hydroxide. The anal delivery of HGG plus 
ammonium chloride resulted in considerably lower levels of antibodies than after 
oral and lP delivery of HGG with ammonium chloride and also than those 
achieved with the other delivery systems. The degree of reduction of the plasma 
antibody response was considerably less,after oral delivery of HGG with 
ammonium chloride,by comparison with the decrease in the antibody titre after 
anal delivery. This may be a reflection of the proposed decreased absorption 
of orally delivered ammonium chloride,after its passage through the stomach by 
comparison with anal delivery which avoids this and may be the reason for the 
disparity between antigen absorption after oral and anal delivery. An increased 
absorption of ammonium chloride,as evidenced from mammalian studies,caused 
a considerable reduction in the antigen presentation capacity of the enterocytes 
and the resultant immune response (Bland and Whiting,l990). The passage of 
the antigen through the enterocytes appears to be considerably affected by the 
lysosomotrophic action of ammonium chloride which subsequently affects the 
function of antigen presenting cells in the GAL T and it is this function of the 
enterocytes which is increasingly considered to be a fulcrum of immune 
responses initiated in the gut (Mayer,l991). 
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The current study represents the first,preliminary,investigation on the 
effects of three specific adjuvants,cholera toxin B-subunit,aluminium hydroxide 
and ammonium chloride,on the enteric and parenteral delivery of HGG in 
O.mossambicus. The requirement for the testing of these substances in oral 
delivery systems has been recently highlighted (McLean,1987;EIIis,1988; 
Davidson,1991} and further work is required to ascertain their exact modes of 
action in vivo and in vitro and to expand their use in experimental systems with 
other species. 
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FIGURE ~7:2. 
Figure 7.2 shows the ,temporal· absmption1 ofHGG :into ·the ,plasma,aJter 
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FIGURE 7.4. 
Figure 7.4 shows the temporal absorption of HGG into the plasma after 
the oral and anal delivery of lOmg/ml (0.2ml dose) 1:1 w/w with ammonium 
chloride (NH4Cl). Error bars are 75% limits. 
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FIGURE 7.7. 
Figure 7.7 shows the temporal antibody response in the plasma after the 
oral,anal and intraperitoneal (lP) immunisation with lOmg/ml (0.2ml dose) 
HGG in combination with 50J.Lg cholera toxin B-subunit. 
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FIGURE· 7.8~ 
Figure 7~8 shows the temporal antibody response in the plasma after the 
.orai,anal and intraperitoneal ~IP) ,immunisation with lOITlg/iiiJ (021Tll: dose) 
.HGG 'adsorbed 1:1 w/w with :aluminium hydroX:id~ (AlOH3). 
Fig. 7.8 Plasma antibody response after 
immunisation with HGG plus AIOH. 
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FIGURE 7.9. 
Figure 7.9 shows the temporal antibody response in the plasma after the 
oral,anal and intraperitoneal (lP) immunisation with 10mg/ml (0.2rnl dose) 
HGG mixed 1:1 wfw with ammonium hydroxide (NH4CI). 
Fig. 7.9 Plasma antibody response after 
immu~isatio~ wi.fh HGG plus NHCI. 
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CHAPTER 8. CONCLUDING REMARKS. 
There exists a requirement for the development of oral delivery systems 
for the administration of macromolecules and antigens in clinical,veterinary and 
aquacultural situations (Ellis,1988;0gilvie,l988; Ebrahim,1990). The enteric 
delivery of antigens of pathogens is the most logical route of immunisation to 
achieve a response specifically designed to maximise immunological protection 
at mucosal surfaces,and to induce the active expression of immunity in the 
secretions of the mucosae involved with the transmission of the pathogen into 
the host body. Oral delivery of antigens,potentially,combines relative ease of 
administration and opportunity for the rapid boosting of any immune response 
by the secondary delivery of antigens. Recently it has become increasingly 
evident that the delivery of antigen to the gut-associated lymphoid tissue may 
allow,under optimal conditions,the generation of a locally produced immune 
response rather than (or in addition to) the direct stimulation of a systemic 
(antibody) immune response that may be less effective (Mestecky and 
Eldridge, 1991). Additionally, the enteric delivery of antigens has also been 
shown to be able to disseminate the specificity of a generated immune response 
to diverse mucosae,distanced from the site of antigen introduction (gut),via 
antigen-specific B-cells committed to secretory immunoglobulin production 
(Czerkinsky et a/.,1991). 
However,the direct enteric delivery of antigen to the intestine often 
results in either a very poor immune response locally,or systemic 
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hyporesponsiveness to the antigen or both. The immunological mechanisms that 
affect such tolerogenic processes are complicated and only partially 
understood,even in mammalian investigations. Thus the oral administration of 
antigens requires the development of rationalised delivery systems that 
incorporate antigens specifically designed,or in such quantities,to avoid such 
tolerogenic responses. Incorporation of immunomodulatory substances 
(adjuvants) may overcome some of the barriers that exist to the efficient 
generation of a protective immune response. The design of oral vaccination 
regimes has also concentrated on the use of adjuvants not only to increase the 
overall (quantitative) level of the immune response but to also possibly induce 
an aspect of the immune response that would otherwise remain unstimulated 
such as aspects of cell-mediated immunity. 
The oral delivery of macromolecules,and specifically of stimulatory 
antigens,in fish has also been recognised as a primary requirement,especially for 
commercially important diseases such as furunculosis,salmon lice,vibriosis and 
bacterial kidney disease. It has also been viewed as the most convenient mode 
of vaccination ,for much the same reasons as those identified in clinical and 
veterinary situations as well as for the fact that it is a logistically convenient 
method for the delivery to large numbers of fish in aquaculture systems. Recent 
studies have localised and characterised the GALT in various fish species (Hart 
et a/.,1988) and have also shown,as in mammals,it is probably one of the major 
arms of the immune system. Phenotypically,the GALT of fish is very 
complicated and ultrastructural and functional studies have shown that all the 
component cell types required for the active generation of a primary immune 
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response are present (Hart et al.,1988;Rombout et al.,1989a,l989b;Davidson, 
1991). The enteric delivery of antigens,therefore,may potentially be able to 
induce an immune response,generated at the GALT,that can be protective for 
antigens from pathogens (Rombout et al.,1989b). Recent investigations have 
also demonstrated substantial evidence towards this,with intestinally delivered 
antigens being able to induce an antibody response and the possibility of the 
existence of a common mucosal immune system,in fish,being postulated 
(Rombout et al., 1989b;Davidson,1991). The absorption of orally delivered 
protein antigens may,physiologically,have roles that are divorced from those 
required for an oral vaccination regime per se. Absorbed protein antigens may 
contribute nutritionally to fish physiology although the significance of 
this,quantitatively,has been recently disputed (reviewed by McLean and 
Donaldson,1990). It has also been suggested that protein absorption may be 
associated with some mechanism of entero-pancreatic enzyme recirculation that 
operates in the fish alimentary tract. 
However,the current status of oral delivery systems for antigens from 
important pathogenic organisms remains,as it does in mammals,in a state of flux 
with rationalised delivery systems and adjuvants particularly suited for these 
delivery systems being largely unrealised and the availability of oral vaccination 
systems being poor (the most widely studied,and available,data from oral 
vaccination regimes remains those carried out with Salmonella typhi Ty21a and 
its derivatives, in humans)(Biack et al., 1990). 
The current study represents a detailed investigation of the design and 
use of oral delivery systems for the administration of a protein antigen,human 
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gamma globulin (HGG),to the cichlid teleost Oreochromis mossambicus. The 
enteric (oral and anal) delivery of HGG was monitored using a sensitive 
immunocytochemical detection system which allowed a chronological assessment 
of the absorption of the intact molecule,or its epitopes,across the intestine of 
these tilapia. The administration of HGG was altered by the incorporation of 
tbe saponin adjuvant Qui/laja saponaria [Molina] into the delivery system as 
either a direct adjuvant,as a three-dimensional immune stimulatory complex 
(ISCOM) or as a micellar delivery vehicle for the antigen. The incorporation 
of the adjuvant,in the delivery system,caused an increase in the absorption of 
HGG across the intestine of tilapia and an increase in the interaction of the 
absorbed antigen with GALT cells by a variety of mechanisms mostly visualised 
as alterations in the integrity of the lumenal membrane of the intestinal 
enterocytes. The observed (largely) transcellular absorption of the antigen 
corresponds to the observed effects of the delivery of Quit-A with antigens in 
mammalian studies (Maharaj et al., 1986;Mowat et al., 1991 ). 
The absorption of HGG into the blood plasma was monitored by the use 
of a sensitive ELISA assay system. Enterically delivered HGG was absorbed in 
a temporally complex manner into the plasma in amounts that were 
immunologically significant. The incorporation of Quit-A into the delivery 
system prior to,concurrently with,and as a delivery vehicle for the antigen 
significantly increased the levels of absorbed HGG over a narrow range of 
concentrations. This evidence represents a considerable improvement in the 
development of useful oral delivery systems,albeit for a test antigen, in fish where 
the circumvention of the reduced effective dose inherent after oral vaccination 
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procedures is a prerogative for the potential generation of an immune response. 
The qualitative nature of the delivered antigen reaching the intestine and 
the GALT is another major factor determining the eventual (immunological) 
fate of orally delivered antigens. The administration of HGG,alone,results in 
the appearance of the intact molecule in the plasma and a range of epitopes of 
various molecular weights. The gastric degradation of orally delivered antigen 
often results in the production of epitopes that mediate tolerogenesis by being 
in configurations that are particularly suited to the stimulation and induction of 
T-suppressor cells in the epithelium of the intestine (Michael,1989). The 
delivery of Quil-A resulted in alterations in the qualitative nature of the HGG 
absorbed into the plasma and in increasing the number and complexity of its 
fragmentation profiles. Quii-A delivery probably altered the nature of the 
processing undertaken of the antigen in the intestinal lumen and/or the 
intestinal enterocytes. The processing of orally delivered antigen by the 
intestinal enterocytes is increasingly being realised as a primary factor in the 
determination of the efficacy of the eventual immune response and IS 
susceptible,in vivo,to the addition of adjuvants (Bland and Whiting, 1990). 
The immune response,as measured by the antibody titres in the 
plasma,bile and cutaneous mucus,was considerably lower following enteric 
delivery of HGG alone,by comparison with the titres achieved after 
intraperitoneal immunisation. The inclusion of Quii-A in the delivery 
system,enterically,resulted in dramatically increased antibody responses in the 
plasma,bile and cutaneous mucus by comparison with immunisations without 
adjuvant. These increases in the immune response were probably mediated by 
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the aforementioned alterations in the levels of absorbed HGG,the alterations 
in its interactions whilst in the intestinal tissue,the changes in its fragmentation 
and by immunomodulatory affects of the adjuvant that were not studied and 
remain hypothetical in fish (e.g. possible an increase in the levels of interleukin 
release). Levels of antibody were also dramatically increased in the bile and 
cutaneous mucus suggesting that the incorporation of optimised Quil-A into the 
delivery system greatly elevated the specific mucosal immune response and lends 
a body of data towards the conclusion that there is a common mucosal immune 
response mechanism in teleosts that may be initiated by the judicious delivery 
of enteric antigens. 
The present study has also shown that cholera toxin and its B-subunit are 
potentially useful as targeting agents for the oral delivery of antigens in fish as 
their use caused both an increase in the levels of HGG absorbed and the 
subsequent plasma antibody response. Preliminary studies have also indicated 
that the enteric use of both aluminium hydroxide and ammonium chloride,at 
least in this test system,had little beneficial immunomodulatory effect. 
The current study illustrates that the immune response,to well 
characterised antigens,in teleost fish can be manipulated by the incorporation 
of the antigen in specifically tailored delivery systems. The precise composition 
of any potential oral delivery system will be dependent on the nature of the 
protective antigens from the specific pathogen and the requirement of the 
immune response to that pathogen i.e. the site of the immune response,the 
nature of the response (e.g. a cellular response is likely to be more efficacious 
than a humoral response for intracellular pathogens) and the degree to which 
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the delivered antigen will be absorbed and acted upon by the intestinal 
enterocytes. 
In order to achieve these aims future studies will have to generate 
considerably more basic information on the mucosal immune responses in fish 
with respect to the requirements for its efficient induction through a 
combination of in vivo and in vitro experiments and also to the nature of its 
potential dissemination from an immunisation site of the intestine i.e. the degree 
of its similarity to the mucosal immune response of mammals. In addition to 
this the extent of the degradation of the delivered antigen in both the lumen and 
in the intestinal enterocytes should be studied with the aim of discerning the 
role that the enterocytes have on antigen processing and presentation . Such 
information will lend itself to being able to avoid tolerogenic epitopes of vaccine 
antigens or to the manipulation of antigen processing functions so that the 
endocytic pathways which reveal them are diverted. The use of vaccine 
adjuvants will probably be essential to overcome some of the other problems 
inherent in oral vaccination such as the reduction in delivered antigen load due 
to gastric degradation. The practical use of oral vaccines for a particular fish 
pathogen will require a rationalised delivery system utilising specific antigens 
("classically",synthetically or recombinantly derived) and specific adjuvants 
tailored towards the induction of a useful,protective and sustained immune 
response. 
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APPENDIX L REAGENTS USED. 
A}. REAGENTS FOR IMMUNOHISTOCHEMISTRY AND 
IMMUNOCYTOCHEMISTRY (all volumes are per litre.unless 
stated). 
1) Phosphate buffered saline,PBS (pH 7.2-7.4). 
Sodium chloride,NaCI - 8g. 
Disodium hydrogen orthophosphate,Na2HP04 - 1.15g (anhydrous). 
Potassium dihydrogen orthophosphate,KH2P04 - 0.2g. 
Potassium chloride,KCI - 0.2g. 
2) Tris-Saline (pH 7.4) for the preparation of ISCOMS. 
O.lM Tris (Trishydroxymethylaminomethane) - 12.llg. 
O.OSM Sodium chloride,NaCI - 2.92g. 
3) Ammonium acetate for the dialysis of ISCOMS. 
O.OSM Ammonium acetate - 3.854g. 
4) Tris-saline (pH 7.6) for streptavidin-biotin-HRP 
immunocytochemistry. 
O.OSM Tris - 6.055g. 
0.15M Sodium chloride,NaCI - 8.766g. 
5) PBS (pH7.2) for immunogold silver staining. 
Sodium chloride,NaCI - 8.0g. 
Potassium chloride,KCI - 0.2g. 
Potassium dihydrogen orthophosphate,KH2P04 - 0.2g. 
Disodium hydrogen orthophosphate,Na2HP04.2Hp - 1.44g. 
6) Silver enhancement solution for immunogold-silver staining. 
a) lM Citrate buffer pH 3.5. 
12.7Sg Citric acid.H20 
11.75g Trisodium citrate.2Hp in lOOml D.Water. 
then: 
20ml Citrate buffer pH 3.5. 
30% w/v gum Arabic in D.Water- 33ml. 
17ml D.Water. 
Silver lactate- O.llg in 15ml D.Water. 
Hydroquinone - 0.8Sg in 15ml D.Water. 
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ID. REAGENTS FOR ENZYME-LINKED IMMUNOSORBENT 
ASSAY (ELISA). 
1) PBS pH 7.4 as in A). 
2) PBS-TWEEN. 
PBS (as above) plus 0.5% v/v TWEEN 20 (polyoxyethylene sorbitan 
monolaurate ). 
3) Bicarbonate/Carbonate coating buffer pH 9.6. 
Disodium carbonate,NaC03 - 1.59g. 
Sodium hydrogen carbonate,NaHC03 - 2.93g. 
4) Citrate/Phosphate conjugate/developing buffer,pH 5.0. 
Citric acid, - 4.23g (Anhydrous). 
Disodium hydrogen orthophosphate,NaHC03 - 5.80g anhydrous. 
5) Heparin -Anti coagulant for plasma collection. 
lOmg/ml Heparin in saline. 
6) Development substrate. 
Orthophenyldiamine (OPD) - 20mg in 
5ml Citrate/phosphate buffer plus 
20J.Ll H20 2• 
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Q.. REAGENTS FOR SODIUM DODECYL SULPHATE (SOS) 
POLYACRYLAMIDE GEL ELECTROPHORESIS (PAGE) .. 
1) Separating gel buffer (all volumes are lOOml,unless stated). 
Tris - 36.3g. 
N',N',N',N', -Tetra methylethylenediamine (TEMED)- 0.23ml. 
plus 90ml D.Water. 
pH to 8.9. 
Volume to lOOm!. 
2) Stacking gel buffer. 
Tris - 5.98g. 
TEMED - 0.46ml. 
to 80ml with D.Water. 
pH to 6.7. 
Volume to lOOm!. 
3) Separating gel solution. 
Acrylamide - 28.0g. 
N',N', -Methylenbisacrylamide - 0.74g. 
4) Stacking gel solution. 
Acrylamide - lO.Og. 
Bis-Aacrylamide - 2.5g. 
5) SDS-Solution. 
Sodium dodecyl sulphate,SDS,lauryl sulphate - 0.21g. 
6) 2X Sample buffer (reducing). 
Tris - 1.51g. 
Glycerol 20ml in 35ml D.Water. 
Adjust to pH 6.75. 
Add SOS- 4g. 
B-Mercaptoethanol - 10ml. 
Bromophenol blue - 0.002g. 
Volume to lOOm!. 
7) Electrode buffer (2.0 Litres). 
Tris - 6.05g. 
Glycine - 28.8g. 
SOS- 2g. 
pH at approximately 8.3 (unadjusted). 
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J21 REAGENTS FOR COOMASSIE BLUE STAINING OF 
ELECTROPHORESIS GELS. 
1) Coomassie blue solution. 
Coomassie brilliant blue-R - 1.25g. 
in 500ml of: 
Methanol - 400ml. 
Glacial acetic acid - 70ml. 
D. Water - 530ml. 
Filter (Whatman number 1 paper). 
2) Destain/Fixer. 
Methanol - 400ml. 
Glacial acetic acid - 70ml. 
D.Water - 530ml. 
3) Coomassie brilliant blue-G colloidal concentrate (BBG). 
A working solution of 800ml plus BBG. 
Add 4:1 working solution BBG : ANALAR methanol. 
Destain in 10% v/v acetic acid in 25% vjv Methanol. 
4) Fixing solution for BBG staining. 
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A 1:5 solution of 60% wjv trichloroacetic acid (TCA) plus 17.5% w/v 
Sulphosalicylic acid : D.Water. 
El REAGENTS FOR NEUTRAL SILVER STAINING OF 
ELECTROPHORESIS GELS. 
1) Fixer solution. 
30% v /v Ethanol - 300ml. 
10 v/v Acetic acid- lOOm!. 
D.Water - 600ml. 
2) Silver equilibration solution. 
Silver nitrate concentrate - 7.5ml. 
D.Water - 292.5ml. 
3) Development solution. 
Sodium carbonate - 30ml. 
D.Water - 120ml. 
Formaldehyde- 0.17ml. 
4) Stop solution. 
Acetic acid solution 1% v /v in D. Water. 
5) Reducer solution. 
Potassium ferricyanide - 2ml. 
Sodium thiosulphate - 4ml 
Sodium carbonate - 0.7ml. 
D.Water - 293.3ml. 
.fi REAGENTS FOR IMMUNOBLOTTING. 
1) Transfer buffer (2 Litre volume). 
Tris- 6.1g. 
Glycine - 28.8g. 
Methanol - 400ml. 
D.Water - 1600ml. 
2) Tris-saline (pH 7.5) for immunoblotting. 
Sodium chloride,NaCI - 11.68g. 
Tris - 6.05g. 
3) Tris-saline-milk (TSM) pH 7.4. 
Tris-saline (as in 2) plus 3% w /v "Marvel" very low-fat Dried milk. 
4) Ami do Black. 
Amido Black- 0.1% v/v. 
Methanol - 45% vfv. 
Acetic acid - 10% v /v. 
5) Amido Black destain. 
Methanol -90% v /v. 
Acetic acid - 2% v /v. 
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D.Water- 8% vjv. 
6) India ink. 
India ink - 100~-£1. 
PBST lOOml. 
Destain in PBS pH 7.2. 
7) Peroxidase blot development solution: 
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SOmg 3'3 Diamino benzidine tetrahydrachloride (DAB) in lOOml D.Water 
plus 100~-£1 H20 2• 
Q1 SOS-PAGE GEL MOLECULAR WEIGHT MARKERS. 
1) 6H High Molecular Weight markers. 
Carbonic anhydrase (Bovine erythrocytes) - 29kDa. 
Ovalbumin (Egg) - 45kDa. 
Bovine albumin (Plasma) - 66kDa. 
Phosphorylase B (Rabbit muscle) - 97.4kDa (subunit). 
B-Galactosidase (E.coli) - 116kDa (sububit). 
Myosin (Rabbit muscle) - 205kDa (subunit). 
2) 7H Low Molecular Weight Markers. 
a-Lactalbumin (Bovine milk) - 14.2kDa. 
Trypsin inhibitor (soybean) - 20.1kDa. 
Trypsinogen (Bovine pancreas) - 24.0kDa. 
Carbonic anhydrase (Bovine erythrocytes) - 29kDa. 
Glyceraldehyde-3-phosphate dehydrogenase (Rabbit muscle)- 36kDa. 
Ovalbumin (Egg) - 45kDa. 
Albumin (Bovine plasma) - 66.0kDa. 
3) Pre-stained molecular weight markers. 
Triose phosphate isomerase (Rabbit muscle) - 26.6kDa. 
Lactic dehydrogenase (Rabbit muscle) - 36.5kDa. 
Fumarase (Porcine heart) - 48.5kDa. 
Pyruvate kinase (Chicken muscle) - 58kDa. 
Fructose-6-phosphate kinase (Rabbit muscle) - 84kDa. 
B-Galactosidase (E.coli) - 116kDa. 
a 2-Macroglobulin (Human plasma) - 180kDa. 
4) Native (Non-denaturing) Molecular Weight Markers. 
a-Lactalbumin (Bovine milk) - 14.2kDa. 
Carbonic anhydrase (Bovine erythrocytes) - 29kDa. 
Ovalbumin (Chicken egg) - 66kDa (Monomer). 
Jack bean urease (Jack Bean) - 132kDa (Dimer). 
- 272kDa (Trimer). 
- 545kDa (Hexamer). 
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